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ABSTRACT 
X-ray crystallography is the most widely used method to determine the structure 
of proteins, providing an understanding of their functions in all aspects of life to advance 
applications in fields such as drug development and renewable energy. New techniques, 
namely serial femtosecond crystallography (SFX), have unlocked the ability to unravel 
the structures of complex proteins with vital biological functions. A key step and major 
bottleneck of structure determination is protein crystallization, which is very arduous due 
to the complexity of proteins and their natural environments. Furthermore, crystal 
characteristics govern data quality, thus need to be optimized to attain the most accurate 
reconstruction of the protein structure. 
Crystal size is one such characteristic in which narrowed distributions with a 
small modal size can significantly reduce the amount of protein needed for SFX. A novel 
microfluidic sorting platform was developed to isolate viable ~200 nm – ~600 nm 
photosystem I (PSI) membrane protein crystals from ~200 nm – ~20 μm crystal samples 
using dielectrophoresis, as confirmed by fluorescence microscopy, second-order 
nonlinear imaging of chiral crystals (SONICC), and dynamic light scattering. The 
platform was scaled-up to rapidly provide 100s of microliters of sorted crystals necessary 
for SFX, in which similar crystal size distributions were attained. Transmission electron 
microscopy was used to view the PSI crystal lattice, which remained well-ordered 
postsorting, and SFX diffraction data was obtained, confirming a high-quality, viable 
crystal sample. Simulations indicated sorted samples provided accurate, complete SFX 
datasets with 3500-fold less protein than unsorted samples. 
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Microfluidic devices were also developed for versatile, rapid protein 
crystallization screening using nanovolumes of sample. Concentration gradients of 
protein and precipitant were generated to crystallize PSI, phycocyanin, and lysozyme 
using modified counterdiffusion. Additionally, a passive mixer was created to generate 
unique solution concentrations within isolated nanowells to crystallize phycocyanin and 
lysozyme. Crystal imaging with brightfield microscopy, UV fluorescence, and SONICC 
coupled with numerical modeling allowed quantification of crystal growth conditions for 
efficient phase diagram development. 
The developed microfluidic tools demonstrated the capability of improving 
samples for protein crystallography, offering a foundation for continued development of 
platforms to aid protein structure determination. 
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CHAPTER 1 
INTRODUCTION 
 
1.1. Structural Biology and Proteins 
Life around us is governed by the cohesive operation of millions of biological 
entities such as proteins, which comprise the makeup of any living creature. An important 
step in understanding the major processes of this operation is discovering which proteins 
are involved, and establishing a database compiling their functions, activity levels, and 
location in the organism. This discovery process is very cumbersome as the protein is 
often isolated through a very complicated purification process. The mechanisms driving 
the biological process being studied can then be deduced by examining the structure of 
the protein in extreme detail to determine how the individual molecules and atoms 
comprising the protein interplay to convey its function. The number and types of 
functions of proteins are endless, but two examples with great societal impact are worth 
mentioning for context: solar energy and drug development.  
The former aforementioned example dates far into the past when the earth formed 
billions of years ago as an uninhabitable planet for humans and the species we coexist 
with. The atmosphere contained significantly less oxygen than the 21% we require to 
survive today. Hundreds of millions of years ago, evolution introduced autotrophs that 
undergo photosynthesis to oxygenate the atmosphere, which is governed by the cohesive 
functioning of photosystem proteins. Understanding the structures of these proteins can 
deduce the mechanisms behind the success of photoautotrophs at solar energy 
conversion, which is a pressing global issue in the quest to wean off fossil fuels. With a 
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greater understanding of bioenergetics, the exceptional abilities of nature can be 
translated to our own technologies to greatly improve sustainable energy efforts.1 
In the second aforementioned example, all diseases, in some form, affect proteins 
in our body and alter their functions, disrupting homeostasis and triggering physiological 
problems that cause temporary or permanent unfavorable health outcomes. The quest to 
impede and cure these dysfunctions is a major motivation for drug development as many 
pharmacological targets are proteins.2-4 For example, drugs that interact with cellular 
receptor or transporter proteins to combat biochemical alterations occurring in a disease 
state are often created to obstruct the pathway of disease (e.g. antihistamines, antivirals, 
antineoplastics, etc.). When successful, these treatments can significantly reduce disease 
morbidity and mortality toward a complete recovery in otherwise terminal illnesses such 
as cancer and viral infections. Because there are often thousands of biomarkers and 
possible pathways affected by a disease, effectively combatting complex diseases will 
require a multimodal medicinal regiment that targets various pathways involving unique 
proteins to provide therapy. 
 
1.1.1. X-ray Crystallography 
Determining the structure of a protein is important for a complete understanding 
of how the function of the protein is conveyed. The most practiced way of doing this is 
through X-ray crystallography, a technique responsible for solving 90% of the protein 
structures in the Research Collaboratory of Structural Bioinformatics Protein Data Bank 
(RCSB PDB), with the remainder being solved with nuclear magnetic resonance (NMR) 
or electron microscopy.5 The general workflow of X-ray crystallography begins with 
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purifying the protein sample from a crude biological source. The purification process is 
tailored to the source; however, for simplicity, two classes of proteins will be discussed. 
Soluble proteins are ubiquitous and as their name suggests, are soluble in aqueous 
solutions. The structures of these proteins have been determined most frequently due to 
their chemical stability and compatibility in many common solvents and buffer systems. 
To be water-soluble, the protein must have residues with chemical groups that are 
hydrophilic (namely polar) covering the majority of the surface of the protein exposed to 
water.6 Some very commonly studied, model soluble proteins include lysozyme (an 
antibacterial enzyme),7 xylanase (an enzyme that breaks down sugars in plants),8 
thaumatin (a low calorie sweetener),9 insulin (a hormone regulating glucose intake),10 and 
ferritin (a globular protein for iron storage),11 among many others. 
Membrane proteins are a second major class of proteins and comprise some of the 
most important and complex proteins known to date, including the photosystems 
(PSI/PSII),12, 13 G protein-coupled receptors (GPCRs),14 and ion channels.15 Again, as the 
name suggests, these types of proteins reside in a membrane (commonly the lipid bilayer 
of a cell) and provide access between the outer and inner areas of the system of interest 
(e.g. the cytosol and extracellular fluid surrounding a cell). Furthermore, these proteins 
exist in multiple environments with drastically different characteristics, thus the protein 
itself contains heterogeneous characteristics compatible with the local surroundings. 
Generally, they are amphipathic molecules in which domains within the membrane are 
hydrophobic and domains exposed to the cellular fluids surrounding the membrane are 
hydrophilic.6 Consequently, isolating and suspending the entire protein in an aqueous 
system for subsequent studies is very difficult because all chemical properties must be 
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satisfied to avoid denaturation and degradation. Yet, methods have been developed to 
accomplish this through the addition of lipidic detergents that stabilize the hydrophobic 
moieties to a buffer solution containing salts to stabilize exposed charges.16 
Purity of the isolated protein is key for growing a crystal comprising the protein, 
which is the next step in crystallography. An initial protein sample with ≥ 95% purity 
provides a more perfect protein crystal which is important to determine an accurate 
structure.17 Crystallizing a protein is very cumbersome and is the bottleneck of the entire 
structure determination process, hampering it by years in some cases. In an 
oversimplified view, a certain concentration of protein in solution is introduced to a 
precipitating agent (i.e. a precipitant) that reduces the solubility of the protein. As the 
solvent-protein interactions lessen, the protein begins to interact with itself to bring 
stability to the overall system. Under optimal conditions, this occurs in an ordered 
fashion to build a crystal (details on protein crystallization are discussed in Chapter 2, 
Section 2.4).17 The next step in X-ray crystallography is exposing the crystal to X-ray 
radiation, which diffracts from the atoms comprising the protein collectively as a 
diffraction pattern representing the protein structure. Currently, an individual protein 
molecule does not provide a detectable amount of diffracted signal from the light 
elements in its structure, which is why a crystal containing many protein molecules is 
needed. The diffracted X-rays from this ensemble of molecules constructively interfere to 
amplify the signal to a detectable regime.17 Once diffraction patterns are obtained, 
extensive data analysis is performed to convert the two-dimensional patterns into a three-
dimensional map of the electron density, commonly designated as the final structure with 
graphical software. The resolution of the data becomes important for maximum structural 
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detail, as atomic resolution on the order of a few angstroms is desired to see bonds in-
between atoms and atomic orientations. Resolution is a function of many factors 
including crystal quality and X-ray beam brilliance.17 Over the last few decades, 
synchrotron sources have provided high brilliance to achieve atomic resolution of large 
crystals; however, within the last few years, new X-ray laser technology has emerged that 
is disrupting the field and allowing groundbreaking structures to be determined, as 
discussed in the next section. 
 
1.1.2. Serial Femtosecond Crystallography (SFX) 
One requirement of traditional X-ray crystallography is a large protein crystal, on 
the order of a hundred micrometers in size. This is due to the scattering intensity being 
proportional to the ratio of the crystal volume to unit cell volume18 (e.g. small crystals 
comprised of large unit cells scatter weakly). Additionally, a single small crystal cannot 
tolerate the X-ray dose needed to attain a complete dataset due to repeated exposures at 
various scattering angles to cover all lattice planes.19 Many impactful proteins, namely 
membrane proteins, add a further layer of difficulty to the crystallization process and do 
not readily grow crystals of a suitable size for synchrotrons.20 Usually, the upper limit is 
in the ~ 1-10 micrometer range, which is a major reason why this class of proteins only 
comprises 2% of the protein structures deposited into the PDB.5 Within the past few 
years, X-ray free-electron lasers (XFELs) have been developed that are suitable for X-ray 
crystallography.21 This has allowed new classes of proteins to be studied by an emergent 
technique termed serial femtosecond crystallography (SFX).22 XFELs provide orders of 
magnitude greater beam brilliance and have extremely short pulses on the order of tens of 
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femtoseconds, allowing even the smallest nano- and microcrystals (< 2 µm) to produce 
detectable diffraction patterns at high resolution (< 2 Å) before they are destroyed. 
Furthermore, as a serial method, many crystals are delivered into the path of the X-ray 
beam to collect enough diffraction patterns for a complete dataset to determine the 
structure of the protein. SFX is a key motivation for the work presented in this thesis and 
the applications of this technology will be discussed further in ensuing chapters. 
 
 
Figure 1.1. General schematic of serial femtosecond crystallography. Adapted from 
Boutet et al.22 Reprinted with permission from AAAS. 
 
Unlike single-crystal X-ray crystallography where a large crystal is mounted in 
the path of the X-ray beam and rotated to obtain diffraction from many planes in 3D 
space,17 a continuous stream of different crystals with various sizes and orientations is 
sent into the path of the beam in SFX (Figure 1.1).23 The resulting patterns thus represent 
the same protein but have different features for several reasons. These include the crystal 
being exposed at different angles to the beam, having different numbers of protein 
molecules per crystal, and interacting with the full beam diameter to varying degrees. 
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Additional beam fluctuations are discussed in detail in Chapter 6. Analysis of SFX data 
becomes significantly different than that for single-crystal crystallography and improving 
the methods and tools to obtain an accurate structure has been an ongoing effort.24 In 
addition to developing and improving software algorithms and procedures for accurate 
data analysis, the sample itself can also be optimized to improve protein structure 
determination by SFX. 
 
1.1.3. SFX Sample Optimization 
Ideally, the exact same crystal at known orientations is introduced to the X-ray 
beam to provide consistent diffraction data that can be indexed with known parameters. 
This leads to several distinct pathways toward improving SFX: solving the random 
crystal orientation problem, the wide crystal size distribution problem, or a combination 
of both. Proposed methods to orient crystals in a controlled fashion are extremely 
complex considering the number of crystals in the sample stream, the speed they travel, 
and the generally small size of the crystals. While the products of protein crystallization 
for SFX usually have a nano/microscale modal size distribution, the wide range of crystal 
sizes existing in a sample aliquot is a parameter that could be controlled more readily. 
This is a foundation of the work presented in this dissertation and two possible avenues to 
accomplish this are explored: fractionating a bulk crystal suspension to generate a crystal 
sample with a narrowed size distribution and controlling protein crystal growth 
conditions to produce a desired size range. Since SFX is in its infancy and is a novel 
technology, new and unique problems arise and a platform to address them is needed. 
With crystal sizes for SFX generally ranging between 100 nm to 10 μm, microfluidic 
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devices with dimensions < 100 µm provide the ability to manipulate and control analytes 
on this scale, thus was used to build devices for SFX sample optimization and the 
advancement of crystallography. 
 
1.2. Microfluidic Technologies 
Microfluidics is a field involving systems that utilize small amounts of sample on 
the order of nanoliters using pathways and chambers on the order of tens to hundreds of 
micrometers (Figure 1.2).25 Generally, these chambers are referred to as channels and can 
be used to perform chemical and biological reactions and separations, among many other 
applications. Originally, these systems were created for analytical purposes26, 27 and have 
several general advantages: minimal sample and instrumentation requirements, 
economical fabrication, customizable, high precision, and multiplexability.28 Ancestors of 
microfluidics include commonly used and powerful instrumentation in separations 
science such as gas and liquid chromatography and capillary electrophoresis. As 
technology advanced over time, these systems improved in sensitivity and required less 
sample, leading to a new generation of microscale implementation.29 There was also a 
significant contribution from the microelectronics industry, which created the foundation 
for accessible fabrication of microfluidic devices. Microelectromechanical systems 
(MEMS) introduced photolithography procedures and instrumentation, which became 
one of the most widely used fabrication methods for microfluidics (discussed more in 
Chapter 2, Section 2.1). Some of the same materials for MEMS fabrication have been 
applied to microfluidic device fabrication, for example, patterning silicon wafers with 
photoresist and creating structures in glass materials.30 However, more recently, 
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microfluidic devices more clearly distinguish themselves from MEMS devices as 
polymers have become a favorable material for fabrication and experimentation is more 
chemical and biological in nature.31 Tying this into the applicability of microfluidic 
devices for crystallography, separations and biochemical processes (i.e. protein 
crystallization) are the major functions incorporated into the microfluidic devices 
demonstrated in the coming chapters. 
 
 
Figure 1.2. Photo of a microfluidic device setup. The chip is mounted to a 
fluorescence microscope with connected electrodes for the application of an external 
force, in this case an electric potential. 
 
1.3. Potential of Microfluidics to Improve Crystallography 
The versatility of microfluidic devices has been demonstrated through numerous 
implementations of particle separations and protein crystallization (see Chapter 2, 
Sections 2.3 and 2.5). Particles can be manipulated using the unique flow regimes found 
in microfluidic devices in addition to the variety of external forces that can be 
incorporated. Furthermore, highly controlled reactions can be performed on the 
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microscale via the selectable introduction of various reagents in desired proportions and 
flow rates, all of which can be quantitated and scaled-up for high-throughput, automated, 
and continuous operation. 
Protein crystallography can be improved using microfluidic devices. In a general 
sense, microfluidic crystallization has already been demonstrated using a variety of chip 
designs and methodologies in the literature. In all cases, sample consumption is 
significantly reduced, which alleviates the burden on precious protein resources. Most 
methods can also be parallelized for high-throughput screening to reduce the time 
requirement for protein structure determination. Taking it a step further, simple device 
fabrication and operation make the platform accessible to a wide range of laboratories. 
Lastly, incorporating a quantitative component enables an understanding of the 
crystallization conditions for a protein. Hence, the goal of making protein crystallization 
a routine step in crystallography becomes possible through the microfluidic devices 
referenced above and detailed in later chapters. 
An initial purpose of microfluidic devices was analytical applications, namely 
separations, some of which are summarized in Section 2.3. Consequently, microfluidic 
devices can be used for fractionation of heterogeneous crystal samples, namely to isolate 
nano/microcrystals with desired characteristics for SFX. One challenge with microfluidic 
devices is converting a proof of concept device operating in a controlled laboratory 
setting to a robust device for field-use. With SFX, the ideal scenario is to prepare crystals 
on-site at an XFEL facility and deliver them into the instrument as soon as possible to 
mitigate protein degradation. Chapters 4–6 detail the progression of building a 
microfluidic platform to optimize crystal samples for SFX from the initial proof of 
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concept study to the final application at the XFEL. With further advancements in this 
materialized microfluidic fractionation device (or others) and sample delivery 
technologies at XFELs, a single Lab-on-a-Chip device could be created for on-demand 
sample optimization for SFX. Improved sample quality would mature this 
crystallography method and progress protein structure determination. 
 
1.4. Dissertation Overview 
This dissertation describes the development and application of several 
microfluidic devices with the purpose of improving protein crystallography. Following 
this introductory chapter, an overview of the experimental and theoretical background of 
the major physical processes occurring within the developed microfluidic devices is 
discussed. A review of microfluidic devices incorporated with appropriate surface 
modifications for a vast variety of applications is then presented in Chapter 3. The 
remaining chapters are split according to the two major themes of this dissertation: i) 
microfluidic sorting of protein crystals by size for SFX sample optimization and ii) 
creating time and resource-conscious protein crystallization screening devices for X-ray 
crystallography. Chapter 4 examines the initial development of a proof of concept 
microfluidic sorting device operating on the principles of dielectrophoresis to fractionate 
nano- and microparticles. A theoretical study is presented showcasing synthetic particle 
sorting by numerical modeling, then confirmed experimentally with qualitative and 
quantitative characterization of particle size fractions. The capabilities of the device were 
then demonstrated by sorting protein crystals into narrowed, submicron size distributions. 
Chapter 5 continues with the development of the sorting platform by scaling-up the 
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device to accommodate high-throughput capabilities. An extensive modeling study to 
optimize device geometries is described and the device was again tested with synthetic 
particles and protein crystals to demonstrate its sorting capabilities. Chapter 6 culminates 
the work on microfluidic sorting with a detailed characterization of protein crystals sorted 
using a second-generation device. Fractions were quantitatively examined with several 
size analysis techniques and qualitatively characterized using imaging methods. The 
device was also operated on-site at an XFEL to directly apply the sorting mechanism to 
SFX, where sorted crystals successfully produced diffraction patterns. 
Chapter 7 shifts into the second major theme, protein crystallization. The first 
device implemented diffusion-based crystallization (modified counterdiffusion). A 
precipitant is introduced to a protein residing in a microchannel which then diffusively 
mixes along the channel to establish a concentration gradient of various crystallization 
conditions. The device was applied to both soluble proteins and membrane proteins. A 
numerical model of the diffusion process was also created and applied to develop parts of 
a crystallization phase diagram. Crystallization was also implemented into a microfluidic 
device to facilitate direct mixing of protein and precipitant (batch), as discussed in 
Chapter 8. In this case, a gradient generator was created to establish many different 
concentrations of protein and precipitant in separate wells for screening. A valve system 
was incorporated to isolate each well for crystal growth and analysis. A model was also 
developed for quantitative analysis of each well condition to develop phase diagrams. To 
close, Chapter 9 provides a summary with major conclusions of the work presented in 
this dissertation as well as future directions for continued development of microfluidic 
devices for protein crystallography. 
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CHAPTER 2 
EXPERIMENTAL AND THEORETICAL BACKGROUND 
 
2.1. Microfluidic Device Fabrication 
Microfluidic devices can be fabricated by a multitude of methods and materials 
that are continually being engineered and optimized (see Chapter 3 for a broad overview 
of examples). Some common materials used over the past few decades are glass and 
polymers such as polycarbonate, poly(methyl methacrylate) (PMMA), and 
polydimethylsiloxane (PDMS). Each have their own advantages and disadvantages and 
selecting one over the other is generally governed by the application at hand and 
available facilities. The microfluidic devices described in this dissertation were made 
with PDMS due to its favorable optical, electrical, and surface properties, chemical 
inertness, low cost, non-toxicity, and rapid prototyping capabilities. A robust lithography 
process originally developed by the Whitesides group was employed for fabrication.32, 33 
Prior to lithography, the microfluidic channel designs are drawn in CAD software and 
then etched (e.g. chrome deposited on glass) or printed on a transparency film at high 
resolution. The structures are then patterned onto a substrate such as a silicon wafer 
(similarly to MEMS fabrication) using an epoxy-based photoresist material.34 The 
general process involves exposing the photoresist material to UV light which changes its 
chemical properties. There are two types of photoresists: negative tone which is 
chemically altered in the presence of UV light to become insoluble in a development 
solvent (that normally strips it from the wafer) and positive tone which becomes soluble 
in the development solution when exposed to UV light. For this work, a negative  
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Figure 2.1. Overview schematic of microchip lithography. a) Photoresist is spin 
coated onto a silicon wafer. A photomask is placed above for UV exposure. b) After 
development, the exposed regions remain on the wafer. c) PDMS is poured onto the 
wafer and cured. d) The cured PDMS is removed with embossed channels and oxygen 
plasma treated with a glass slide. e) The two surfaces are brought together to seal the 
system. 
 
photoresist formula (“SU-8”) was used and is available in a variety of viscosities for 
different structure thicknesses.35 The photoresist is uniformly spin coated onto the wafer 
and the solvent component is evaporated by heating to improve adhesion to the silicon 
wafer and activate subsequent photochemical reactions. UV radiation (i.e. Hg i-line, 365 
nm) exposure of the transparent regions of the mask containing the channels is then 
facilitated by contact photolithography whereby the mask is placed in direct contact with 
the wafer to eliminate diffraction effects that reduce resolution (Figure 2.1a).36 To 
expedite cross-linking of the exposed regions, the wafer is heated followed by 
submersion in a development solvent to strip away the unexposed, soluble negative 
photoresist. What remains on the wafer are the structures comprising the microfluidic 
channels and features (Figure 2.1b). This master wafer is then used for soft lithography to 
stamp the structures into a deformable elastomer (i.e. PDMS).33, 37 PDMS comes as a kit 
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containing the polymer base and crosslinker which are usually mixed at a set ratio. The 
negative relief of the structures emboss into the uncured PDMS and after curing become 
stationary (Figure 2.1c) with a generally rectangular cross-section. 
The surface chemistry of PDMS consists of repeating units of [SiO(CH3)2]n, 
making it hydrophobic (contact angle > 90°) and uncharged in its native state.33 When 
fabricating microfluidic chips, the section of PDMS with embossed channels is bonded to 
another layer of material (usually another layer of PDMS or glass) to seal the channels. 
This bonding is accomplished by treating the surfaces with oxygen plasma (Figure 2.1d) 
which oxidizes the surface, generating a surface largely consisting of Si-OH groups. 
When these silanol groups interact with each other, a condensation reaction occurs to 
form an irreversible siloxane (Si-O-Si) bond.33 This method of creating a sealed system 
(Figure 2.1e) is much simpler than prior techniques for glass or other materials that 
require extreme heat, pressure, and/or voltage for long durations that can degrade the 
structures (e.g. anodic bonding).38 The surface chemistry change of PDMS after oxidation 
reduces the contact angle of the elastomer to < 40°, making it hydrophilic and compatible 
with aqueous solutions. This is an added benefit for microfluidics as it allows channels to 
be filled by capillary action alone. This surface conversion is not permanent, however, as 
hydrophobic recovery occurs due to the reorientation of internal Si-CH3 groups back to 
the surface over a period of several hours (and faster when heated).39 To oppose this 
recovery, the surface needs to be in contact with an aqueous solution which can be 
facilitated by storing filled channels under high humidity to prevent evaporation. 
Additionally, when plasma-treated channels are filled with solutions having a pH > ~ 3, 
the oxidized PDMS surface becomes negatively charged (Si-O-). This is important for 
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electrokinetic transport mechanisms (discussed in detail in Section 2.2) and compatibility 
with various ionic surface treatments to generate complex surface chemistries for a 
variety of applications (Chapter 3 provides an extensive review of chemical 
modifications of PDMS). 
 
2.2. Transport Phenomena in Microfluidic Channels 
Within microfluidic channels, there are a variety of transport processes that can 
move the bulk liquid and suspended analytes. In this regard, the versatility of 
microfluidics can be exploited based on the application at hand, for example, to 
determine which external forces to apply for transport. The processes pertaining to this 
dissertation are discussed in the following subsections. 
In a general sense, the motion of incompressible, Newtonian liquids is described 
by the Navier Stokes equation:40 
 
𝜌 (
𝜕𝒖
𝜕𝑡
+ 𝒖 ∙ ∇𝒖) = −∇𝑝 + 𝜇∇2𝒖 + 𝒇𝑏 (2.1) 
where 𝜌 is the liquid density, 𝒖 is the liquid velocity, 𝑝 is pressure, 𝜇 is the liquid 
viscosity, and 𝒇𝑏 is a body force acting on the liquid. As Eq. (2.1) represents the balance 
of momentum between inertial forces (left side of the equation) and other forces 
influencing the liquid flow, several terms can be neglected in the case of the microfluidic 
systems described in this work. The Reynolds number is an important parameter, as it 
represents the ratio between the inertial forces to the viscous forces driving the flow. For 
a rectangular microchannel (i.e. the cross section created using SU-8 photoresist), this 
can be equated to:40 
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𝑅𝑒 =
𝜌𝑣
𝜂
(
2𝑤ℎ
𝑤 + ℎ
) (2.2) 
where 𝜌, 𝜂, and  𝑣 are the density, viscosity, and velocity of the liquid, respectively, and 
𝑤 and ℎ are the width and height of the channel cross section, respectively. 𝑅𝑒 is 
generally < 1 for microfluidic dimensions, whereby laminar flow occurs (flow 
streamlines are parallel and in the same direction). Furthermore, the inertial terms on the 
left side of Eq. (2.1) can be neglected as viscous effects dominate the flow in microfluidic 
channels, which is characterized as Stokes or creeping flow. 
 
2.2.1. Pressure-Driven Flow 
Referring back to Eq. (2.1), under pure pressure-driven flow, the inertial terms in 
addition to the 𝒇𝑏 term (representing acting body forces) can be neglected, further 
simplifying the equation:41 
 −∇𝑝 + 𝜇∇2𝒖 = 0 (2.3) 
Pressure-driven flow can be implemented in several ways, including capillary action (as 
in Chapter 7), external pressure pumps (as in Chapter 8), and hydrostatic pressure due to 
imbalances in reservoir liquid levels at the ends of a microchannel. Capillary flow is a 
common way to fill a hydrophilic microfluidic channel (e.g. oxygen plasma-treated 
PDMS channels) and is driven by the capillary pressure (∆𝑝𝑐), which is defined for 
rectangular channels as follows: 
 
∆𝑝𝑐 = 2𝛿 [
cos(𝜃)
ℎ
+
cos(𝜃)
𝑤
] (2.4) 
where 𝛿 is the interfacial surface tension and 𝜃 is the contact angle of the channel 
surface. Once the channels are filled, there is generally liquid in the reservoirs at the ends 
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of the channels. If there are differences in the liquid levels (ℎ), hydrodynamic flow 
ensues (due to a gravitational hydrostatic pressure difference: ∆𝑝ℎ = 𝜌𝑔ℎ). This flow 
becomes insignificant when the liquid levels rebalance (ℎ → 0). 
The pressure-driven laminar flow profile in a microfluidic channel is related to the 
Hagen Pouiselle equation, which describes the velocity across the channel cross section 
by solving Eq. (2.3). Using a circular cross section for simplicity, this equates to:41 
 
𝑣(𝑎) =
∆𝑝
4𝜂𝐿
(𝑟2 − 𝑎2) (2.5) 
where ∆𝑝 is the pressure drop across the channel, 𝐿 is the length of the channel, 𝑟 is the 
radius of the channel, and 𝑎 is the distance from the centerline of the channel. The flow 
profile follows a no-slip condition at the channel walls, whereby 𝒖 → 0. By plotting 
Eq. (2.5), a parabolic flow profile arises, as drawn in Figure 2.2a. For rectangular 
channels, a complex Fourier series is required to solve for the two-dimensional cross-
sectional plane, but results in a similar parabolic profile obeying a no-slip condition.41 
 
2.2.2. Electroosmosis 
An alternative to pressure-driven flow is electroosmotic flow (EOF), which 
gained widespread use in capillary electrophoresis as a precise and homogeneous way to 
control liquid and analyte flow. Naturally, EOF was exploited in microfluidic devices for 
a variety of applications as it allows flow to be generated using the same external stimuli 
used for separations and other electrically-driven applications (e.g. the sorting devices 
described in Chapters 4–6). Specifically, EOF is powered by an electric field established 
in a microchannel, making it a type of electrokinetic phenomena. 
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Figure 2.2. Schematics of liquid flow in a microchannel (not to scale). a) Parabolic 
flow profile characteristic of pressure-driven flow. b) EDL formed at the microchannel 
wall. c) “Flat” flow profile characteristic of EOF. 
 
In order for EOF to be generated, the walls of the channel need to be charged, 
(e.g. buffers with pH > ~ 3 in plasma-treated PDMS channels).33 EOF depends on the 
presence of an electrical double layer (EDL) at an interface, i.e. where the channel wall 
and bulk liquid meet (see Figure 2.2b).42 Counterions in the bulk solution become 
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attracted to wall charges, the nearest to the wall becoming immobilized (designated as the 
“Stern layer”). Moving away from the wall, the Coulombic attraction decreases leading to 
a layer of free counterions termed the “diffuse layer”. Similarly, the EDL potential (𝜓) 
decays exponentially moving away from the wall, eventually reaching 0 mV in the bulk 
solution, as depicted by the green line in Figure 2.2b. For channel walls that are widely 
separated, the aforementioned 𝜓 distribution can be represented as follows:43  
 
𝜓(𝑦) = 𝜓𝑦=0 exp [−
𝑦
𝜆𝐷
] (2.6) 
where 𝑦 is the distance from the channel wall and 𝜓𝑦=0 is the EDL potential at the 
interface. The term 𝜆𝐷is the Debye length (the characteristic EDL thickness, usually ~ 
10-100 nm) and is governed by a variety of factors. In the case of a single, monovalent 
electrolyte:42 
 
𝜆𝐷 = √
𝜀𝑟𝜀0𝑘𝐵𝑇
2𝑁𝐴𝑒2𝐼
 (2.7) 
where 𝜀𝑟 is the relative permittivity of the bulk medium, 𝜀0 is the vacuum permittivity, 
𝑘𝐵 is the Boltzmann constant, 𝑇 is the temperature, 𝑁𝐴 is Avogadro’s number, 𝑒 is the 
elementary charge, and 𝐼 is the ionic strength of the bulk medium. 
Under the application of an electric field, the diffuse layer ions accelerate toward 
the cathode, creating a body force that drags the entire bulk solution, facilitating liquid 
flow. To account for EOF, the 𝒇𝑏 term in Eq. (2.1) becomes 𝜌𝑒∇𝛷, where 𝜌𝑒 is the net 
charge density of the EDL and 𝛷 is the total electrical potential, which in microfluidic 
chips is designated as the externally applied voltage (𝜓 is negligible in comparison). To 
determine the EOF velocity (𝒖𝐸𝑂𝐹), the Navier Stokes Equation (Eq. (2.1)) is solved in 
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which inertial and pressure terms are neglected. The body force terms 𝜌𝑒 and ∇𝛷 are 
represented by 𝜓 and electric field strength (𝑬), respectively, to obtain:42 
 
𝜂
𝑑2𝒖𝐸𝑂𝐹
𝑑𝑦2
− 𝜀𝑟𝜀0
𝑑2𝜓
𝑑𝑦2
𝑬 = 𝟎 (2.8) 
Solving for 𝒖𝐸𝑂𝐹 and considering 𝜓 equals the zeta potential (𝜁) at the shear plane 
(Figure 2.2b), the Helmholtz-Smoluchowski equation results, describing the velocity 
profile of EOF (Figure 2.2c) and the EOF mobility (𝜇𝐸𝑂𝐹):
42 
 
𝒖𝐸𝑂𝐹 =
𝜀𝑟𝜀0𝜁
𝜂
𝑬 = 𝜇𝐸𝑂𝐹𝑬 (2.9) 
 
2.2.3. Electrophoresis 
Another common transport phenomena in microfluidic devices is electrophoresis, 
which is the movement of charged particles under the influence of an electric field.44 This 
is the second type of electrokinetic process, yet applies to particles rather than bulk liquid 
flow. For electrophoresis to occur, particles must be charged and the bulk liquid must be 
conductive whereby cations migrate toward the cathode and anions migrate toward the 
anode. This is due to an electrical force equal to the product of the charge of the ion (𝑞) 
and electric field strength (𝑭𝐸𝑃 = 𝑞𝑬).
44 Similar to EOF, the overall electrophoretic 
velocity (𝒖𝐸𝑃) can be defined as follows:
44 
 
𝒖𝐸𝑃 =
𝜀𝑟𝜀0𝜁𝑝
𝜂
𝑬 = 𝜇𝐸𝑃𝑬 (2.10) 
Where 𝜁𝑝 is the zeta potential at the particle/liquid interface and 𝜇𝐸𝑃 is the electrophoretic 
mobility. When particles are highly charged, 𝒖𝐸𝑃 can play a significant role in the total 
electrokinetic flux; however, in the systems described in this dissertation, the particles 
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were often negligibly charged, thus 𝒖𝐸𝑃 was disregarded and EOF was assumed as the 
significant electrokinetic contribution. 
 
2.2.4. Dielectrophoresis 
A second particle transport phenomena is dielectrophoresis (DEP), which is the 
main mechanism used to separate particles in Chapters 4–6 (discussions of DEP theory in 
relation to the microfluidic separations devices can be found in those chapters). The term 
was originally coined by Pohl, who defined DEP as the translational motion of a 
polarizable particle in the presence of a non-uniform electric field.45, 46 Contrary to 
electrophoresis, the particle does not need to be charged (but must be polarizable) and the 
electric field must be inhomogeneous. These two criteria can be explained by examining 
how DEP arises and induces particle transport. 
Classically, a dipole exerts a time-averaged force (𝑭) given by the following 
equation:46 
 𝑭 = (𝒑 ∙ ∇)𝑬 (2.11) 
where 𝒑 is the effective dipole moment, which is defined for a homogeneous dielectric 
sphere by the following equation: 
 
𝒑 =
4
3
𝜋𝑟3𝛼𝑬 (2.12) 
where 𝛼 is the polarizability of the particle, defined as:47 
 
𝛼 = 3𝜀𝑚 (
𝜀𝑝
∗ − 𝜀𝑚
∗
𝜀𝑝∗ + 2𝜀𝑚
∗) = 3𝜀𝑚𝑓𝐶𝑀 (2.13) 
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where 𝜀𝑝
∗ and 𝜀𝑚
∗ are the complex permittivities of the particle and medium, 
respectively, and 𝑓𝐶𝑀 is the Clausius-Mossotti factor. Combining Eqs. (2.12) and (2.13) 
leads to: 
 𝒑 = 4𝜋𝑟3𝜀𝑚𝑓𝐶𝑀𝑬 (2.14) 
Further, combining Eqs. (2.11) and (2.14) allows the time-averaged DEP force (𝑭𝐷𝐸𝑃) to 
be formulated:47 
 𝑭𝐷𝐸𝑃 = 2𝜋𝑟
3𝜀𝑚𝑓𝐶𝑀∇|𝑬𝑟𝑚𝑠|
𝟐 (2.15) 
The sign of 𝑭𝐷𝐸𝑃 is directed by the sign of 𝑓𝐶𝑀, which is related to properties of 
the particle and medium. For example, if 𝜀𝑚
∗ > 𝜀𝑝
∗, the force is negative resulting in 
negative DEP (nDEP), and in the opposite case, positive DEP (pDEP) arises. The 
complex permittivity (𝜀∗) can be expanded as follows: 
 𝜀∗ = 𝜀 − 𝑖
𝜎
𝜔
 (2.16) 
where 𝜎 is the conductivity and 𝜔 is the frequency of the applied electric field. 
Experimentally, the frequency dependence of DEP can be examined, whereby the 
frequency at which pDEP behavior changes to nDEP can be determined (termed the 
cross-over frequency). Furthermore, under DC and low-frequency AC electric fields, the 
frequency terms become negligible. Expanding 𝑓𝐶𝑀 with Eq. (2.16), segregating 𝜎 by 
rearrangement, and considering 𝜔 → 0 allows 𝑓𝐶𝑀 to be redefined as follows: 
 𝑓𝐶𝑀 =
𝜎𝑝 − 𝜎𝑚
𝜎𝑝 + 2𝜎𝑚
 (2.17) 
where 𝜎𝑝 and 𝜎𝑚 are the conductivities of the particle and medium, respectively. In this 
case, 𝜎𝑚 can be adjusted experimentally to induce a pDEP or nDEP response. 
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Figure 2.3. Generic schematic of DEP. a) In pDEP, the particle has a greater 
permittivity/conductivity than the medium and is attracted toward the high electric field 
gradient at the cathode. b) Conversely, in nDEP, the particle is repelled from the high 
electric field gradient and moves toward the anode. 
 
Examining Eq. (2.15), the ∇𝑬𝟐 term represents the gradient of the electric field 
squared, which is generated with non-uniform electric fields (Chapters 4–6 describe 
methods to accomplish this with microfluidic devices). In a simplistic case, this scenario 
can be represented by an electric field created between two dissimilar shaped electrodes 
(Figure 2.3). Additionally, the particle response in a non-uniform electric field under both 
pDEP and nDEP conditions can be represented. In the former (Figure 2.3a), particles that 
are more polarizable than the medium (due to having a higher permittivity or 
conductivity) gather more charge within, resulting in the effective dipole being aligned 
with the electric field, thus moving the particle toward high field regions (i.e. toward high 
∇𝑬𝟐). Conversely, in nDEP (Figure 2.3b), the effective dipole is aligned against the 
electric field, moving particles toward low field regions (i.e. away from high ∇𝑬𝟐).47 
Exploiting this transport process allows controlled particle migration in microfluidic 
devices for a variety of applications. 
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2.2.5. Modeling Transport Processes with Finite Element Analysis 
The transport processes described in the previous subsections can be modeled 
within complex microfluidic channel designs using finite element analysis, namely with 
software packages such as COMSOL Multiphysics.48 Modeling is a critical step as it 
allows the system of interest to be studied with various microfluidic designs for 
optimization prior to fabrication, in addition to providing insight into initial experimental 
conditions for the application at hand. Finite element analysis discretizes a complex 
geometric structure with various applied boundary conditions into many smaller domains 
defined by a “mesh” structure and solves the mathematical inputs representing the global 
conditions for each small domain separately. These inputs are incorporated into a system 
of partial differential equations in two or three-dimensions and solved for under a 
stationary or time-dependent state, depending on the set model type and physics being 
studied. For the models described in the coming chapters, three major components were 
solved for (equations and further details can be found in Chapter 4, Section 4.3): (i) the 
transport of species in the microchannels by either pressure gradients, EOF, and/or DEP 
whereby a convection and diffusion equation equates the flux of the species, (ii) the fluid 
flow profile due to pressure-driven flow or EOF by solving the Navier-Stokes equations, 
and (iii) the electric field profile and field gradients to be incorporated into the EOF and 
DEP velocity equations used to determine species flux and the flow velocity profiles. The 
solutions to the elements are then combined to approximate the result of the entire 
structure (i.e. the set domain where a given type of physics is applied) by minimizing the 
error in the solution through an iterative solver process. The size and shape of each 
element can be controlled, in addition to many other parameters to promote convergence 
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toward a solution to the complete numerical model (e.g. specifying initial conditions to 
provide a foundation for the partial differential equation solver). Each of the devices 
described in Chapters 4–8 were modeled using tailored geometries, parameters, and 
boundary conditions appropriate for their experimental counterparts, thus further details 
on the individual models can be found in those respective sections. 
 
2.3. Examples of Transport in Microfluidics for Separations 
Transport processes play a key role in particle separations, namely those unique to 
microfluidic devices, which has led to extensive and widespread development.49 In 
addition to protein crystal fractionation, there are several major implementations of 
separations science in microfluidic devices which will be summarized here. 
 
2.3.1. Passive techniques 
Passive separation methods do not rely on externally applied fields and operate 
based on channel geometry, the unique liquid flow effects at the microscale, and sample 
behavior and interactions. These methods offer the benefit of not requiring any external 
forces when conserving energy is a priority, but generally suffer from reduced separation 
efficiencies. 
A common passive separation method is pinched flow fractionation (PFF) which 
is established with two converging inlet liquid lines, one containing the analyte(s) of 
interest and the other containing the same liquid with no analyte(s) (Figure 2.4a).50 A key 
to PFF is laminar flow allowing the analyte-free solution to focus the particle-containing 
solution within a narrow “constriction” channel region. In this region, particles move 
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with flow streamlines in accordance with their size: small particles tend to migrate 
toward streamlines near channel walls and large particles, excluded from the area nearest 
the wall due to their size, move toward streamlines in the center of the device. Once 
differential migration occurs, the particles enter a wider channel and remain in separate 
streamlines due to laminar flow where they can be collected into separate outlets.51 For 
PFF to work, the focused liquid stream width must be smaller than the diameter of the 
smallest particle. PFF can also be enhanced by combining other effects such as inertial 
sedimentation in curved channels and centrifugation allowing particles with different 
densities to be separated.52 Furthermore, valves can be incorporated to tune flow rates 
into outlet channels. When the flow rate is decreased in the side outlet channel adjacent to 
the constriction channel, maintenance of larger particles in the central flow path is 
enhanced while smaller particles attracted to the constriction walls remain in a pathway 
toward the adjacent outlet, causing separation.53 
Inertial fractionation has also been applied in microfluidic devices operating on 
the physics of two types of lift forces: shear-gradient and wall-effect.54 The former is due 
to the parabolic profile of pressure-driven flow forming a transverse velocity gradient 
from the channel centerline that causes particles to move toward the higher gradient 
region approaching the channel wall (this is the mechanism behind PFF). The latter 
occurs when the flow profile near a channel wall is disrupted by a dramatic increase in 
channel width. At this interface, turbulent flow develops near the wide channel walls 
which provides a lift force repelling the particle opposite the shear-gradient lift force. The 
magnitude of this laterally occurring wall-effect lift force is dependent on particle size, 
with larger particles driven centrally to a greater extent than small particles, facilitating 
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separation. Microchannels with varying narrow and wide channels can be used to induce 
both effects whereby in the narrow channels, shear-gradient lift drives particles toward 
the walls and as the particles enter a wide channel, wall-effect lift repels them. In a 
repetitive design, large particles focus toward the center of the device away from small 
particles that remain nearer the channel walls forming separate streams that can be 
collected into distinct outlet channels (termed MultiOrifice Flow Fractionation, see 
Figure 2.4b).55, 56  
 
 
Figure 2.4. General schematics of microfluidic chips for separations. a) Pinched-flow 
Fractionation. b) MultiOrifice Flow Fractionation. c) Deterministic Lateral Displacement. 
(d) Active separations where the applied stimuli could be any from Subsection 2.3.2, 
either embedded or externally applied in a reservoir. In all cases, small particles are 
designated by red arrows and large particles by blue arrows. 
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Inertial fractionation has also been performed in spiral microchannels in which a 
centrifugal drag force component acts in addition to the lift forces.57 The drag force is 
caused by a secondary outward flow known as Dean flow, formed due to a decreasing 
pressure gradient from the inner to outer channel walls balanced by an inward flow at the 
channel ceiling and floor to satisfy the conservation of mass, creating cross-sectional 
turbulence. With this additional drag force, small particles near the channel ceiling and 
floor (due to the shear-gradient lift force) migrate toward the inner wall of the spiral. 
Conversely, large particles residing in the midplane of the channel cross section (due to 
the wall-effect lift forces) move toward the outer channel wall. 
An additional practiced passive separation scheme is deterministic lateral 
displacement (DLD).58 Devices implementing DLD consist of an array of post structures 
within a channel that cause particles to displace due to laminar flow properties around the 
posts at a magnitude related to the size of the particle (Figure 2.4c). Each row of posts is 
slanted at a set angle to induce a lateral shift in the laminar flow profile which 
accumulates down the rows of posts toward the outlet. Particles separate by following 
different flow streamlines in-between the posts with the theoretical number of streamlines 
equal to the number of rows between the initial and final row of the array. Furthermore, 
the width of each theoretical fluid stream depends on the total number of streams and the 
post width. This stream width determines the behavior of particles based on their size: If 
the center of mass of the particle falls within the theoretical stream width, it will follow 
that streamline and zig-zag through successive post rows without displacing laterally. 
Conversely, particles with a greater critical diameter than the stream width move laterally 
into different flow streams as they move down the channel due to the angular array 
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geometry, separating from the smaller particles. By having various post array geometries 
throughout the device, the critical diameter changes dynamically, allowing particles with 
more than two sizes to be separated. 
 
2.3.2. Active techniques 
Active techniques rely on an external stimulus to drive fractionation (Figure 2.4d) 
and generally yield greater separation efficiencies and control over particle migration. 
One such force is magnetic which drives separations in magnetophoresis.59, 60 This 
technique requires the analyte to have magnetic properties which can limit its 
applicability. Particles are flowed into the microchannel and differentially trapped or 
deviated into channels based on their magnetic force, causing separation. As many 
particles are not naturally magnetic (e.g. cells), labeling is often necessary to induce 
differential magnetic properties. In one example, a magnetic substrate was patterned onto 
a channel wall which caused magnetic particles to trap under the application of a 
magnetic field, while non-magnetic particles flowed unhindered. An additional 
magnetically-active side channel can be added to pull the trapped particles into a separate 
collection area.61 Additionally, an “H-filter” design can be used. It contains separate 
inlets with particles and focusing buffer flowing into a single channel. A magnetic field is 
applied along one wall of this middle channel to laterally displace magnetic particles into 
the focusing buffer toward a separate outlet channel. This can also be scaled-up to 
include multiple outlet channels to isolate various particle sizes based on their 
magnetophoretic force displacement. 
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Fractionation by optical stimulus is also possible using optical tweezers.62, 63 In 
this case, when light is scattered from a particle, a force is generated due to the change in 
momentum of the scattered photons relative to the incident beam. Because the beam has a 
Gaussian intensity profile, the particles move toward the maximum intensity at the center 
of the beam when the refractive index of the particle is less than that of the medium. 
Laser parameters such as wavelength and channel geometry can be adjusted to establish a 
differential force for separation and using filters and mirrors, intricate optical landscapes 
can be developed, yet often require complex instrumentation. 
Acoustic waves can also be applied as an external force, generated on-chip using 
transducer electrodes to drive particles in acoustophoretic fractionation.64, 65 The acoustic 
force is dependent on particle size and the densities of the medium and particle and can 
be applied in microchannels similarly to the other active mechanisms. Particles can be 
driven into a channel and focused hydrodynamically, then passed through acoustic waves 
where they laterally migrate to an extent based on their acoustic force (related to their 
size and density) into collection channels. Conversely, particles from narrow inlets can 
disperse into a wide channel and refocus into the center of the channel to an extent based 
on their acoustic force, followed by collection into outlet channels. 
The final active fractionation method is driven by electrical force. In short, 
particles can be fractionated based on their size and intrinsic electrical properties 
allowing them to be deviated differentially in the presence of an electric field. Within 
microfluidic devices, the electric field can be easily established and creatively directed to 
guide particles into channels or to concentrate them in traps. Two major methods exist: 
electrophoresis (Subsection 2.2.3) and DEP (Subsection 2.2.4). Electrophoresis is 
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generally performed using a T-shaped channel system, whereby the sample plug is driven 
into a separation channel by EOF using a gated or pinched injection scheme.66-68 
Electrodes are placed at the ends of channels to establish a uniform electric field whereby 
analytes differentially migrate toward an outlet electrode based on their 𝒖𝐸𝑃. This causes 
separation, in which each analyte is detected downstream by a variety of methods. DEP is 
implemented slightly differently as a non-uniform electric field is required. This can be 
generated by patterning electrodes within channels or using insulating materials to 
manipulate electric field lines by incorporating posts, alternating channel geometries, or 
other creative techniques.69-71 Furthermore, sample can be driven through the channels 
using EOF or by decoupling fluid dynamics with pressure-driven flow. DEP will be 
discussed extensively throughout Chapters 4–6 as it is the selected mechanism used 
within the developed sorting devices to fractionate crystal samples for SFX. 
 
2.4. Protein Crystallization 
2.4.1. Overview and Process 
A critical step in protein structure determination using crystallography is the 
growth of the protein crystal. This step is the bottleneck of the entire workflow as it is 
unfortunately largely empirical and the least understood. This problem can be attributed 
to the extreme complexity and diversity of proteins, making it initially difficult to purify 
the protein from its source and then create a universal recipe for protein crystallization.72 
Furthermore, proteins exist in their native environments with little tolerance for change, 
therefore precise and stable conditions must be maintained throughout the process to 
avoid denaturation. To form the crystal, protein molecules must interact with each other 
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in an ordered fashioned to build the lattice. This adds another layer of complexity, as 
protein molecules can have a variety of interactions (leading to inconsistencies in growth) 
and generally have low numbers of crystal contact zones, all largely governed by 
characteristics of their structure and the surrounding solution. These characteristics lead 
to internal disorder and reduced crystal structure rigidity, allowing multiple protein 
conformations to exist in a single crystallization event, further complicating the crystal 
growth process.73 
On a molecular level, the protein crystallization process can be grouped into three 
major steps: nucleation, growth, and termination.74 To begin the process, the protein 
solution needs to be supersaturated (i.e. taken beyond the solubility limit of the protein), 
which can be accomplished by changing the solution properties such as pH, temperature, 
etc. or by adding a precipitant. There are a large number of precipitants that have been 
used, but two that are commonly employed are salts and large polymers such as 
polyethylene glycols (PEGs). Salts compete with the protein for the solvent water 
through ionic interactions, depriving the protein of solvent beyond its solubility limit, 
whereas PEGs exclude the protein from the solvent by occupying a significant amount of 
space in solution. The exact mechanics of protein crystal nucleation are dynamic and still 
under debate, but can be approximated using classical nucleation theory which defines 
the rate at which nucleation events occur (𝑅𝑁) as follows:
75 
 
𝑅𝑁 = 𝜌𝑆𝑍𝑗 exp (
−∆𝐺∗
𝑘𝐵𝑇
) (2.18) 
where 𝜌𝑆 is the number density of nucleation sites, 𝑍 is the probability factor of the 
nucleus proceeding toward complete growth, 𝑗 is the rate at which molecules contact the 
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nucleus, ∆𝐺∗ is the free energy of nucleation, and 𝑘𝐵𝑇 represents the thermal energy. As 
shown, ordering molecules is energetically unfavorable, thus an activation barrier needs 
to be overcome for the crystal to grow. Additionally, available nucleation sites and 
molecules in the vicinity of the nucleation site are needed. After a stable, energetically 
favorable nucleus forms, growth proceeds in a non-equilibrium fashion as the free energy 
of the protein in the crystalline state is lower than that in the solution state. During 
growth, protein is depleted near the crystal and is replenished by diffusion in most cases. 
Crystal growth is generally governed by two main mechanisms: two-dimensional 
nucleation along the surface of the crystal or screw dislocation whereby part of the crystal 
surface is raised by one lattice vector exposing a perpendicular boundary for growth in a 
spiral fashion.74 Protein molecules must orient themselves correctly for proper interaction 
and ordered growth, in which slow nucleation by gradual supersaturation is often ideal to 
avoid non-ordered aggregation. The third and final step, termination, occurs when the 
local crystal environment becomes depleted of protein, returning to a thermodynamic 
equilibrium state below the solubility limit. This can occur once all available protein is 
incorporated into the crystal or if diffusion is too slow at introducing more protein 
molecules to the local crystal growth area.74 
 
2.4.2. Phase Diagrams 
Once crystal growth occurs under a given condition, a way to map known 
nucleation/growth conditions for a protein is essential toward improving and optimizing 
crystallization. Furthermore, this provides a starting point for crystallizing similar 
proteins. Thermodynamically, crystal growth is separated into two phases: the solid  
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Figure 2.5. Example protein crystallization phase diagram. The various zones and 
solubility curve are labeled for a scenario where increasing concentration transitions from 
the undersaturated to the precipitation zone. The blue dashed arrow represents the path an 
FID experiment follows and the orange dashed arrow shows the path a batch experiment 
follows. 
 
crystalline phase and surrounding liquid phase. Kinetic factors come into play as well, 
thus the classical phase diagram is modified to instead represent crystal growth outcomes 
such as observed crystal growth or aggregate formation under various conditions.74 
Nevertheless, the complexity of the molecular processes and experimental variables 
(including precipitant variety and screening method) only realistically allow attaining a 
simplified version of this information. Consequently, crystallization phase diagrams 
generally compare protein concentration to the concentration of one or two components 
of the precipitant (or other factors influencing crystallization) and their combined 
relationship to phase information.76 An example is illustrated in Figure 2.5, whereby 
several common phases or zones are marked: undersaturated, metastable, nucleation, and 
 36 
precipitation. The boundary between the undersaturated and metastable zones constitutes 
the solubility line for the system, which is the equilibrium position between the liquid and 
solid phase. Nucleation and crystal growth do not occur in the undersaturated region 
because the protein is below its solubility limit, and in the metastable zone, nucleation 
does not occur because supersaturation is too low, however crystal growth from a formed 
nuclei can proceed. The nucleation zone is the ideal region to seek as spontaneous crystal 
growth occurs, unlike the neighboring precipitation zone where supersaturation is too 
large, leading to aggregation and amorphous precipitate.76 To reach these zones, there are 
several strategies to set up a crystallization scheme to drive supersaturation, two of which 
are relevant to this dissertation.  
 
2.4.3. Crystallization Methods 
While there are many important techniques to supersaturate a protein in solution, 
the two methods of relevance are free-interface diffusion (FID) and batch. In traditional 
FID, the protein and precipitant solution are interfaced with each other in a capillary by 
stacking solutions of differing densities.17 Over time, the two solutions diffuse into one 
another, polling the phase diagram. As shown in Figure 2.5 (blue dashed arrow), the 
pathway of the protein can be traced from a high initial concentration that gradually 
decreases as precipitant concentration increases from diffusive mixing. Once the 
conditions enter the nucleation zone, crystal growth proceeds until the solubility limit is 
surpassed. A modified version of FID similar to that employed in Chapter 7 known as 
counterdiffusion operates on an analogous principle, yet the protein is spread out in a 
capillary (i.e. a microfluidic channel) and a small amount of precipitant is added to one 
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end to diffuse into the protein-filled channel, leading to a concentration gradient of 
crystallization conditions.77 Within that one channel, many conditions exist throughout 
the phase diagram, allowing large portions to be deduced. The second relevant 
crystallization scheme is known as batch which is simply mixing the protein and 
precipitant directly, ideally at final concentrations that are in the nucleation zone.17 If that 
is achieved, crystal growth proceeds and terminates as normal, following an overall 
shorter path compared to FID, as indicated in Figure 2.5 (dashed orange arrow). Batch 
methods have been scaled-down significantly to microbatch and have been employed in 
microfluidic devices, including the device developed in Chapter 8. 
 
2.5. Examples of Microfluidic Protein Crystallization 
The various protein crystallization methods have been implemented in 
microfluidic chips78 where the sample is precious and/or not abundant. Finding crystal 
growth conditions (known as crystallization screening) is very cumbersome, requiring 
many trials. Microfluidic devices allow parallelization and multiplexing of many 
experimental trials, using tiny sample amounts per trial. Additionally, they can be 
operated in an automated and efficient manner while supporting concurrent qualitative 
and quantitative analyses. The subsequent step in X-ray crystallography (exposing the 
crystal to the X-ray beam) can also be performed on-chip, demonstrating the possibilities 
of a full Lab-on-a-Chip system. To accomplish this, several platforms have been 
developed. 
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2.5.1. Droplet-based systems 
Microfluidic droplet generators have been used for a variety of purposes and can 
be applied to protein crystallization. Droplets are formed by flowing an aqueous solution 
into an oil carrier fluid.79 This can be done using a T-junction system where an aqueous 
channel meets with a perpendicular oil channel or using a pinched-flow system where 
two oil channels converge on a single aqueous channel. Due to surface tension 
differences and immiscibility of the two streams, an aqueous droplet forms. Droplets can 
be generated continuously under a constant liquid flow and droplet size can be adjusted 
by relative flow rate differences between the inlets. Furthermore, multiple aqueous inlets 
can be combined upstream to create droplets that serve as individual reaction vessels 
since no chemical exchange occurs between droplets.80 In the case of protein 
crystallization, the droplets contain a protein solution and its precipitant which mix 
within the droplet to form crystals (Figure 2.6a).81 Thousands of nanoliter (and below) 
droplets can be formed with consistent solution conditions or with varying conditions 
based on the relative flow rates of each aqueous stream. Complex channel networks can 
also be designed to introduce various precipitant types on the same chip while 
simultaneously allowing concentrations to be changed by adjusting aqueous flow rates 
on-the-fly. Furthermore, changes in the local crystallization environment can also be 
implemented, for example, by dehydrating crystallization droplets in an osmotic bath, 
effectively increasing the protein and solute concentrations within.82 This can also be 
done using a water-permeable carrier fluid to osmotically remove water from the droplet 
and change the concentrations of the contents within. 
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Figure 2.6. Methods of microfluidic protein crystallization.78 a) Droplet-based 
crystallization with two precipitants and protein with controllable ratios based on applied 
flow rates between them. b) SlipChip showing solution loading and mixing after the 
plates are slid. c) Free interface diffusion using a valve-based system. Protein (red) and 
precipitant (blue) are loaded on separate sides and a valve is actuated to open access 
between the two. d) Counterdiffusion on-chip showing the continuous concentration 
gradient of precipitant. 
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2.5.2. Well-based systems 
In non-microfluidic crystallization, wells are the most commonly used apparatus 
to perform protein crystallization by a variety of processes. For example, protein and 
precipitant can be manually pipetted or robotically dispensed into a 96-well plate. With 
microfluidics, channels and wells can be creatively patterned with dimensions orders of 
magnitude smaller than macroscale plates, yet are too small for manual pipetting. To set 
up nano/microwells, a novel device was developed by the Ismagilov group termed 
“SlipChip”.83 This device consists of two layers, one containing wells with protein and 
the other containing wells with precipitant, both filled using inlet channel networks 
(Figure 2.6b). The surfaces containing the wells are slid (or “slipped”) together to align 
the wells into a single chamber, mixing the two solutions. The SlipChip can also be 
modified to perform diffusion-based crystallization in which protein and precipitant are 
introduced to one another in a convection free environment.84 In this case, a narrow 
channel connecting the two wells is implemented and the wells are aligned at opposite 
ends. The protein enters the channel and precipitant diffuses into the channel creating a 
concentration gradient of different crystallization conditions. A simplified version of 
“counterdiffusion” also exists in linear channels filled with protein solution coupled to an 
access reservoir at the end of the long protein-containing channels where precipitant is 
introduced (Figure 2.6c).77 As the precipitant diffuses into the channel, a similar 
concentration gradient establishes for crystallization screening (this is the principle of the 
device demonstrated in Chapter 7). 
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2.5.3. Valve-based systems 
Valves can also be used to control liquid flow into various microfluidic channels 
within a single device. Pneumatic valves have been designed for microfluidic devices 
fabricated with elastomeric materials (i.e. PDMS), allowing complex channel networks to 
be controlled with common instrumentation and minimal fabrication requirements.85 The 
major implementation of these valves for crystallization exists in devices facilitating 
diffusive mixing of protein and precipitant.86 Generally, protein and precipitant inlets are 
separated by a connecting channel overlaid with a closed valve (Figure 2.6d). When the 
valve is opened, the two solutions are introduced and mix by diffusion to create a 
concentration gradient, as discussed in the previous section. By altering channel lengths, 
diffusion times and the slope of the gradient can be adjusted to establish various 
screening conditions. Complex systems have also been developed using valves in which 
inlet channels can be selectively opened on-demand to transfer various crystallization 
reagents in desired ratios into sealed reaction channels, followed by dispensing into 
independently controlled outlet channels.87 The use of custom-made multichannel 
pressure sources allows each valve to be controlled instantaneously and independently 
permitting these devices to be automated and have large scale channel networks for high-
throughput screening. Automated screening platforms have also been developed for well-
based systems that generate concentration gradients of protein and precipitant. 
Incorporated valves allow each well to be isolated to maintain solution conditions for 
crystal growth, which is demonstrated in the device in Chapter 8. 
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CHAPTER 3 
MICROFLUIDIC DEVICE SURFACE TREATMENTS AND APPLICATIONS 
 
3.1. Introduction 
Microfluidic devices have attracted interest in the medical and diagnostic fields as 
they have the potential to perform many current large scale applications at a much 
smaller scale so as to reduce sample consumption and instrument size. Some applications, 
especially electrophoretic separations, have demonstrated excellent performance such as 
rapid separations on the order of seconds and efficient separations of diagnostically 
relevant species.29, 66, 88 For example, rapid DNA sequencing has been demonstrated in a 
high-throughput format89 and microfluidic-based protein and DNA separations, similar in 
working principle to gel electrophoresis techniques, have now been commercialized for 
over a decade.90 A further advantage of swift analysis is also appreciated in time-critical 
situations such as during surgery or for analytes that change composition over time. 
Another intriguing advantage of microfluidic devices is their portability and potential for 
point-of-care diagnostics,91 which has been demonstrated via a variety of marketed 
applications.92 Additionally, as most microfluidic devices only require sample volumes in 
the nanoliter range or below for analyses, they are further suited for situations when 
sample amount is limited, such as in minimally invasive diagnosis. As medical and 
diagnostic applications of microfluidic devices focus on qualitative or quantitative 
determination of biomolecules, the biocompatibility of these devices becomes critical.  
The latter refers to several requirements for microfluidic devices: First, 
microchannel surfaces should resist non-specific adsorption of biomolecules (see 
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Figure 3.1) and provide a stable and non-altering composition over the course of an 
analysis. Due to the high surface-to-volume ratio apparent in microchannels, there is a 
high potential for surface adsorption and deterioration, especially in combination with 
diagnostic samples such as body fluids. Consequently, microfluidic applications strongly 
depend on the tailoring and controlling of surface properties in such devices. Second, for 
cell-based assays, the microfluidic environment has to be adapted so that cells can adhere 
to surfaces if required and that intra- and intercellular processes proceed regularly which 
poses an important requirement for the matrices used to embed or hold specific cells. 
Third, several other specific surface conditions arising from the particular application at 
hand have to be considered such as temperature compatibility, stability under flow and 
applied electric fields, and solvent compatibility. Considering these guidelines and 
requirements, most microfluidic applications require some sort of surface pretreatment 
prior to analysis. Treatments can involve passivation strategies to prevent non-specific 
adsorption or unwanted changes in surface properties during the course of an analysis. 
Furthermore, if the sensing element in a microfluidic application is a biomolecule, 
immobilization strategies rendering a high yield of active biomolecules on a surface are 
required. The control of specific biomolecule immobilization is thus another important 
requirement in many microfluidic applications. 
Microfluidic devices can be created with a variety of materials thus surface 
treatment strategies strongly depend on the properties of the material. Covalent 
immobilization schemes require specific active surface groups which vary from material 
to material deeming such strategies specific for a given microfluidic device. Bi-functional 
linker molecules may also be used which allow for specific linkage to a surface reactive  
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Figure 3.1. Schematic representing the prevention of non-specific adsorption to 
surfaces via adequate coating strategies. Left: proteins (here an IgG molecule is shown 
schematically) can adsorb to the untreated surface. Right: Due to coating with a blocking 
agent (i.e. another protein as specified in Subsection 3.4.1) the IgG molecules are 
hindered from non-specific adsorption. Coatings can be of other non-covalent type or 
covalently bound to the surface. 
 
group but also react specifically with functional groups on biomolecules. In contrast to 
covalent immobilization schemes, adsorptive coatings may present an alternative, less 
complex route to coat microfluidic surfaces for various purposes. Knowledge of the non-
covalent interactions driving an adsorptive coating is important for the quality of the 
coating. In general, such interactions are determined by electrostatic, van der Waals, 
and/or hydrophobic interactions. The functionality of the coating can be tuned similarly 
to covalent strategies and non-specific adsorption can be suppressed in most cases. 
Functional groups of the adsorptive coating material can also be used for further specific 
biomolecule immobilization. The ease of use of adsorptive strategies and often diverse 
applicability to various materials has led to their widespread recognition in microfluidics. 
The objective of this chapter is to provide an overview of the various strategies 
used to accomplish surface coating procedures for medically related microfluidic devices. 
First, covalent strategies are described in sections based on various substrate material 
properties and thus surface functional groups. Next, adsorptive coatings are discussed 
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based on the specific class of coating materials. Finally, selected microfluidic 
applications for medical research are detailed and future perspectives on coating 
procedures are discussed.  
 
3.2. Covalent Immobilization Strategies: Polymer Devices 
Covalent strategies are characterized by a chemical bond formed between a 
functional group of the substrate surface, i.e. the microfluidic channel walls, and a 
functional group of the coating agent (see Figure 3.2). The chemical reactivity of the 
functional group of the coating agents is specifically chosen based on the functional 
group on the substrate. Covalent coatings are usually characterized by their excellent 
stability during microfluidic manipulations; however, they have to be adapted to the 
available surface functionality of the microfluidic material. This makes universal 
strategies between different microfluidic device materials difficult compared to other 
surface treatment methods. Covalent strategies for the most popular microfluidic device 
materials are outlined in this section separated into subsections based on compatible 
substrates. 
 
 
Figure 3.2. General scheme of covalent coating strategies (X = reactive functional 
group of substrate surface, Z = reactive functional group of coating agent). 
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3.2.1. Polydimethylsiloxane (PDMS) Devices 
Microfluidic systems fabricated with polydimethylsiloxane (PDMS) represent a 
significant portion of microfluidic devices, especially those used for important 
bioanalytical and medical applications.93-97 A major advantage of this material arises due 
to its widely ranging optical transparency in the visible and ultraviolet light regions, 
which makes it amenable for many fluorescence-based applications. Additionally, PDMS 
is gas permeable which accommodates cell culturing within microfluidic devices 
fabricated with this material; a considerable advantage for cell-based studies. Moreover, 
PDMS devices can be fabricated from a pre-structured master exhibiting the negative 
relief of a desired microdevice. The pre-structured master can be obtained via standard 
photolithography techniques and minimal clean room infrastructure is further required for 
PDMS chip assembly. PDMS devices thus provide a suitable route for prototyping 
techniques which has led to their widespread adoption in microfluidics research. 
One issue with PDMS devices – as for many other microfluidic devices – is an 
inconsistent surface composition over the time course of an analytical measurement. Due 
to its polymeric character and long chain polymer reorientation effects on the surface, 
strategies need to be developed in order to maintain a given surface composition. The 
various strategies reported for bioanalytical and biomedical applications are described in 
the following sections as well as suitable techniques for stable surface functionalization. 
 
Silanization strategies: 
One of the most commonly used covalent attachment strategies involves the 
linkage of alkoxysilane derivatives via hydroxyl group bearing surfaces resulting in 
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siloxane linkages (see Figure 3.3a). This method has been extensively used with glass 
and silica surfaces (see Subsection 3.3.1), but has also found widespread use for its 
application in PDMS-based microfluidic devices. A considerable advantage of this 
technique is the fact that the linkage can be mediated via one to three alkoxy groups of 
the reacting silane, providing a means for proper orientation and stable cross-linking to 
the surface. Furthermore, the functionality of the silane can be adjusted to obtain a 
desired chemical reactivity. As a result, hydrophobic or hydrophilic side-chains can be 
introduced, but also various chemical functionalities become accessible for further cross-
linking if desired. This is a key benefit of PDMS as a variety of chemical functionalities 
can be established on PDMS microchannel surfaces in contrast to other polymers which 
are more limited towards generalized surface functionalization. It is important to 
understand that silanization strategies are only successful with a considerable amount of 
hydroxide groups on the surface. Hydroxyl groups can be created on microchannel walls 
via oxidative treatments including oxygen plasma, air plasma,37 or UV irradiation98 in an 
oxygen rich atmosphere (this pre-treatment step is not a covalent immobilization strategy 
but merely provides necessary functional groups on the substrate surface. See Section 3.5 
for more details). PDMS surfaces treated with these techniques are hydrophilic and 
exhibit contact angles on the order of < 20 degrees in contrast to native PDMS which 
exhibits a contact angle on the order of ~120 degrees.99 Although the mentioned 
treatments are very effective, PDMS devices need to be stored in aqueous solutions or 
used immediately after oxidative treatment due to the hydrophobic recovery 
phenomenon;100 an effect that renders a hydrophilic PDMS surface hydrophobic with a 
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half-life of one day due to the reorganization of surface polymer chains when exposed to 
air. 
Probably the most utilized silane molecules are amino derivatives usually in the 
triethoxy- or trimethoxy-silane form. The amino group serves as the linker molecule for 
well-known amide bond formations with carboxylic groups mediated by carbodiimide.101 
For example, aminopropyltriethoxysilane (APTES) has been used for antibody 
attachment and cell adhesion to PDMS.102, 103 Furthermore, Yu et al.104 reported 
improved covalent immobilization of proteins due to increased hydrophilicity after 
APTES treatment. This was achieved by binding an aldehyde modified dextran to 
APTES immobilized on a PDMS surface. With this covalent strategy, a PDMS-based 
device could be used to detect various biomarkers via an enzyme-linked immunosorbent 
assay (ELISA). Other silanization examples consist of the use of trimethoxymethylsilane 
to suppress non-specific protein adsorption and attach biomolecules to microchannel 
walls after a silanization procedure.105 Silane-based coatings have also been demonstrated 
that significantly reduce non-specific protein adsorption and improve cell adhesion to 
PDMS surfaces.106 This silanization process was applied via a patterning procedure 
consisting of a silane-copolymer anchor bound to a functional polyethylene glycol (PEG). 
Control of electroosmotic flow (EOF) in a microchannel is also critical in many types of 
experiments to improve reproducibility between trials and substrate types and to increase 
analysis times. In addition to its use for immobilization purposes, a methoxysilane can be 
used to link a highly ionizable carboxyl-polymer to PDMS to introduce a high EOF.101 
Another strategy for attaching silanes has been demonstrated via the self-
assembly of thiolated-silanes on gold surfaces. After coating PDMS microfluidic devices  
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Figure 3.3. Schematics for selected covalent-immobilization schemes. a) Silanization 
refers to the condensation reaction of alkoxysilanes with hydroxyl groups on surfaces. 
This reaction can generally be used on hydroxylated surfaces, but has also found 
application on oxidized PDMS. (R2= alkyl or alkoxy, R3=functional end-group such as -
NH2 or -COOH). b) Grafting is a widespread method for immobilizing a variety of 
polymers. After activation and radical formation on the surface, reaction with monomers 
results in covalent polymer immobilization on a surface. Also shown is the activation 
scheme for UV activated grafting of acrylamides on native PDMS surfaces.  
 
with a thin gold layer, attachment of the thiolated silanes is accomplished via the self-
assembly and stable linkage of thiols to gold. This approach is very popular in surface 
derivatization applications and has been applied to render surfaces hydrophilic via 
PEGylated thiols in microfluidic networks107 as well as in microcontact printing 
applications.108 Furthermore, 3-mercaptopropyl trimethoxysilane has been employed as a 
coating procedure in a PDMS device to detect CD4+ T cells using an ester-based 
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coupling agent functionalized to the surface followed by the immobilization of avidin and 
a biotinylated CD4 antibody to the surface.109 CD4 cells could then be isolated from 
whole blood and counted which is necessary when monitoring the stages of a disease 
such as HIV in positively tested patients. Similarly, an optical real-time affinity biosensor 
developed using a PDMS-based channel for multi-analyte detection was also reported 
using thiolated silanes and biotin/avidin immobilization.102 
Derivatized silanes can also be exploited to covalently attach a wider variety of 
molecules to PDMS surfaces. A combination of UV activation with silanization to 
covalently pattern polyacrylamide to the surface of PDMS has been explored by Xiao et 
al.110, 111 An initial UV exposure oxidizes the PDMS which allows silanes to self-
assemble on the surface. In this case, a trichlorosilane was adhered to the surface due to 
its capability of initiating atom-transfer radical polymerization of polyacrylamide. The 
resulting formation of a polyacrylamide layer on the PDMS surface reduces non-specific 
adsorption and maintains hydrophilicity, two important improvements critical for 
efficient and highly sensitive biomolecule separation and diagnostics. 
 
Other immobilization schemes on PDMS: 
An effective and commonly used alternative method to silanization is 
photoinitiated UV grafting to facilitate the covalent linkage of polymers to PDMS 
surfaces112 (see Figure 3.3b). A major motivation for this approach is its ability to 
increase surface hydrophilicity while reducing protein adsorption on the substrate. 
Additionally, stabilization of EOF can be achieved using this surface treatment which 
results in a significant increase in the resolution of electrophoretic separations. In the 
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follow-up work, the dynamics of this approach were studied by examining the ability to 
differentially pattern various regions on a PDMS surface using UV initiated grafting 
which proved to be feasible.113 In terms of biomedical applications, UV grafting can be 
used to selectively micropattern PDMS in specific regions to direct cell attachment and 
growth as well as to immobilize antibodies for immunoassays.113 
Another alternative to silanization is to coat PDMS with poly-xylylenes via a 
chemical vapor deposition method.114 Such polymer coatings can be employed to 
immobilize molecules, facilitate antibody/biotin binding assays, and improve cell 
adhesion assays for pharmacology studies. Follow-up studies of this approach also 
employed chemical vapor deposition to discontinuously pattern bio-inert species and 
reduce non-specific protein adsorption.115, 116 Another polymerization strategy utilizing 
Cerium-catalyzed polymerization of various monomeric compounds can be employed for 
polymer coatings. The exploited Ce-catalytic action originates from the formation of 
siloxane radicals which further react with selected monomers resulting in their 
immobilization. When applied to electrochromatography studies, an increased separation 
efficiency and selectivity can be realized.117 
 
3.2.2. Polymethylmethacrylate (PMMA) Devices 
Polymethylmethacrylate (PMMA) is also a very popular material for microfluidic 
applications. A variety of different surface activation and coupling procedures addressing 
a broad range of functionalities have been reported for PMMA. Several of these methods 
are aimed at introducing amine functionalities on PMMA surfaces (see Figure 3.4). One 
example of this is a poly(ethyleneimine) (PEI) coating which is an amine-bearing 
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polymer that can enhance antibody binding to the surface of PMMA.118 An improved 
antibody surface coverage with up to a tenfold increase in overall binding was 
demonstrated with this immobilization strategy, leading to significant improvements in 
immunoassay performance. 
 
 
Figure 3.4. Amination on PMMA is shown via activation of a short bifunctional 
amine. Other methods exist to create aminated PMMA as discussed in the text. Amine 
groups can further be used to link other functional molecules, such as that shown in the 
reaction with the bifunctional glutaraldehyde and subsequent immobilization of amine-
bearing molecules, such as proteins. 
 
Another example surface treatment of PMMA with amine functionalities is based 
on an activation procedure with lithiated diamines to link alkylcyanates to PMMA.119 
This method was further employed by Hashimoto et al.120, 121 for improved detection of 
single DNA base mutations. Similar activation strategies can be used to detect low 
abundance mutations in DNA using a microarray.122 Primers are linked to a PMMA 
surface functionalized with amines, followed by a ligase detection reaction with 
immobilized primers to induce hybridization detection. Additionally, PMMA can be 
silanized to incorporate a larger variety of functional groups on the surface such as 
specialized amines for the immobilization of biomolecules. A procedure using lithium 
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aluminum hydride (LAH) to expose hydroxyl groups on the PMMA surface can be 
applied for further functionalization with organosilanes that facilitate the immobilization 
of DNA oligos for DNA microarray analysis.123 
Oxidation for carboxylic acid functionality has also been reported as a suitable 
covalent immobilization strategy for PMMA. For example, McCarley et al.124 discussed a 
device to capture and concentrate cells and proteins using treatments for patterning 
polymers to substrate surfaces. For this purpose, carboxylic acid groups can be patterned 
on a PMMA surface with UV treatment in an oxygen rich environment onto which 
antibodies are immobilized for the detection of cells (for example MCF-7 breast cancer 
cells) and other proteins in solution. Antibody linkage for immunoassays has also been 
reported via a sol-gel immobilization strategy.125 Sol-gel films are first adsorbed to 
substrate surfaces in which biomolecules can be immobilized within the gel networks. 
The mildness of this procedure is beneficial in that bioreactivity is preserved, non-
specific adsorption is reduced, and effective immobilization of target analytes can be 
achieved for immunosensing with low detection limits. For example, this method has 
been applied in a microreactor for proteolysis via trypsin immobilization on a sol-gel 
coated PMMA microchannel surface.126 
An indirect approach to immobilize antibodies within a PMMA/polycarbonate 
microfluidic device to perform ELISA is also possible using functionalized carbon 
nanotubes (CNTs).127 In this example, a pressure driven device was used and antibody 
immobilization was achieved via linkage onto carbon nanotubes functionalized with 
poly(diallyldimethylammonium chloride). This functionalization step renders a positive 
charge on the coated CNTs, therefore immobilization is achieved via electrostatic 
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interactions with a negatively charged antibody. The developed ELISA was used to 
detect bacterial toxins such as Staphylococcal Enterotoxin B (SEB) with detection limits 
comparable to conventional ELISA leading to a point-of-care device that could perform 
with high sensitivity.  
Various other coating procedures based on commercial coating agents have been 
reported including the chemical SurModics (a company specializing in surface coatings 
for medical applications) and Reacti-Bind™ procedures.128 These methods and the 
cetrimonium bromide (CTAB) surfactant were tested in the development of microfluidic 
hybridization array (MHAC) devices in which DNA probe attachment is a crucial step. It 
was shown that the Reacti-Bind™ method is the least effective of the three whereas the 
CTAB method provides improved immobilization of amine modified DNA oligos and the 
SurModics procedure is the most effective in producing high quality spots along the array 
with the least amount of surface pretreatment. As a whole, all of these methods can 
improve DNA-oligomer immobilization and consequently chip efficiencies, hybridization 
kinetics, and detection limits. 
 
3.2.3. Polycarbonate Devices 
A successful approach to covalent linkage on polycarbonate involves the creation 
of carboxylic groups on the surface. Accordingly, several of the previously described 
reaction schemes can be employed. For example, UV/ozone treatment can be used to 
create COOH groups for the linkage of amino groups via carbodiimide activation.129 
Subsequently, DNA probes can be attached within a polycarbonate DNA microarray 
coupled to PDMS microchannels for hybridization assays. Complementary DNA 
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fluorescence assays carried out in such a device show great selectivity against 
mismatched pairs, giving them great potential to be used for portable plastic biochips. For 
the attachment of antibodies and other proteins, carboxylic groups can be patterned as 
described previously for PMMA. This approach is applicable for mammalian cell capture 
such as capturing MCF-7 breast cancer cells in addition to protein capture by 
immobilizing various amide polymers.124 Another approach that has been successful on 
PMMA can also be exploited for polycarbonate.120, 121 Surface activation with lithiated 
diamines can also be used with polycarbonate for the coupling of DNA on microfluidic 
surfaces to detect single base pair mutations in addition to improving polymerase chain 
reaction (PCR) applications. Furthermore, spraying a photosensitive polymer (‘3D’ link 
blocking solution of SurModics brand ‘CodeLink®’) as a thin film followed by UV 
polymerization can also successfully derivatize polycarbonate surfaces. CodeLink® 
coatings utilize a hydrophilic polymer containing N-hydroxysuccinimide ester reactive 
groups which promotes binding of amine modified DNA while suppressing non-specific 
adsorption.130 This approach can also be used to treat DNA microarrays coupled to PCR 
experiments.131 An improvement of hybridization kinetics (efficiency of the process 
increasing hybridization velocity) was reported with this approach for the purpose of 
studying single nucleotide polymorphisms using a patterned CodeLink® coated array.  
 
3.2.4. Polystyrene Devices 
Although it’s the least common polymer used in medical microfluidics, 
polystyrene can also be used as a microfluidic device material. One well received 
example utilizes a gold coating and thiol–linker with a carboxylic acid head group for 
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self-assembly on polystyrene surfaces.132 In this example, carbodiimide activation was 
employed to covalently bind to the amino-groups of immunoglobulin G (IgG) molecules 
and the device was tested with a surface coated antibody/antigen assay to detect IgG via 
fluorescence microscopy. Detection limits were in the range of typical microfluidics 
detection assays with a wide linear response for the immunosensor. In comparison to 
conventional immunoassay-based detection methods such as ELISA, this method 
provided a significantly lower time requirement on the order of 25 minutes (compared to 
several hours for competing methods) and had a more conservative sample volume 
requirement. 
 
3.3. Covalent Immobilization Strategies: Glass Devices 
Silicon dioxide (SiO2) surfaces are likely the most studied surfaces for 
microfluidic applications. Their surface properties are suitable for a variety of 
applications not only in microfluidics but also in capillary chromatography and capillary 
electrophoresis. Glass, fused silica, and quartz materials can all be derivatized via the 
same coupling chemistry. By far the most used derivatization strategy is silanization via 
silanol groups generated on SiO2 surfaces. Activation schemes involve reactive oxygen 
treatment, pre-activation with acids such as piranha acid or other strong acids, and 
treatment with strong bases such as NaOH.  
 
3.3.1. Silanization 
As discussed in Subsection 3.2.1, silanol groups on SiO2 surfaces react with 
alkoxysilanes forming a stable covalent bond. Silanes similar to those used with PDMS 
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are employed for SiO2 and subsequent covalent reactions to bind other entities occur 
depending on the employed silane head group. The applications of silanization on glass 
are multifarious and several examples are given in the following paragraphs. 
Proteins such as antibodies can be immobilized to glass microchannel substrates 
for the detection of bacteria via a biosensor using APTES. APTES is used to create an 
amine reactive surface to bind carboxyl-groups for antibody attachment. A device of this 
type operates with a continuous flow of a bacterial suspension through a microchannel to 
facilitate specific immobilization of bacteria to an antibody derivatized channel wall for 
sensitive detection.133 Silanization can also be employed for bilayer lipid membrane 
(BLM) attachment on glass surfaces to reconstitute membrane proteins for 
electrophysiological and single molecule studies. For example, perfluorooctyl-
trichlorosilane (PF-TCS) can be used to render glass hydrophobic followed by an 
injection of a lipid-based solution to facilitate the formation of BLMs. The incorporation 
of a spark assisted chemical engraving method to develop the glass microstructures 
makes the complete device fabrication process simple and quick for easy integration.134 
A slightly different application of silanization can be used to immobilize 
antibodies on glass beads to detect pathogens within a microchannel.135 Initially, the glass 
beads are coated with an aminosilane (APTMS) and functionalized with aldehydes to 
form a carboxy terminus for covalent immobilization with the primary amines of various 
antibodies. The channel is then packed with the functionalized beads and in this example 
was used to specifically bind with IgG as well as E. coli using their respective antibodies. 
Highly specific binding to the target analyte can be achieved with this method and the use 
of glass beads provides a greater functionalized surface area thus a higher antibody 
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concentration resulting in improved detection sensitivity compared to devices where only 
channel walls are treated. Application of this method in a glass microfluidic channel is 
also possible to covalently attach enzymes for biocatalysis studies.136 Another antibody 
immobilization technique via silanization in a glass microchannel involves a protein A 
surface coating following a necessary pre-silanization step for IgG attachment.137 Coating 
channels with protein A for antibody binding reduces antibody denaturation and provides 
a higher binding affinity compared to direct glass immobilization resulting in increased 
antibody pre-concentration and assay sensitivity. Additionally, protein A bound 
antibodies are oriented correctly for efficient antigen binding resulting in an even greater 
increase in immunoassay efficiency. 
Bifunctional silanization of a glass substrate can also be applied to microfluidic 
PCR138 or capillary electrophoresis139 coupled with a secondary treatment using various 
polymers. Untreated or not properly treated devices have the potential to inhibit PCR 
making it important to develop devices with optimal surface chemistries. Possible PCR 
compatible silanes include SurfaSil™ and SigmaCote™ coated with the polymers 
polyglycine and polyadenylic acid. It has been shown that higher yields of amplified 
product are obtained from channels coated with SurfaSil™ and a polymer, namely 
polyglycine, with results comparable, and in some cases exceeding, those obtained from a 
conventional PCR experiment. In terms of capillary electrophoresis, 
polydimethylacrylamide can be immobilized to glass capillary walls with 
trimethoxysilane via a well-known coating procedure to reduce EOF (high EOF reduces 
resolution by causing the sample plug to broaden) and non-specific adsorption of analytes 
(which leads to a heterogeneous spatial distribution of the analyte thus poor separation). 
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This method has been applied extensively for the aforementioned benefits, namely in lab-
on-a-chip devices that incorporate cell lysis, DNA amplification by PCR, and analysis by 
CE.140 
Silanization strategies are also used for flow-through DNA microarray devices.141 
One distinct example is a glass/PMMA hybrid device in which a PMMA microfluidic 
channel is used to deliver sample to a microarray patterned on glass via ‘shuttle 
hybridization.’ As mentioned previously, PMMA can be silanized and functionalized 
with organosilanes for DNA immobilization.123 To immobilize DNA on the glass portion 
of the device, the surface is silanized with triethoxysilane and then functionalized with an 
aldehyde derivative for immobilization of amine-functionalized DNA oligo probes. 
Overall, the continuous flow mechanism within the device significantly reduces DNA 
hybridization time. Similar silanization methods are employed within three-dimensional 
DNA microarray devices that connect glass microfluidic channels perpendicular to a 2D 
glass surface. In these devices, channel walls are silanized and functionalized to 
immobilize amine-derivatized DNA oligos on the glass channel surface onto which 
injected analyte can be hybridized. Using this surface treatment method, high-density 
immobilization is successfully attained compared to traditional two-dimensional array 
patterning methods.142, 143 
 
3.3.2. Polymer Immobilization 
Immobilization of the polymer polyvinylalcohol (PVA) has been used extensively 
for applications related to electrophoresis. Generally, PVA-based coatings increase 
device efficiency by reducing non-specific adsorption which improves separations due to 
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reduced analyte-wall interactions. PVA coatings are further stable in a broad pH range 
and facilitate the suppression of EOF while concomitantly increasing the resolution of the 
applied separation. To demonstrate PVA-based coatings and illustrate its advantages, 
several groups have coated glass microfluidic devices for electrophoresis.144, 145 The PVA 
coating procedure is very simple and non-complex as a 1% aqueous solution of PVA is 
simply flushed through microchannels to coat them. Thermal bonding is then used to 
covalently attach the polymer to channel walls. PVA coated devices versus non-coated 
devices exhibit controllable and suppressed EOF, reduced non-specific adsorption of 
analyte fluorophores, and a three-fold increase in separation efficiency. Furthermore, 
sensitivity is increased and the need to wash or etch devices for reuse is unnecessary thus 
improving robustness. To potentially increase separation efficiency even further, PVA 
coatings coupled with an organic background electrolyte solution can be used.146 The use 
of a lower conductivity buffer solution allows for stronger electric fields to be applied 
thus increasing sensitivity. Under these conditions, a similar comparison of PVA versus 
non-PVA coated channels showed that PVA coated channels improved the resolution of a 
complex separation while non-coated channels could not even achieve baseline 
resolution. The same PVA coating procedure can also be applied to a PDMS-based 
device to achieve similar improvements in overall electrophoretic separation.147 
 
3.4. Adsorption Strategies 
In contrast to covalent attachment techniques, adsorption strategies rely on 
intramolecular interactions between the coating material and the substrate surface. They 
can be mediated via electrostatic interactions, van der Waals forces, and/or hydrophobic 
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interactions. A major characteristic of these coatings is their ease of use, since 
microchannels generally have to be incubated with a solution containing the coating 
agent for a certain length of time. Subsequent use for biomedical applications is 
straightforward and advantageous as minimal washing procedures are required. In some 
cases, the coating agent can even be added to the solution during specific analyses which 
is referred to as dynamic coating. In contrast, coating of the substrate prior to the actual 
analyses is termed static coating. 
 
 
Figure 3.5. Schematic of adsorptive coatings discussed in Section 3.4. 
 
Adsorptive coatings have been widely adopted and can perform similarly to 
covalent strategies in terms of preventing biofouling and non-specific adsorption as well 
as to serve as linker molecules for further biomolecular attachment. Due to their non-
covalent nature, strategies for adsorptive coatings vary from material to material and are 
also based on previous surface treatment steps. Adsorptive coating agents can be 
classified into four major groups which are characterized by multivalent interactions with 
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the substrate surface, strong electrostatic interactions, or a combination of the two. In the 
following sections, polymer, polyelectrolyte, surfactant, and protein adsorptive coatings 
are described which constitute the majority of non-covalent coating strategies for 
microfluidic applications as schematically depicted in Figure 3.5. 
 
3.4.1. Proteins 
Protein coatings represent a very popular approach to coat microfluidic channel 
surfaces. For example, coating with the protein bovine serum albumin (BSA) has been 
used in molecular biology for several decades to block surface sites from non-specific 
adsorption. BSA is a soluble protein with a high tendency to adsorb to hydrophobic 
surfaces such as wax-coated, paper-based microfluidic immunoassay devices where it can 
be used as a surface coating to reduce non-specific adsorption.148 Despite this 
characteristic, BSA surface treatments are not only limited to hydrophobic surfaces but 
can also be applied to hydrophilic surfaces, a contributing factor to its widespread use. A 
representative application of BSA coating applied to PDMS has been described by 
Eteshola et al.149 who reported background reduction by reducing the non-specific 
adsorption of analytes in a sensor detecting IgG molecules for immunohistochemical 
analysis. BSA was not only employed to directly suppress non-specific adsorption but 
also as a linker to covalently bind protein A for subsequent directed immobilization of 
IgG. A detection limit in the nanomolar range was reported in the employed sensor 
performing an enzyme linked immunosorbent assay (ELISA). Further discussion of BSA 
as an advantageous medical device surface coating can be found in Subsection 3.6.2. 
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The tetrameric protein streptavidin has also been employed extensively as a linker 
molecule by taking advantage of its very high binding affinity to biotin. Biotin-
streptavidin binding is nearly covalent in strength and the small molecule biotin can be 
readily derivatized with other linker molecules or proteins. As a result, this binding pair 
has found widespread application in the physical and life sciences and can also be 
employed in adsorptive strategies for microfluidic surface coatings. Utilizing multilayers 
of biotin and NeutrAvidin, a derivative of streptavidin with similar binding characteristics 
to biotin, is one method to accomplish this on PDMS.150 The multilayer approach consists 
of sandwiched layers of biotinylated IgG, followed by NeutrAvidin and biotinylated 
dextran. This three-layer sandwich has the ability to reduce non-specific protein 
adsorption and maintain stable EOF for electrophoresis applications. The same strategy 
can also be used to immobilize other biomolecular probes to biotinylated surfaces. There 
are other less complex protein-based dynamic coatings to reduce non-specific adsorption 
and control EOF, as demonstrated in PMMA-based microfluidic devices, but likely 
compatible with a variety of substrates.151 Protein blocking agents commonly found in 
ELISA procedures such as Block Ace and UltraBlock as well as lysozyme can be used 
for this purpose. Depending on the protein coating employed, EOF can be enhanced or 
reduced and its direction can be changed depending on buffer pH and charge on the 
protein. 
For cell-based assays, other strategies mimicking extracellular matrices are 
commonly pursued. The matrices can be applied with an adsorptive strategy that allows 
for embedding biological cells for subsequent in vitro studies. A key point is to provide 
biocompatible surfaces in which cell studies can be performed in optimized and non-
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hazardous environments. An example for a cell-based assay with potential in tissue 
engineering, cell-matrix interactions and cellular communication studies within a 
patterned microfluidic PDMS device has been demonstrated by Hou et al.152 PDMS in its 
native state resists cell adhesion and growth which is necessary in cell-based assays thus 
motivating the need for an appropriate surface coating procedure. An extracellular matrix 
mixture consisting of collagen, fibronectin, and hyaluronic acid can be coated onto 
PDMS to facilitate cell adhesion and growth with sufficient biocompatibility. 
Furthermore, a technique for layer-by-layer deposition of extracellular matrix has also 
been developed to micropattern cell co-cultures as a future tissue engineering tool to 
study cell-cell communication and cell-matrix interactions.153 Others have also suggested 
complete fabrication processes using alternate substrates such as polystyrene to overcome 
some of the potential disadvantages of PDMS in cell-based assays such as gas 
permeability, substrate deterioration, small molecule adsorption, and hydrophobic 
recovery.154 Cell assays including cell culture and blood neutrophil migration detection 
have been successfully performed with a polystyrene device surface coated using similar 
extracellular matrix proteins to promote cell adhesion. 
 
3.4.2. Adsorptive Polymer Coatings 
Adsorptive polymer coatings have proven to be a versatile method for a variety of 
adsorptive coating strategies; however, the choice of the coating polymer depends 
strongly on the microfluidic surface due to variations in surface interactions among 
materials. Because glass, silica, and PDMS exhibit a similar surface chemistry, similar 
polymer-based coating strategies can be applied. 
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In Section 3.3.2, polyvinylalcohol immobilization was discussed; however, 
dynamic coating of this polymer is also possible and advantageous for electrophoretic 
applications. The dynamic coating method can be more stable than static immobilization 
due to constantly replenishing the substrate surface with coating material. Furthermore, a 
variety of polymer microfluidic materials have been subjected to dynamic coating 
procedures. On PMMA, dynamic adsorptive coating of cellulose was reported to enable 
long term use (100+ runs) of a single microfluidic device for DNA electrophoresis. 
Devices with this type of coating can last on the order of one month and only require 
replenishment of the coating agent daily. The application of gel electrophoresis was 
performed multiple times in which consistently high and reproducible separation 
efficiencies were realized for the duration of the device’s lifetime.155 An added benefit in 
this case is that the same medium containing the coating agent also contains the sieving 
medium that drives the separation which simplifies their integration. 
An additional dynamic coating of PDMS with poly(dimethylacrylamide) (PDMA) 
can be applied to electrophoresis applications. The coating procedure is simple in that 
0.01% PDMA is added to the normal running buffer solution which is then injected into a 
microchannel in the same manner as conventional capillary electrophoresis. In a study of 
this procedure, PDMA surface adsorption was confirmed with contact angle 
measurements and infrared spectroscopy indicating a successful and stable surface 
coating when applied.156 PDMA coated channels show a reversal in EOF to a negative 
polarity which allows for improved injection of negatively charged samples. 
Additionally, a suppression of EOF occurs which improves sensitivity and a hydrophilic 
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surface is maintained within the microchannel which increases substrate robustness and 
reproducibility. 
 
3.4.3. Polyelectrolyte Multilayers 
Polyelectrolyte multilayers (PEM) represent another adsorptive approach that has 
been widely used for a variety of applications. The interaction forces between the coating 
and substrate surface are mediated via electrostatic interactions which contribute to the 
stability of such coatings. Compared to the short lifetime of many physical adsorption 
strategies, PEMs can offer a more robust solution. Additionally, in electrophoretic 
applications, PEMs have the potential to control EOF in that they can reduce or even 
reverse EOF according to the polyelectrolyte charge characteristics of the exposed layer. 
This resulting EOF stabilization is a key player in increasing separation efficiency and 
resolution. For example, capillary electrophoresis coupled to electrospray ionization – 
mass spectrometry (ESI-MS) benefits from the use of PEMs such as polyamine-coated 
glass surfaces in which ESI-MS can be performed without an external pressure source or 
spray tip.157 The reduction of non-specific adsorption and control of EOF contributed to 
this efficient, stable, and sensitive microfluidic mass spectrometric approach for protein 
detection. On glass and silica as well as polymers, PEM coatings are able to change the 
direction of and control EOF due to differing surface charges in the employed 
polyelectrolyte solution.158, 159 
PEM coating procedures called successive multiple ionic-polymer layer (SMIL) 
coatings can also be applied by placing a cationic polybrene solution between the anionic 
polymer dextran sulfate and the channel wall. These types of coatings maintain stability 
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across a wide pH range, show robustness against strong acids and bases, and improve 
device reproducibly. Another PEM example of the many available utilizes a positively 
charged poly(allylamine hydrochloride) layer electrostatically self-assembled to a 
negatively charged silicon surface.160 A similar approach can be applied to a PDMS 
microfluidic electrophoresis device to attain EOF control and improve overall stability.161 
It becomes apparent that the large variety of polyelectrolytes and their simple 
administration as a surface treatment makes this method versatile for a diverse set of 
applications and microfluidic substrates. More extensive methods for further fine tuning 
can be employed as well. To further study the stabilization PEMs provide, devices made 
of various substrates have been compared for consistency in separation performance.162 
In this study, PMMA and glass microchannels were coated with 
poly(diallyldimethylammonium chloride) and polystyrene sulfonate (PSS) and compared 
to non-coated glass channels to show that PEM coated glass had a stable EOF that was 
independent of solution pH. Additionally, PMMA coated with PEMs provide 
comparable, and in some cases better, separation efficiency than glass devices which is 
generally not the case due to fabrication inconsistencies with polymer-based substrates. 
Polystyrene and poly(ethylene terephthalate) glycol (PETG) substrates have also been 
studied due to their significantly different polymer surface chemistries and EOF 
mobilities in relation to more popular polymers. With these polymers, similar results can 
be realized with alternating layers of cationic poly(allylamine hydrochloride) and anionic 
PSS that give either negative or positive surface charges, respectively, for directional 
control of EOF.163, 164 EOF mobilities of this system in both polymers were measured and 
demonstrated the ability to bring the dissimilar EOF characteristics of the untreated 
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polymers into close proximity of one another with a uniform PEM coating. This overall 
increase in performance and reduced variation between substrate materials as a result of 
PEM surface coatings opens up the possibility to confidently use cheaper and easier to 
fabricate polymeric-based substrates to improve many biomedical microfluidic 
applications. 
PEMs can also be employed as a stable surface coating procedure that can be 
combined with subsequent immobilization of analytes. The polyelectrolytes 
poly(ethyleneimine) and poly(acrylic acid) can improve specific protein binding as well 
as long term stability and bioreactivity due to an increase in the hydrophilicity of a coated 
PDMS substrate.95 A slightly more complex multistep protein modification of PDMS can 
also be accomplished with PEM coating, gold nanoparticle patterning, and protein 
patterning. An example application of such a device illustrated the ability to separate a 
group of neurotransmitters as well as environmental pollutants with high separation 
efficiency, reproducibility, and stability.165 
Cell immobilization can also be undertaken using PEM coatings. 
Poly(diallylimethylammonium chloride) and PSS have been shown to improve cell 
adhesion due to increasing the wettability of PDMS.166 Using this method to treat PDMS, 
the degree of adhesion of various cell types with dissimilar cellular morphologies has 
been examined in which an overall improvement in cell culturing capability was realized 
regardless of cell type. The importance of this PEM method becomes apparent in tissue 
engineering applications where cell proliferation and adhesion are imperative and require 
a cell-friendly substrate material. 
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3.4.4. Surfactants 
Surfactant molecules are generally amphiphilic consisting of a hydrophobic tail 
and hydrophilic head moiety and have the potential to combine these two unique 
properties into an effective surface coating. First, the hydrophilic, often charged moiety 
can be employed for electrostatic attachment. Second, the hydrophobic moiety can be 
employed to further control surface properties such as reducing non-specific protein 
adsorption or to control EOF velocity and direction. It has to be noted that depending on 
substrate surface properties, these two properties of the surfactant can be interchanged 
such that the more hydrophobic entity interacts with the surface more strongly. 
A commonly employed surfactant in traditional protein analyses is sodium 
dodecyl sulfate (SDS) which also been adapted and employed as an adsorptive coating 
agent in a variety of microfluidic applications. For example, the influence of SDS on the 
separation of hydrophobic species by micellar electrokinetic chromatography in PDMS 
devices has been studied.167 Notably, SDS forms a pseudo-chromatographic phase 
eliminating protein adsorption and increasing EOF, consequently resulting in a rapid, 
highly resolved and efficient separation. Mixed coatings with other polymers can also be 
employed with SDS to tune the degree of adsorption to PDMS surfaces based on the 
concentration of SDS in solution.168 
The non-ionic polyoxyethylene Brij®-35 and cetyltrimethylammonium bromide 
(CTAB) surfactants are also candidates for the reduction of non-specific binding and 
EOF control in electrophoretic separations. Usually these surfactants are employed as 
dynamic coating agents and are added to an electrophoresis running buffer; however, 
cross-linked PDMS layers on silica capillaries and glass devices in conjunction with a 
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Brij®-35 adsorptive surface treatment can also decrease EOF in addition to reducing 
buffer pH dependence.169 Furthermore, CTAB and SDS were shown to work as 
alternative adsorptive surface coating agents for additional control of EOF. An even 
simpler Brij®-35 coating only involving the incubation of PDMS channels with the 
surfactant can be used to improve separation efficiency by increasing wettability and 
significantly reducing non-specific adsorption and EOF for a wide solution pH range.170 
The majority of non-ionic surfactants are block-copolymers consisting of long 
chains of ethylene oxide (or PEGs) and propylene oxide, commercialized under the 
trademark “Pluronic®.” Good resistance to protein adsorption on PDMS surfaces was 
demonstrated with Pluronic® F108 under dynamic coating conditions.171 Triton X-100™, 
another amphiphilic Pluronic® polyethylene oxide, can also be used as a coating agent 
that yields an acceptable reduction in protein adsorption as well as improved performance 
in capillary-based electrophoretic applications in PDMS/glass devices.172 In addition to 
dynamic coating, non-ionic surfactants can also be successfully applied as surface coating 
agents statically. Various Pluronics® on PDMS surfaces have been reported to reduce 
EOF as well as maintain long term stability when statically coated.99 
A final and slightly different surfactant that has gained popularity are 
phospholipid bilayer systems which form by spontaneous fusion of lipid vesicles with 
microchannel walls made of substrates such as PDMS or glass.173 These systems can be 
employed for ligand binding assays in which ligand-receptor binding can be measured 
under simulated membrane conditions along a microchannel, for example with 
dinitrophenyl conjugated lipids and corresponding antibodies. Additionally, fluorescence 
assays can be used to rapidly construct complete binding curves in one experiment, thus 
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using less protein sample compared to traditional methods.174 Controlled bilayer 
environments also open up new possibilities for biosensors in cell signaling studies in 
which key cellular functionalities stem from cell membrane ligand-receptor mechanisms. 
 
3.5. Other Strategies Utilizing Surface Treatments 
The coating strategies discussed thus far function either by covalently binding 
suitable molecules to various substrates or by an adsorptive coating to form surface 
layers, mostly based on organic molecules. Although these two categories encompass 
many of the surface treatments available for microfluidic devices, there remain other 
approaches that can be used to change the surface properties of biomedical microfluidic 
devices. For instance, exposure to reactive plasma gases can produce radicals that change 
the chemical composition of a surface or physical sputtering techniques can be used to 
deposit thin layers on surfaces. One common example of this involves the use of reactive 
oxygen species to alter PDMS and glass surfaces via UV or plasma treatment in oxygen 
or ozone atmospheres. While these treatments may be required as a precursor to 
subsequent covalent strategies such as silanization (discussed in Section 3.2), they can 
also be used as a standalone method to alter surface properties as desired. 
UV and UV/ozone exposure has been shown to increase surface wettability with 
UV/ozone treatment, being more effective based on greater observed changes in surface 
chemistry.98 Polycarbonate that has been irradiated with UV light shows a similar 
increase in wettability in addition to EOF changes that are pH independent after treatment 
unlike with glass substrates.175 Increasing the wettability of substrates such as PDMS 
improves performance in bioanalytical applications, a possible example being DNA 
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electrophoresis in a UV treated device yielding high resolution and reproducibility. 
UV/Ozone treatment can be taken a step further to form porous polymer monoliths by 
adsorbing a UV activated photoinitiator and monomers to channel walls followed by 
polymerization to non-covalently adhere the polymer to the surface. The durability and 
robustness of this attachment has been shown to withstand high pressures, despite its 
adsorptive nature.176 
Oxygen plasma treatment is a considerably widespread surface modification 
method for microfluidic devices, mainly PDMS-based, but can also be used with other 
substrates. A short treatment on the order of one minute produces hydroxyl groups on the 
PDMS surface allowing for the formation of covalent siloxane bonds (Si-O-Si) with other 
substrates including itself, glass, silicon, polystyrene, and others. This adhesion is 
irreversible and bond strengths between PDMS and other substrates have been shown to 
increase linearly with the degree of plasma exposure.177 This high correlation between 
bond strength and plasma exposure can be used to develop optimized plasma treatment 
parameters based on the degree of bonding needed. Concomitantly, an increase in surface 
wettability occurs due to the creation of silanol groups (Si-OH), rendering negatively 
charged channel walls for electroosmosis.33 Changes in PDMS wettability after plasma 
treatment and after exposure to several chemicals has also been studied.178 While plasma 
treatment increases the wettability of PDMS, treatment with several different acids and 
bases including strong acids such as H2SO4 revert the contact angle of plasma-treated 
PDMS to a more native hydrophobic and less wettable state. This opens up the possibility 
of differentially patterning hydrophobic and hydrophilic regions on the same substrate in 
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a lab-on-a-chip microfluidic device depending on the surface properties needed at each 
zone. 
Metal sputtering methods can also be utilized in surface treatment schemes, for 
example sputtering and evaporation of gold on microchannel surfaces. The gold-coated 
surfaces serve as templates for self-assembled monolayers (SAMs) to which a variety of 
coupling schemes can be applied with an adequate choice of thiol head groups (see also 
Subsection 3.2.1). One example of this involves binding collagen to SAMs using Schiff 
base chemistry for the development of cell analysis arrays with improved cell adhesion 
and attraction to treated channel walls.179 Other metals can also be coated on microfluidic 
devices, for example aluminum sputtering coupled with plasma treatment to create a 
biocompatible surface for increased cell adhesion and proliferation.180 The metal is 
etched in areas designated by a mask to expose a hydrophilic and reactive PDMS surface 
that favors cell adhesion. The novelty of this inexpensive and simple method over others 
discussed is that only a single-component substrate is used without the need for 
surfactants or extracellular matrix protein adsorption methods previously described. 
 
3.6. Examples of Applications 
The majority of the microfluidic surface modifications mentioned in this chapter 
have a specific focus in terms of application. While popular surface modifications were 
discussed, the applications they are tuned for were only briefly mentioned. In this section, 
three diagnostic applications are examined in further detail to demonstrate the great 
potential of microfluidics in the medical sciences as well as to further emphasize the 
necessity of adequate surface coatings for successful analyses. The applications selected 
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are those that are highly regarded in their respective fields and take proof-of-concept 
surface treatment studies and apply them to biological and medically focused 
applications. The microfluidic devices discussed herein are considered to be complete 
lab-on-a-chip devices in that they are fully integrated analysis systems capable of 
complete diagnostics-based studies. 
 
3.6.1. Lab-on-a-Chip Drug Analysis of Blood Serum 
Throughout this chapter, a significant number of the surface treatments discussed 
were applied to bioanalysis assays using microfluidic capillary electrophoresis. Two 
major issues with capillary electrophoresis in a microfluidic device are sample adsorption 
to capillary walls and unstable, high EOF. Both of these effects reduce resolution and 
efficiency and therefore need to be addressed to attain a high quality separation. As 
presented in many of the previous sections, a variety of channel wall surface treatments 
have been shown to significantly reduce EOF as well as non-specific adsorption. There 
are benefits and drawbacks of different surface coatings based on invasiveness, difficulty, 
and durability in which an ideal coating would be easy to apply, not interfere with sample 
analytes, and be robust throughout multiple trials over time using the same device. 
A lab-on-a-chip device with complete drug analysis capabilities including sample 
mixing, immunoreaction, separation using capillary electrophoresis, and analysis has 
been realized using a glass microfluidic device181 (see Figure 3.6a). The automatability 
and positive results achieved with this device have opened new possibilities to further 
develop such devices for clinical use. Specifically in this study, the detection and analysis 
of the asthma drug theophyllin (Th) from a blood serum sample was demonstrated. The  
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Figure 3.6. Lab-on-a-chip applications. a) Drug detection device (Subsection 3.6.1) 
schematic showing the various operating regions. Mixing of the antigen (Th) with the 
tracer (Th*) is performed between J1 and J3. Antibody (Ab) is then mixed with antigen 
and tracer in the J3-J4 immunoassay region. J4 shows the injection point into the 
electrophoresis region followed by detection. Reproduced from (Chiem and Harrison 
1998) with permission. b) A representative electropherogram showing actual results from 
a complete experiment. The bottom-most plot represents a control containing only tracer 
in buffer. The middle plot represents a mixture of antibody and tracer and the top plot 
represents a sample immunoassay with tracer and antibody. The Ab-Th* complex shows 
a distinct peak that is high when only tracer is present (middle) but decreases when Th is 
added due to competitive binding to Ab. A comparison of the two is used to quantify Th 
concentration. Reproduced from (Chiem and Harrison 1998) with permission. c) 
Schematic of the single cell transcriptome device (Subsection 3.6.2). Numbers 1-11 
represent independently controlled valves and the center “cells in” region is used for 
sample injection. Initially, valves 1-3 are used to pump sample and cell trapping occurred 
at closed valves 4-7.  Valves 8 and 10 were used to add cell lysis reagents and reverse 
transcriptase for PCR. Reproduced from (Bontoux et al. 2008) with permission. 
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mixing portion involved the labeling of diluted blood serum with a tracer and 
immunoreaction with a specific antibody, anti-Th. The free Th was then separated from 
antibody-bound Th for quantitative analysis (see Figure 3.6b). The performance of the 
device was comparable to traditional, non-integrated methods with great detection limits 
and analysis times were significantly shortened due to the microscale nature of the 
device. 
Because surface treatments are the focus of this chapter, it is important to mention 
the contribution of a surface treatment to the success of this integrated device. Similar 
devices without surface treatment showed low efficiency, tailing of analytes, and 
background fluorescence due to adsorption.182 Dynamic coating using the non-ionic 
surfactant Tween® 20 was utilized to reduce non-specific adsorption for a variety of 
reasons including ease of application compared to covalent methods and biocompatibility 
(Tween® 20 is a common immunoassay washing agent that prevents non-specific 
antibody binding). Additionally, this surface coating contributed to stable sample 
migration times due to a stabilization of EOF.183 In this specific experiment, Tween® 20 
was shown to be beneficial; however, as mentioned throughout this chapter, a multitude 
of different surface coatings have been utilized for capillary electrophoresis. When 
selecting a surface coating for your application, it is important to consider all aspects of 
the experiment and choose one that meets the requirements of the experiment (substrate, 
analyte, etc.). 
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3.6.2. Single Cell Transcriptome Analysis with Microfluidic PCR 
Gene expression is a highly studied area to improve our understanding of 
organisms including their regulatory pathways, growth, etc. To investigate complete 
genetic expression or the transcriptome, single cell analysis is appropriate. Due to small 
sample volume availability in these types of studies, microfluidics is an excellent 
platform to employ, especially since there is the potential for complete lab-on-a-chip 
development. Similar to the analysis of proteins examined in Subsection 3.6.1, DNA 
analysis poses similar obstacles in terms of substrate/analyte interactions that can impede 
successful analysis, exemplifying the need for surface treatments. Advancements in 
microfluidics have led to the development of a PDMS device that can capture and lyse 
cells followed by reverse transcriptase polymerase chain reaction (RT-PCR) 
amplification and analysis to study gene expression in mouse brain.184 The layout of this 
device is schematically depicted in Figure 3.6c. Injection of individual neuronal cells into 
the device and subsequent processing and analysis allowed for an average detection of 
5000 genes per cell, the expected number in a single cell of this type. This exceptional 
sensitivity and ability to study a cell’s transcriptome is a significant clinical advancement 
towards rapid and more complete genetic analysis to understand the pathology and 
physiology of an organism. 
A necessary and common surface treatment was used in this device: dynamic 
channel coating with the protein bovine serum albumin (BSA). Due to its 
biocompatibility and ease of use, BSA surface passivation has been commonly used in 
microfluidic PCR to reduce adsorption185 in addition to other applications discussed in 
Subsection 3.4.1. It has been reported that Taq polymerase adsorption is significant and 
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contributes the most to poor PCR performance compared to DNA adsorption which still 
occurs but to a lesser extent.186 BSA has found widespread use due to its competitive 
adsorption to substrate walls with Taq and DNA, effectively reducing unwanted analyte 
adsorption. A potential explanation of this phenomenon is that BSA has similar charge 
characteristics as DNA under microfluidic PCR conditions and therefore has similar 
attraction to substrate channel walls.187 An added benefit of BSA is that it acts as a 
stabilizing agent of polymerase enzymes in solution. Similar to the Tween® 20 capillary 
electrophoresis surface coating, an appropriate surface coating for DNA PCR was applied 
with multiple benefits to ensure increased performance whilst remaining simple to apply 
without introducing detrimental side effects to the sample. Following a common theme, 
in addition to the selected example, a vast number of surface treatments have been 
developed for microfluidic PCR and have been reviewed in the literature.188, 189 
 
3.6.3. Immunosensor to Detect Pathogenic Bacteria 
Immunoassays such as ELISA are very common diagnostic tools in the health 
sciences due to their high specificity, sensitivity, and versatility to detect a wide range of 
target analytes. Traditional immunoassays involve an antibody coated on a substrate such 
as a standard titer plate to which a sample is applied. If target antigens are present, they 
bind to the immobilized antibodies and can be detected by a variety of readout methods. 
One can imagine that bound antibodies required in immunoassays could also be coated to 
the surface of a microfluidic device as discussed in Section 3.2 for a variety of substrate 
materials.  
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An important real world health application for immunoassays is the detection of 
pathogens such as E. coli in the food industry due to the health risks associated with 
foodborne pathogens. Consequently, rapid analysis of low sample volumes is needed 
which makes microfluidics favorable over complex, labor intensive immunoassays such 
as conventional ELISA. This has led to the development of simpler detection methods 
using impedance measurements, classified as immunosensors. One such example based 
on immunosensing is a PDMS micro-immunosensor that can detect dangerous foodborne 
pathogens such as E. coli and S. aureus. The device utilizes an integrated nanoporous 
alumina membrane to which bacterial antibodies are covalently immobilized to a self-
assembled, epoxy-functionalized trimethoxysilane monolayer.190 As described in other 
silanization procedures, reactive hydroxyl groups on the substrate surface are needed (in 
this case formed with H2O2 treatment) to react with silane methoxy groups to silanize the 
surface. Amino groups on the antibodies then react with an open epoxy group 
functionalized to the silane which provides a covalent linkage between the antibody and 
the substrate surface. When a sample flows into the membrane, sensing is accomplished 
when bacteria attach to the antibodies and begin to block a nanopore, effectively 
increasing the impedance through the device (see Figure 3.7a). 
Similar surface chemistry has also been applied to a glass microfluidic bacterial 
immunosensor.133 Instead of an integrated membrane, the immunoassay takes place in a 
chamber within the glass chip silanized to immobilize antibodies (Figure 3.7b). As 
sample flows into the chamber, bacteria bind to antibodies and act as insulators by 
replacing equal volumes of conducting solution, thus altering the impedance of the 
system. In both of the aforementioned examples, analysis times are very rapid and high  
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Figure 3.7. Examples of immunosensors. a) Immunosensor schematic showing the 
capture of bacteria as it passes through a nanopore membrane. Antibodies immobilized to 
the surface trap bacteria which block the pores leading to an increase in impedance 
through the system. Reproduced from (Tan et al. 2011) with permission. b) Another 
example of an impedance based immunosensor using a simpler two chamber design in 
which glass is silanized to immobilize antibodies. As bacteria flow from the inlet into the 
large chamber (top), they are captured by the antibodies (bottom) which alters the 
electrical properties of the chamber. Bacterial sensing is accomplished by observing a 
change in impedance. Reproduced from (Boehm et al. 2007) with permission. 
 
sensitivity is attained, illustrating the capability of microfluidics as a platform for 
immunosensing. Furthermore, the versatility of silanization and covalent immobilization 
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of antibodies is illustrated with the ability to apply this surface treatment to multiple 
substrates and device designs. Despite these differences, the treatment remains effective 
in driving the immunoassay and maintaining high sensitivity. Further versatility can be 
realized by considering the ability to immobilize a variety of antibodies to various 
surfaces to detect complex bacterial samples or other biological analytes. 
 
3.7. Conclusions and Future Trends 
It is apparent that surface coatings are essential for the success of many medical 
microfluidic devices for a variety of applications whether applied to sensitive diagnosis 
or as research tools in the field of medicinal biology and chemistry. As was demonstrated 
throughout this chapter, the variety of materials and coating strategies for microfluidic 
materials is enormous. Among those, silicon dioxide-based devices are the best 
characterized and their covalent surface chemistry can be well adapted to a specific 
problem. It is therefore not astonishing that glass devices are used in many commercial 
microfluidic devices, such as in the cartridges used for the Bioanalyzer instrument from 
Agilent, for example. On the other hand, most polymer devices are flexible; a property 
that could become advantageous for point-of-care devices, implantation, and continuous 
monitoring. Additionally, most polymer devices can be fabricated with mass replication 
tools such as injection molding which allows for economical and mass production. 
Nowadays, such replication tools can even be generated with nanometer-sized features 
allowing for versatile integration and parallelization.  
Despite advancements in microfluidics, the surface chemistry of polymer devices 
strongly depends on the chemical composition of the polymer employed making general 
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surface treatment schemes, such as that provided by the silanization of glass, not 
available. Consequently, the application of polymer devices greatly depends on the 
choice of the polymer material thus available immobilization strategies will have to be 
adapted to novel polymer materials. A large variety of successful usages of polymer 
devices has been demonstrated and discussed throughout this chapter illustrating that 
adequate surface coatings can be developed for polymers to compete with glass devices 
in various applications. A specific advantage of polymer materials over glass devices 
arises due to their gas permeability, which becomes important for cell-based studies and 
diagnosis. PDMS, for example, has shown excellent gas permeability and cell culturing 
capability in tandem with appropriate surface treatments. In summary, one can expect the 
continuation of silicon dioxide-based devices for high sensitivity applications and where 
reproducibility is greatly influenced by covalent and stable coatings. Polymer devices 
have great potential for point-of-care and single use applications where within-chip 
reproducibility is not a stringent requirement but cost effectiveness is essential.  
For protein crystallography, a vast number of versatile microfluidic platforms 
exist for the endless variety of proteins and types of experiments being conducted. For 
example, the material used to fabricate a microfluidic device has significant implications 
for on-chip X-ray diffraction where X-ray transparency and absorbance become an issue. 
Furthermore, proteins and protein crystals are biomolecules with properties that favor 
binding to surfaces with compatible chemical groups (as described extensively in this 
chapter). For sustained use of a device in an SFX study (e.g. a crystal sorter), robustness 
is key in which non-specific adsorption must be controlled. This is also true for 
crystallization screening devices where nucleation and crystal growth can be influenced 
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(either positively or negatively) based on microchannel surface properties. Consequently, 
choice of material and surface coating can further improve the applicability of 
microfluidic devices to protein crystallography by broadening their use to the vast variety 
of samples in existence.
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CHAPTER 4 
DIELECTROPHORETIC SORTING OF MEMBRANE PROTEIN NANOCRYSTALS 
 
4.1. Introduction 
The importance of studying membrane proteins lies in their ubiquitous nature, 
representing 30% of cellular protein content191 and 70% of drug targets,192 and their 
functionality as transporters, signal transduction mediators, and light harvesting centers 
as well as electron transfer mediators in photosynthesis,193 among other key processes.23 
Membrane protein structure elucidation has been ridden with obstacles because of 
difficulties in forming large crystals necessary for traditional X-ray crystallography,20 in 
part due to the fact that these proteins are isolated as protein-detergent micelles.194 While 
smaller crystals may form more easily, they are destroyed by the high dose of radiation 
necessary to obtain adequate diffraction patterns and therefore cannot be used to obtain 
high-quality structure information by traditional means.18 
For these reasons, advancements in X-ray beam technology have furthered the 
development of new approaches to crystallography such as femtosecond 
nanocrystallography21, 195-198 to obtain high-resolution diffraction patterns from small 
membrane protein nanocrystals. Accordingly, X-ray exposure time is reduced to the 
femtosecond regime to outrun nanocrystal X-ray damage so that diffraction patterns can 
be obtained before the crystal is destroyed. The first proof of principle experiments for 
femtosecond nanocrystallography have been established with photosystem I (PSI) at 8 Å 
resolution199 and more recently, protein structure determination at atomic resolution has 
also been accomplished using this method.22, 198 
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In order to obtain high-resolution diffraction patterns from crystals, a well-
ordered crystal is necessary so that the diffracted signal is void of crystal lattice 
imperfections.18 Consequently, crystals in the sub-500 nm size regime are desired for 
improved shape transforms, crystal phasing uniformity, and compatibility with the beam 
diameter of the current state-of-the-art free electron lasers employed for 
nanocrystallography as well as the jetting system used to introduce crystals to the beam. 
Variations in crystal size and shape lead to large amounts of single-crystal diffraction 
data, with several hundred thousand images needed for one data set; thus a 
monodispersed sample of nanocrystals with a narrow size distribution could reduce the 
amount of data required by an order of magnitude. Nanocrystals are also desired for time-
resolved studies as diffusion times of reactants into protein crystals are reduced. 
Obtaining a desired crystal size is difficult due to broad size distributions resulting from 
traditional crystallization, and moreover, first attempts to isolate nanocrystals such as 
gravitational settling procedures are time-consuming and result in very low percent 
recoveries of desirably sized crystals.200 Here we present, for the first time, a microfluidic 
device that can sort and fractionate a bulk crystal solution to isolate a high yield of 
nanocrystals with a narrow size distribution. 
The device (Figure 4.1a) is a microfluidic sorter in which electroosmosis is 
responsible for bulk fluid transport and the selective forces deviating particles of various 
sizes are caused by DEP (see Subsection 2.2.4 and Section 4.2). A constriction is placed 
in a wide inlet channel (Figure 4.1b) to create an inhomogeneous electric field, a method 
known as insulator-based dielectrophoresis (iDEP).201 This sorter operates in a 
continuous mode in contrast to other nanoparticle sorting methods utilizing 
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centrifugation202-204 and filtration.205 The latter methods are also critical for precious and 
low abundant protein nanocrystals, as sample loss and crystal fragmentation may occur. 
Other sorting methods employ conjugated206 or chemically functionalized 
nanoparticles206, 207 for efficient separation, yet are invasive to nanocrystallography and 
detrimental to downstream applications. Furthermore, free-flow fractionation methods are 
suitable to separate nanoparticles continuously; however, methods based on free-flow 
magnetophoresis59, 60, 208-210 require the nanoparticle to have magnetic properties and thus 
cannot be applied to protein nanocrystals. DEP has also been previously applied to free-
flow fractionation of nanoparticles,69 has been miniaturized to the microchip format,211-213 
and has been employed to focus particle streams using microfluidic platforms.214, 215 
Moreover, the ability to use an iDEP-based sorting design provides additional benefits 
compared to electrode-based microsorters.216-220 Embedding electrodes complicates 
device fabrication and can lead to electrode fouling and damage to sample analytes such 
as precious protein crystals that need to remain intact during sorting for further 
downstream applications. 
Several microchannels are employed for operation: an inlet channel for sample 
injection and outlet channels to collect various sorted fractions. A reservoir is placed at 
each channel end to extract sorted particles and place independently controlled 
electrodes. To establish an inhomogeneous electric field inducing iDEP, an insulating 
material is shaped into a desired geometry to generate electric field gradients upon 
application of an external electric field. We demonstrate the proof of principle of this 
novel sorter with nanometer-sized beads and show that numerical models accounting for 
the transport process at the constriction are in excellent agreement with experiments. 
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Furthermore, we applied this sorting mechanism to crystals of PSI, a large membrane 
protein complex consisting of 36 proteins and 381 cofactors.20 These crystals constitute 
one of the most challenging samples for any sorting device, as they are very fragile due to 
having a solvent content of 78% and only four salt bridges acting as crystal contact sites. 
Yet, we demonstrate excellent sorting of size-heterogeneous PSI crystal samples using 
size characterization methods such as dynamic light scattering (DLS) and fluorescence 
microscopy as well as second-order nonlinear imaging of chiral crystals (SONICC) as a 
characterization method for sample crystallinity. 
 
4.2.  Theory 
To evoke DEP45 in the nanocrystal sorting device, electric field gradients (∇𝑬) are 
created at the constriction region as demonstrated in Figure 4.1c. Revisiting Chapter 2, 
Subsection 2.2.4, the dielectrophoretic force (𝑭𝐷𝐸𝑃) acting at the constriction region is 
given by Eq. (2.15)46 and is directly proportional to the particle radius, which was 
exploited to sort particles by size within the microfluidic device. Recalling that the sign 
of the DEP force is governed by 𝑓𝐶𝑀, which under direct current (DC) conditions is 
defined by the medium and particle conductivities, 𝜎𝑚 and 𝜎𝑝 per Eq. (2.17).
221 For the 
polystyrene beads employed in the modeling study as well as proof of principle 
experiments, 𝜎𝑝 was considered negligible;
212 therefore 𝑓𝐶𝑀 is negative and nDEP 
prevails, in which particles experience more repulsion from regions with higher ∇𝑬2. 
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4.3. Numerical Modeling 
Two particle sizes (90 nm and 0.9 µm) representative of the polystyrene bead 
experiments were modeled using COMSOL Multiphysics 4.3. A detailed description of 
the various COMSOL modules used in the model is as follows.  
 
4.3.1. Definitions and Geometry 
Using the COMSOL Model Wizard, a blank 2D geometry plane was set up. The 
device geometry was drawn in the software as an exact replicate (sans reservoirs) of the 
microfluidic channel system used experimentally. Settings were left as default unless 
otherwise specified, and parameters were set as global definitions. Using the Materials 
Browser, liquid water was selected and applied to the entire geometry using room 
temperature values for viscosity (𝜂) and permittivity (𝜀𝑚) and the solution conductivity 
used for numerical modeling was 15 µS/cm, 
The DEP component was accounted for by the DEP velocity (𝒖𝐷𝐸𝑃) and mobility 
(𝜇𝐷𝐸𝑃):
213 
 
𝒖𝐷𝐸𝑃 = −𝜇𝐷𝐸𝑃∇𝑬
2 = −
𝑟2𝑓𝐶𝑀𝜀𝑚
3𝜂
∇𝑬2 (4.1) 
Considering a 𝑓𝐶𝑀 of -0.5, 𝜇𝐷𝐸𝑃 values for the 90 nm and 0.9 µm particles were 
calculated to be -1.05 × 10-21 m4/V2s and -1.05 × 10-19 m4/V2s, respectively. A 2 orders 
of magnitude difference is apparent, reflecting the greater DEP response from the larger 
particles. In the case where no DEP contribution was considered, 𝜇𝐷𝐸𝑃 was set to zero. 
Additionally, the electrokinetic (EK) component was accounted for by the electrokinetic 
velocity (𝒖𝐸𝐾) and mobility (𝜇𝐸𝐾): 
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 𝒖𝐸𝐾 = 𝜇𝐸𝐾𝑬 = [𝜇𝐸𝑂 + 𝜇𝐸𝑃]𝑬 (4.2) 
where 𝜇𝐸𝑂 is the electroosmotic mobility, 𝜇𝐸𝑃 is the electrophoretic mobility, and 𝑬 is the 
electric field strength. Because polystyrene particles are large and exhibit negligible 
surface charge, the electrophoretic component is considered small compared to the 
electroosmotic mobility.222 Thus, 𝜇𝐸𝑃 was neglected and a 𝜇𝐸𝑂 of 1.5 × 10
-8 m2/V·s, as 
previously determined in similar devices and buffer conditions,99 substituted for 𝜇𝐸𝐾. 
Combining EK and DEP gives an overall convective velocity (𝒖): 
 𝒖 = 𝒖𝐸𝑂𝐹 + 𝒖𝐷𝐸𝑃 (4.3) 
 
4.3.2. Electric Currents (Electric Field Generation) 
This module was used to generate the electric field within the device in 
accordance with Laplace’s equation. A current conservation equation is established here, 
whereby the current flux (𝑱𝑄) is defined as follows: 𝑱𝑄 ~ 𝜎𝑚𝑬, where 𝜎𝑚 is the medium 
conductivity. For physical channel boundary conditions, the channel walls were set to an 
insulating condition (𝑱𝑄 = 0) and applied potentials were set to +10 V in the inlet (I), -20 
V in the side outlets (MO and O), and ranged from -20 V to -80 V in the center outlet (C). 
 
4.3.3. Creeping Flow (Bulk Fluid Transport) 
To establish medium fluid transport, creeping flow was applied within the 
channels using incompressible flow neglecting inertial terms (Chapter 2, Section 2.2). At 
all channel ends, an open boundary condition was set. Bulk fluid properties were set up 
as previously described in Subsection 4.3.1 and set to remain constant. The in-channel 
velocity field was established according to the Navier Stoke’s equations obeying a no-
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flow condition at the channel walls. For an EOF-driven velocity (𝒖𝐸𝑂𝐹) profile (Chapter 
2, Subsection 2.2.2) this simplifies to the Helmholtz-Smoluchowski relationship (𝒖𝐸𝑂𝐹 =
𝜇𝐸𝑂𝐹𝑬), where the previously stated EOF mobility and solved electric field were applied.  
 
4.3.4. Transport of Diluted Species 
Concentration (𝑐) profiles illustrating particle transport were obtained by 
computing the total flux (𝑱) incorporating DEP, EK, and diffusion:223 
 𝑱 = −𝐷∇𝑐 + 𝒖𝑐 (4.4) 
Diffusion coefficients (𝐷) for each particle size were calculated using the Stokes-Einstein 
equation: 
 
𝐷 =
𝑘𝐵𝑇
6𝜋𝜂𝑟
 (4.5) 
where 𝑘𝐵 is the Boltzmann constant and 𝜂 is viscosity (8.9×10
-4 Pas for water at 298 K). 
For the 90 nm and 0.9 µm particles, this resulted in values of 4.9 × 10-12 and 4.9 × 10-13 
m2/s, respectively. 𝒖 along the x axis (and similarly the y axis) was equated to 
 
𝒖 = [
𝑑
𝑑𝑥
(𝐸𝑥
2 + 𝐸𝑦
2) × 𝜇𝐷𝐸𝑃] + 𝒖𝐸𝑂𝐹 (4.6) 
where 𝑬𝑋 and 𝑬𝑦 are the electric fields along the each axis. Properties of the microfluidic 
device boundaries were also established, whereby a “no flux” (𝑱 = 0) boundary condition 
was set up along the channel walls. A relative particle concentration of 1 was set at the 
inlet (I) channel end boundary. The end position of each outlet channel was set to an 
outflow condition (−𝐷∇𝑐 = 0). Combining these particle and channel conditions, Eq. 
(4.4) was solved at steady state to obtain concentration distributions in the sorting device. 
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 𝜕𝑐
𝜕𝑡
= ∇ ∙ 𝑱 = 0 
(4.7) 
 
4.3.5. Mesh, Study, and Results 
The virtual mesh was built using the default setting for “physics controlled” using 
a “normal” element size. A study was set up as stationary to solve for all defined physics. 
The solver was set to a relative tolerance of 0.001 using the “MUMPS” solver type with 
default parameters. With this modeling framework, concentration profiles were acquired 
for the constriction region and surrounding channel sections as shown in Figure 4.2 and 
discussed in Section 4.5. 
 
4.4. Experimental Methods 
4.4.1. Materials and Chemicals 
SU-8 photoresist was purchased from MicroChem, USA. n-Dodecyl-β-D-
maltoside (β-DDM) was from Glycon Biochemicals, Germany. 2-(N-
Morpholino)ethanesulfonic acid (MES), 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic 
acid (HEPES), and poly(ethylene glycol)-block-poly(propylene glycol)-block-
poly(ethylene glycol) (brand name Pluronic F108) were from Sigma-Aldrich, USA. 
Fluorescently labeled polystyrene beads (1% w/v in aqueous suspension) with diameters 
of 90 nm (“pink”, Ex: 570 nm, Em: 590 nm) and 0.9 µm (“yellow”, Ex: 470 nm, Em: 490 
nm) were obtained from Spherotech, USA. Polydimethylsiloxane (PDMS) (Sylgard 184) 
was from Dow Corning, USA, and glass microscopy slides were purchased from Fisher 
Scientific, USA.  
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4.4.2. Device Fabrication 
The microfluidic sorter was fabricated using standard photolithography and soft 
lithography as reported previously (Chapter 2, Section 2.1).224 Briefly, AutoCAD 
software (Autodesk, USA) was used to design the sorting structure, which was 
transferred to a chrome mask (Photosciences, USA). The mask was then used to create a 
silicon master wafer by patterning structures with the negative photoresist SU-8 via 
photolithography employing suitable exposure and developing steps. A PDMS mold was 
cast using the master wafer as a template in which the negative relief of the structure 
formed microchannels in the polymer. The complete device structure was cut out of the 
mold and reservoirs were punched at the channel ends. The PDMS slab was then 
irreversibly bonded to a glass microscope slide using oxygen plasma treatment to create a 
sealed channel system. 
 
4.4.3. Photosystem I Crystallization 
PSI was purified and crystallized as previously described.200 Briefly, PSI trimers 
isolated from the cyanobacterium Thermosynechococcus elongatus were completely 
dissolved in 5 mM MES buffer containing 0.02% β-DDM and a high concentration of 
MgSO4 (typically 100-150 mM) at pH 6.4. Nucleation is induced by depleting the salt 
concentration via the dropwise addition of MgSO4-free buffer to achieve a final salt 
concentration of 6 mM MgSO4. The concentration of protein in this low ionic strength 
solution is then slowly increased to a chlorophyll concentration of 10 mM, corresponding 
to a protein concentration of 35 µM PSI trimer, and the solution is allowed to incubate 
overnight for crystallization to occur. The crystals are then subjected to several washing 
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steps with buffer containing 3 mM MgSO4 and suspended in MgSO4-free buffer 
containing 5 mM MES and 0.02% β-DDM (pH 6.4). 
 
4.4.4. Sorting Experiments 
For polystyrene bead experiments, 5 µL of 20 mM HEPES/1 mM F108 buffer 
(pH 5.1) were added to all outlet reservoirs to fill channels via capillary action. 
Polystyrene beads of 90 nm (size confirmed by DLS) and 0.9 µm were diluted and mixed 
in the same buffer and sonicated to create homogeneous dispersions. The 1% stock 
solution was used at a final dilution of 1:2000 (0.9 µm beads) and 1:1000 (90 nm beads). 
For PSI experiments, crystals were suspended in their MgSO4-free crystallization 
buffer (5 mM MES, 0.02% β-DDM detergent, pH 6.4). Platinum wire electrodes were 
placed in all reservoirs and electrodes from a multichannel DC voltage source (HVS448, 
LabSmith, USA) were connected. A 5 µL amount of particle/crystal suspension was 
added to the inlet reservoir, and LabSmith Sequence software (ver. 1.15, LabSmith, 
USA) was used to manually control each electrode voltage independently. Sorting 
experiments were generally run for 30 min during method development and testing. In 
addition to single-run, small-volume experiments, a scaled-up sorting experiment was 
performed with PSI to attain a total sorted sample volume of 300 µL. In this case, the 
small-volume sorting experiment was performed 15 times at 3 h durations per run to 
obtain a total of 300 µL of sorted nanocrystals from the MO and O reservoirs (see Figure 
4.1). 
Imaging of polystyrene beads was performed using a fluorescence microscope 
(IX71, Olympus, USA) with a dual band filter set (GFP/DsRed, Semrock, USA) to 
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narrow the fluorescence excitation and emission to that of the bead fluorophores. The 
filter set contained a 468/34-553/24 nm exciter, 512/23-630/91 nm emitter, and 493-574 
nm dichroic. An attached optical beamsplitter (Optosplit, Cairn Research, UK) containing 
510/20 nm and 655/40 nm emission filters and a 580 nm dichroic mirror (Semrock, USA) 
was used to separate the fluorescence signal from each bead type into its own frame using 
a single b/w CCD camera (iXon, Andor, UK). Imaging of PSI crystals was performed 
using fluorescence microscopy with a microscope filter set containing a 470/40 nm 
excitation filter, 580 nm dichroic mirror (Semrock, USA), and a 690/70 nm emission 
filter (Chroma, USA). The optical beamsplitter was not employed for crystal sorting 
experiments. Micro-Manager (ver. 1.4, UCSF, USA) and ImageJ (ver. 1.46, NIH, USA) 
software were used for image acquisition, processing, and analysis. 
 
4.4.5. Sample Analysis 
For polystyrene beads, 90 nm bead data were analyzed using fluorescence 
intensity in microchannel sections due to resolution limits of these smaller beads. Bead 
concentrations in each outlet channel were determined by comparing the fluorescence 
intensities of the outlet channels to that of the inlet channel. For 0.9 µm bead data, the 
Image J particle tracking plugin was used to count particles in the outlet channels for 
quantitative analysis. 
For PSI small-volume experiments, DLS (Spectro Size 302, Molecular 
Dimensions, USA) was used to analyze reservoir solutions and determine particle size 
distributions. After sorting crystals for approximately one hour, reservoir solutions were 
extracted with a transfer pipet and stored at 4°C. A 3 µL hanging droplet was set up in a 
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24-well crystallization plate and aligned to the DLS laser until a response signal was 
obtained. Each sample was subjected to 10 consecutive measurements lasting 30 s, which 
were combined into intensity heat maps. For the large-volume PSI experiments, DLS and 
second-harmonic generation microscopy imaging via SONICC (Formulatrix, USA) were 
performed on the sorted solution to confirm nanocrystal isolation and post-sorting 
integrity of protein crystals, respectively. To quantify crystal sizes in the center outlet 
reservoirs, an imaging threshold analysis was further performed to count particles present 
in the image frame. The image frame dimensions in pixels were scaled to micrometers, 
and areas were obtained for each of the traced particles to calculate particle radius, 
assuming a spherical geometry. The lower limit of detection for this method was 
approximately 800 nm due to the inability to differentiate smaller particles. 
 
4.5. Results and Discussion 
A schematic of the crystal sorter is shown in Figure 4.1, providing the overall 
channel layout (a) as well as the sorting region (b). The device is 5 mm in total length 
with a single inlet channel (I) of 100 µm width and 12 µm depth, which leads to a series  
of five outlet channels (O: outer, MO: mid-outer, and C: center). A small overall channel 
length was selected so that high electric field gradients could be generated with low 
applied potentials in order to avoid Joule heating effects and sample destruction. The 
junction between the inlet and outlets is a constriction region (Figure 4.1b) of 30 µm 
width where regions of higher gradients of the electric field squared (∇𝑬2) form. This 
geometry thus evokes DEP forces on nanometer- and micrometer-sized particles 
streaming through.224-227 The particles flow through the device from the inlet to outlets  
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Figure 4.1. Schematic of the entire sorting device (without reservoirs for clarity). a) A 
single 100 µm inlet (I) channel is connected to five outlet channels (2 outer channels (O), 
2 mid-outer channels (MO), 1 center channel (C)), where sorted fractions are collected. 
Positive potential (+HV) is applied to the inlet and negative potentials (-HV) are applied 
to outlets. The total device length is 5 mm. Scale bar is 1 mm. b) Zoomed-in schematic of 
the constriction region connecting the inlet channel to the outlets. The 100 µm wide inlet 
converges into 30 µm evoking iDEP. In (c), areas of high ∇𝑬2 are shaded, in which the 
largest DEP response is realized. Due to negative DEP, particles are repelled from these 
areas proportional to their DEP mobilities. Larger particles focus inward toward the 
center of the device, as shown by the thicker, solid arrows. Conversely, smaller particles 
that experience less 𝑭𝐷𝐸𝑃 are deflected into the side outlet channels, as illustrated with 
the thinner, dashed arrows. Scale bar is 20 µm. 
 
via electroosmosis and upon entering the constriction region experience a repulsive DEP 
force from the high-gradient region inward caused by negative DEP (nDEP; see also 
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Section 4.2), indicated as 𝑭𝐷𝐸𝑃 in Figure 4.1c. Larger particles with greater DEP 
mobilities (𝜇𝐷𝐸𝑃) experience more repulsion in this area and are focused into the center 
outlet (C), as indicated by solid, thick arrows. Conversely, smaller particles with lower 
𝜇𝐷𝐸𝑃 experience less repulsion and are able to deflect into the side outlets (O, MO), as 
indicated by the thinner, dashed arrows. 
 
4.5.1. Numerical Modeling 
Numerical modeling with two representative bead sizes (90 nm and 0.9 µm) were 
performed to model the sorting efficiency and reveal the influence of DEP on the  
concentration distributions for polystyrene bead sorting parameters (-60 V center particle 
concentration profiles according to details described in Section 4.3. In Figure 4.2a, the 
concentration distribution for 90 nm and 0.9 µm beads is shown when -20 V is applied to 
all outlet channels (O, MO, C). Both particle sizes completely deflect into all outlet 
channels; thus no sorting occurs. Figure 4.2b and c represent the outlet, -20 V other 
outlets), with and without DEP considered. In the non-DEP case (Figure 4.2b), particles 
completely deflect into all outlets similar to the conditions of Figure 4.2a. However, 
when DEP is added (Figure 4.2c), a focusing effect on the 0.9 µm particles occurs, as 
seen by > 95% of the initial concentration in the center outlet and < 5% of the initial 
concentration in the MO and O outlets. Furthermore, the smaller, 90 nm nanoparticles 
deflect and are equally distributed into all outlet channels (> 95% concentration). The 90 
nm particles are effectively isolated in the MO and O outlet channels, thus demonstrating 
a sorting effect. 
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Figure 4.2. Concentration distributions obtained from numerical modeling (for details 
see Section 4.3) of 90 nm and 0.9 µm particles in the microsorter at various potential 
schemes (+10 V inlet in all cases). a) -20 V in all outlets shows equal distribution for 
both particle sizes. b) -60 V in center outlet without DEP shows deflection of both 
particle sizes. c) -60 V in the center outlet (-20 V in all other outlets) with DEP shows 
focusing of 0.9 µm particles whereas 90 nm particles completely deflect. b) and c) 
indicate the importance of DEP in the sorting mechanism. d) Increasing the potential in 
the center outlet to highly negative values (below -80 V) can focus both particle sizes, 
indicating the importance of an optimal potential scheme. The color legend represents the 
concentration normalized to the inlet concentration. Scale bar is 100 µm. 
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These aforementioned numerical models provide evidence that DEP plays a 
significant role in the sorting process. Moreover, Figure 4.2d considers a higher negative 
potential (< -80 V) focusing both the 90 nm and 0.9 µm particles into the center outlet 
(> 95% concentration) with little deflection into the side outlets (< 5% concentration). 
The importance of an optimal potential scheme balancing the flow at the constriction 
with the DEP forces is thus substantiated with this series of models. Altogether, 
numerical modeling demonstrated that this novel microfluidic sorter provides the needed 
flexibility to adjust the potentials in each outlet channel to optimize the sorting efficiency. 
 
4.5.2. Bead Sorting 
The sorting device was subsequently tested experimentally with 90 nm and 0.9 
µm fluorescently labeled polystyrene beads with known nDEP behavior. Beads were 
suspended in low-conductivity buffer (15 µS/cm) to obtain ionic strengths similar to 
crystallization buffers used with PSI crystals (see below). Channels were dynamically 
coated with F108 blocking polymer to reduce severe adsorption of polystyrene beads to 
PDMS channel walls, reduce electroosmotic flow (EOF),99, 171 and avoid clogging due to 
particle aggregation.228 Bead experiments were initially performed by applying low 
potentials (-20 V to all outlet reservoirs with +10 V to the inlet) in order to avoid possible 
damage to protein crystals in future experiments. At this potential scheme, both bead 
types flowed into all outlet channels without sorting, which is in agreement with the 
corresponding model for identical potentials (Figure 4.2a). To induce focusing, a larger 
negative potential (-80 V and below) was applied to the center outlet, and the outcome 
was again in agreement with modeling data (Figure 4.2d), as both bead sizes focused in 
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the center outlet channel. Finally, the optimum sorting condition was found at 
approximately -60 V in the center outlet while maintaining -20 V in all other outlets. The 
0.9 µm particles focused into the center outlet (Figure 4.3a), whereas the 90 nm particles 
deflected into all outlets (Figure 4.3b). 
 
 
Figure 4.3. Results of polystyrene bead sorting. a) Fluorescence microscopy snapshot 
showing the 90 nm beads distributed in all outlet channels when -60 V is applied to the 
center outlet (-20 V to all other outlets). b) Fluorescence microscopy snapshot of the 
0.9 µm beads focusing at the same potential scheme as in (a). Scale bar is 50 µm. c) 
Quantified particle distributions in each outlet channel (as labeled in Figure 4.1) for both 
particle sizes as measured by fluorescence intensity for the 90 nm beads and particle 
counting for the 0.9 µm beads (see Section 4.4 for details). A relatively equal distribution 
is seen for the 90 nm beads, whereas 90% of the 0.9 µm beads focus into the center 
outlet. Error bars represent the standard deviation. 
 
Fluorescence intensities of the 90 nm beads in the outlet channels relative to the 
inlet channel were analyzed, and 0.9 µm beads were counted since they are large enough 
to be imaged individually. An almost equal distribution of 90 nm beads was found in all 
outlet channels, whereas 90% of the 0.9 µm beads focused into the center outlet (Figure 
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4.3c). This experimental sorting trend is thus in agreement with the numerical models 
shown previously in Figure 4.2c. We attribute this sorting phenomenon to an optimum 
DEP condition acting on the two bead sizes focusing the larger particles while allowing 
smaller particles to disperse into the side outlet channels (MO and O). Four trials were 
further analyzed to determine the sorting efficiency as a percentage defined by the ratio 
of concentration in the deflected solution versus the initial concentration. Figure 4.3c 
indicates that a sorting efficiency of > 90% is achieved for the 90 nm beads in the O and 
MO channels. For the 0.9 µm beads, a sorting efficiency of 90% in the center (C) outlet is 
observed. Additionally, because of an equal distribution of smaller, 90 nm particles into 
all outlets, 80% recovery of these particles is obtained since four of the five outlets 
contained the smaller, 90 nm particles at approximately the same concentration. These 
results indicate high recovery of the 90 nm beads with negligible dilution, which is ideal 
for nanocrystallography where the smaller particle size range is targeted. 
 
4.5.3. Photosystem I Experiments 
PSI crystals were prepared and suspended in a low-salt MES buffer containing the 
detergent β-DDM, which forms protein-detergent micelles that mimic the natural 
lipophilic membrane environment to maintain protein stability and solubility. 
Interestingly, crystal adsorption to untreated PDMS channels was insignificant in 
preliminary experiments. Consequently, the native protein crystallization buffer was used 
to maintain the optimum environment for crystal stability during all sorting experiments, 
and a channel coating agent was not employed. The procedure to sort crystals was similar 
to that of the beads; however, lower potentials were used because EOF velocity increases 
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in native PDMS channels.99 Optimal sorting was achieved with -45V applied to the center 
outlet, -20V to the side outlets, and +10V to the inlet, whereby larger crystals migrate 
toward the center channel and smaller crystals deflect into the MO and O side outlet 
channels, as shown in the fluorescence microscopy snapshot in Figure 4.4a. This 
potential scheme was appropriate under the low ionic strength conditions of PSI; 
however, this scheme can be adjusted to achieve an effective DEP response from protein 
crystals that are stable at high ionic strength, if required. 
 
 
Figure 4.4. Results of PSI crystal sorting. a) Fluorescence image of PSI crystal 
sorting. Large crystals are shown focusing in the center of the device, and smaller 
particles (as indicated by bulk fluorescence) are deflected into side outlet channels. Scale 
bar is 50 µm. b) DLS heat map of the bulk crystal solution injected into the inlet and c) of 
the center outlet focused solution. In (b) and (c), a broad size distribution is determined 
ranging from approximately 80 nm to 20 µm. d) DLS heat map of the solution deflected 
into O and MO side outlets from the same experiment showing a narrower size 
distribution of fractionated nanocrystals around 100 nm in size. 
 
Unlike the simple two-sized bead model, the crystal bulk solution contained a 
large size distribution, making it difficult to determine the crystal sizes being sorted into 
the side channels via fluorescence microscopy. We thus utilized DLS to characterize 
sorted PSI crystal fractions.229 Figure 4.4b-d shows DLS measurements in the form of 
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intensity heat maps for the inlet bulk solution, the combined deflected solutions, and the 
center outlet solution, respectively. As expected, the bulk solution had a wide size 
distribution with particle radii ranging from ~ 80 nm to ~ 20 µm. The center outlet shows 
a similar distribution since particles of all sizes flowed into the center outlet. More 
importantly, the deflected solutions contained nanocrystals with a size range of ~ 80-
200 nm, indicating excellent selectivity for the desired size range below 500 nm. It is also 
worth noting that a DLS signal from the PSI trimer that is ~ 10 nm in size230 is absent, 
indicating the crystals did not dissociate during sorting and that the sorted solution is 
mainly PSI crystals. The proposed dielectrophoretic sorter for nanocrystals thus proved 
suitable to sort PSI nanocrystals in a size range preferred for femtosecond 
nanocrystallography. This is a vast improvement over low-yielding settling procedures to 
isolate nanocrystals from protein crystallization trials of PSI that are currently the only 
method available to safely harvest nanocrystals. 
For complete compatibility with current nanocrystallography instrumentation,231 a 
sample volume of > 250 µL is required. Thus, higher throughput capabilities of our 
device were tested with multiple PSI sorting experiments (see Section 4.4 for details). To 
improve the flow rate through the device by a factor of 3, a different potential scheme 
was utilized. Increasing the inlet and center outlet potentials to +60 V and -60 V, 
respectively, while decreasing the MO and O side outlet potentials to -5 V facilitated 
sorting at higher flow rates (3 µL/h). To analyze whether this new higher throughput 
scheme could actually provide a high volume of fractionated nanocrystals, the deflected 
solutions were extracted from multiple experiments to attain a total volume of 300 µL of 
deflected solution.  
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Figure 4.5. PSI crystal image analysis. a) Fluorescence image of the inlet reservoir 
and b) of the center outlet reservoir solution after sorting a highly polydispersed, larger 
volume sample (+60 V inlet, -60 V center outlet, -5 V MO and O side outlets). Scale bars 
are 50 µm. In c) and d) a histogram of the size distribution from an imaging threshold 
analysis is shown in which a wide range of particle sizes from 800 nm to 20 µm are 
detected for both the bulk and center outlet solutions. The lower limit of detection for this 
method is 800 nm; therefore, nanocrystals below 800 nm could not be individually 
resolved. 
 
Fluorescence microscopy images of the inlet and center outlet reservoirs can be 
seen in Figure 4.5a and b. To quantify the sorting efficiency, an imaging threshold 
analysis was performed to count particles present in the image frame, as DLS is not 
suitable to quantify larger particle sizes and highly polydispersed samples. As expected, 
 105 
both solutions contain a large variation in crystal size. Figure 4.5c and d show histogram 
distributions of the crystal radii obtained from two image frames of the inlet and center 
outlet reservoirs. Particles with radii as large as 20 µm were detected in these solutions, 
which is in agreement with the DLS analysis of the low-throughput experiments. 
Particles in the low micrometer range were present in the largest numbers, indicating 
their focusing into the center outlet (no deviation into the MO and O outlets). 
Images of the deflected solution in the outlet reservoirs highly contrasted that seen 
in the inlet and center outlet reservoirs. As illustrated in Figure 4.6a, the majority of 
particles in the reservoir consisted of sizes below the optical resolution limit, indicating 
that nanocrystals were the major component of this solution. Furthermore, because of the 
higher concentration of crystals obtained from the high-throughput experiment, second-
harmonic generation imaging analysis could be used to verify crystallinity. This analysis 
is important to verify the crystalline content of the sorted solution after the crystals were 
subjected to an electric field. Second-harmonic generation via SONICC was utilized due 
to its powerful imaging capability to exclusively detect protein crystals while not 
producing signal for the trimer or the majority of salt crystals.232, 233 Figure 4.6b shows 
the resulting SONICC image of a droplet of sorted crystals, which indicates non-
centrosymmetric ordered crystals in the solution and thus verifies that crystallinity is 
maintained during the sorting process.  
To analyze crystal size in the large-volume deflected solution, DLS was again 
used. Figure 4.6c shows the DLS heat map of the deflected solution, and Figure 4.6d 
shows a histogram of particle radius with respect to counts for the corresponding DLS 
run. The major peak corresponds to a 100 ± 30 nm radius, and a slight increase in the  
 106 
 
Figure 4.6. Sorted fraction characterization. a) Fluorescence microscopy image of the 
solution in the O outlet reservoir containing the deflected solution (same experiment as 
Figure 4.5). As observed, very few particles can be individually resolved compared to the 
bulk and center outlet reservoirs shown in Figure 4.5, indicating a high content of 
nanocrystals. Scale bar is 50 µm. b) SONICC image of the high-volume sample 
indicating crystallinity of the sample after having passed through the sorting device, as 
indicated by the second-harmonic generation signal observed. c) DLS heat map of the 
deflected solution mainly containing nanocrystals (~ 60-300 nm) with a small 
contribution from microcrystals. d) Histogram of the DLS measurement: The major peak 
represents crystals with radii of 100 ± 30 nm, and an overall distribution shows a radii 
range of ~ 60-300 nm. A small contribution by microcrystals of ~ 1 µm in size is also 
seen here. 
 
overall radius distribution compared to the lower throughput sorting (Figure 4.4) is 
observed with an overall radius distribution of ~ 60-300 nm and a small contribution 
from particles with radii of ~ 1 µm. The slight broadening of the main peak could be due 
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to the duration of the experiment and the equilibrium between the crystal and surrounding 
solution where protein molecules are gained and lost over time, causing larger crystals to 
form at the expense of smaller crystals. This “high-throughput” experiment demonstrates 
the capability of this novel microfluidic sorter to provide large (~ 300 µL) volumes of 
fractionated nanocrystals without considerable dilution in the side channels. Moreover, 
the size distribution remains narrow and within the realm desired for femtosecond 
nanocrystallography. 
 
4.6. Conclusions 
We demonstrated a novel sorter for nanoparticles and large membrane protein 
complex crystals realized within a microfluidic device employing DEP. Numerical 
modeling of the sorting device first demonstrated its suitability for particle sorting of 
solutions containing submicrometer particles. Optimal conditions for polystyrene bead 
sorting revealed in numerical modeling were in excellent agreement with experimental 
results employing 90 nm and 0.9 µm beads. Applying similar conditions in low-
conductivity buffer to PSI crystals demonstrated that nanocrystals of ~ 100 nm in size can 
be isolated from a bulk solution containing a broad crystal size range. Even when 
multiple experiments were performed to provide a large volume of sorted sample, the 
process was reproducible and resulted in a large volume (~ 300 µL) of fractionated 
nanocrystals (~ 60-300 nm). This volume is in the range typically required for 
nanocrystallography experiments, and we have applied for beam time to test the sorted 
PSI crystals at the Linac Coherent Light Source. Furthermore, PSI remained crystalline as 
it passed through the sorting system, as confirmed by second-harmonic generation 
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imaging. The flexibility of this device thus allows fine-tuning for optimal separation of 
delicate particles such as protein crystals even in the demonstrated case of fragile, PSI 
nanocrystals exhibiting high solvent content. 
In the future, isolated nanocrystals extracted from the presented microfluidic chip 
can be delivered to femtosecond nanocrystallography experiments for membrane protein 
structure determination. The described method represents a relatively simple 
microfabrication method, comprised of elastomer molding procedures, and can thus be 
seamlessly used in crystallography laboratories. Applied potentials are below 100 V and 
can be provided through readily available voltage sources. Furthermore, for protein 
crystals in high ionic strength buffers, experimental parameters (e.g., electric potentials) 
can be adjusted to improve the DEP response, or in more extreme cases, the device 
design can be tailored to accommodate a given DEP characteristic. We thus expect our 
method to be easily applied to a large variety of protein crystals and to be highly relevant 
to the endeavor of protein structure determination via nanocrystallography. Besides 
reservoir recovery, the employed microfabrication method could also be directly coupled 
to a similarly fabricated nozzle234 to deliver crystals for femtosecond 
nanocrystallography. These optimal samples would aid in improving the efficiency of 
protein crystallography afforded by this new technology, enabling structure elucidation 
and a new understanding of many proteins with unknown structures that catalyze key 
functions in biology. 
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CHAPTER 5 
HIGH-THROUGHPUT PROTEIN NANOCRYSTAL FRACTIONATION IN A 
MICROFLUIDIC SORTER 
 
5.1. Introduction 
X-ray crystallography is the primary method of choice for protein structure 
determination and has been used for decades to solve more than 85,000 structures. While 
this method is powerful, there are biologically important classes of proteins that have 
eluded the traditional X-ray community, namely, difficult-to-crystallize membrane 
proteins and protein-protein complexes.20, 193, 194 Out of the tens of thousands of protein 
structures deposited in the Protein Data Bank, less than 500 unique membrane protein 
structures have been solved to date,20 largely due to the high degree of long-range 
disorder in their crystals often referred to as “mosaicity”.21 Furthermore, growing large, 
well-ordered single crystals of membrane proteins and large complexes for standard 
crystallography can take months or even decades. The recent advent of the X-ray free-
electron laser (XFEL) has allowed crystallographers to begin to uncover the structures of 
these complex proteins through serial femtosecond crystallography (SFX) experiments 
where smaller crystals can be utilized.23, 195 Submicrometer sized crystals also provide an 
added benefit since they contain only a few hundred or thousand unit cells, thus featuring 
minimal long-range disorder yielding better quality diffraction data for improved 
structure determination. Crystallization methods have been established to grow showers 
of small crystals, but these crystallization products are generally heterogeneous in size 
which can complicate SFX data analysis due to the necessary merging of tens of 
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thousands of diffraction patterns from crystals of different sizes and orientations into a 
final product, the electron density map.18, 235 
A further experimental challenge in SFX data collection is the small dynamic 
range of the X-ray detector, which is damaged by pixel overheating from strongly 
diffracting crystals larger than a few micrometers, requiring the XFEL beam to be heavily 
attenuated to protect the detector at the expense of data quality.  Thus, having a less 
dispersed, submicrometer-sized crystal sample for SFX could reduce the number of 
diffraction patterns needed (thus reducing precious sample consumption and time at the 
XFEL), improve data quality (with an XFEL beam at full intensity), and simplify the 
process of data merging and indexing with more similar diffraction patterns.21 
An effective way to obtain defined size homogeneity is to fractionate a bulk 
crystallization product to isolate smaller crystals for SFX. Ideally, such experiments 
should be automated, continuous, and not alter the sample. Traditionally, fractionation 
has been accomplished using common methods such as capillary electrophoresis,67, 236, 237 
chromatography,238-240 and field flow fractionation (FFF);241-244 however, several 
disadvantages arise such as stringent sample volume requirements or the sample needing 
specific inherent or additive chemical properties for the separation mechanism to work. 
With the rise of microfluidic technologies245 over the past decade, many traditional 
methodologies have been transferred to “labs-on-a-chip”68, 246, 247 where in some cases 
greater experimental control and diversity can be accomplished. Due to the inherently 
small scale of such technologies, separation science has greatly benefitted, namely, in 
relation to biological applications. Examples of microfluidic separations have included 
proteins and DNA,68, 248 cells,249-251 and magnetically-functionalized particles,252, 253 and 
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more recently, the use of DEP has been applied to separation-based particle 
manipulation.71, 254 The latter has sparked great interest due to its applicability to a very 
broad spectrum of sample types in their native state without labels, specifically making it 
attractive for biological separations. 
One requirement to invoke DEP is an inhomogeneous electric field under which 
gradients establish (∇𝑬) that are directly proportional to the DEP force (𝑭𝐷𝐸𝑃 ∝ ∇𝑬
2). 
Such fields can be created by patterning electrodes within microchannels; however, 
fabricating electrodes this way can become arduous for more complex channel designs, 
and sample damage can result due to electrode fouling. Insulator-based DEP (iDEP) was 
introduced as an alternative in which creative microchannel designs are patterned in 
substrate materials (such as elastomers), deviating electric field lines to form DEP-
inducing inhomogeneities.224, 255-258 This method follows all the aforementioned rules 
about maintaining sample integrity, while microfluidics provides a continuous and 
automated platform. 
We previously developed a microfluidic method to sort nanoparticles from 
microparticles using iDEP with the goal of isolating protein nanocrystals for SFX.259 The 
first-generation device reported is presented in Figure 5.1a. As shown, this device 
contained a single inlet channel connected to a series of five outlet channels via a ∇𝑬2-
forming constricted channel region where negative iDEP (repulsion from high ∇𝑬2) is 
induced. Briefly, the sorting mechanism is based on the correlation between 𝑭𝐷𝐸𝑃 and 
particle size, whereby large particles repel from high ∇𝑬2 within the constriction and 
focus centrally in the device while small particles less influenced by DEP deflect away. 
The overall device length is ~ 5 mm, with a maximum reservoir diameter of 2 mm 
 112 
(dotted). Consequently, the possible throughput of this device is limited to a few µL/h 
with a reservoir capacity of 5-10 µL. For SFX, a minimum sample volume of ~ 300 µL is 
necessary; therefore, to prepare one sorted sample of adequate volume, at least 1 week 
was required. This is unfeasible, as such samples ideally should be prepared quickly for 
experimental progression and to ensure sample integrity. 
Here, we describe the development of a second-generation microfluidic sorter 
based on the same sorting mechanism to achieve this goal in a more feasible timespan.  
The development process consisted of a numerical model to optimize a new design 
meeting various experimental requirements (discussed later). During this process, we 
determined several physical relationships between different controllable parameters 
allowing us to predict sorting outcomes from input variables. The theoretical study is 
based on nano- and microbeads with known migration properties since our previous study 
revealed that these parameters are suitable to predict photosystem I (PSI) nanocrystal 
sorting. After optimization with numerical modeling, fractionating two differently sized 
nanobeads from microbeads in the optimized device is demonstrated with high sorting 
efficiencies in addition to effectual sorting  of submicrometer PSI protein crystal fractions 
allowing for their isolation from a bulk crystal suspension.  
 
5.2. Methods 
5.2.1. Numerical Modeling 
The theoretical study presented in this paper consisted of numerical modeling 
performed with the finite element analysis software COMSOL Multiphysics 4.4. 
Theoretical parameters were chosen to reflect experimental subjects (well understood 
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polystyrene beads which show similar sorting behavior to PSI crystals259). The basic 
model was set up as described in Section 4.3 with some variations as follows. 
Using the COMSOL Model Wizard, a blank 3D axisymmetric model was set up. 
Two-dimensional device geometries were created with polylines and 40° fillets using 
AutoCAD software (Autodesk, USA) in the .dxf format, which were imported into 
COMSOL with length unit µm. A work plane was created and the plane geometry was set 
as the imported file. The work plane was homogeneously extruded 100 µm in the z 
direction to form a three-dimensional structure. Settings were left as default unless 
otherwise specified, and parameters were set as global definitions.  
Fluid properties and 𝜇𝐸𝑂𝐹 were set as described in Subsection 4.3.1. Values of 
𝜇𝐷𝐸𝑃 and 𝐷 were calculated for each particle diameter as discussed in Subsections 4.3.1 
and 4.3.4, respectively, and are listed in Table 5.1 for each particle size examined. The 
electric field was generated using the Electric Currents module as discussed in 
Subsection 4.3.2, bulk fluid flow was considered using the Creeping Flow module as 
described in Subsection 4.3.3, and particle transport was incorporated with the Transport 
of Diluted Species module as described in Subsection 4.3.4. The model was solved as 
described in Subsection 0 to generate surface plots for species concentration distribution, 
fluid velocity, electric field, and ∇𝑬2. For the figures, surface plots were exported using 
the snapshot export function to 300 dpi resolution using a defined locked camera view for 
all models. 
To calculate sorting efficiency, concentration values were taken from the ends of 
each side channel outlet. A cutline was drawn spanning the entire channel end domain 
and > 100 values were recorded along this line and averaged to determine the final side 
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channel concentration. Both side channel means were then averaged to produce a final 
concentration value. To produce the ∇𝑬2 vs. position plot, an interval-defined cutline was 
drawn as shown in Figure 5.3 and 30 values at the same x-axis locations for both 
constriction geometries were polled and exported. All final plots shown in the figures 
were created using Origin Pro software (OriginLab, USA). 
 
Table 5.1. Calculated diffusion coefficients and DEP mobilities for all particle sizes 
studied. 
𝒅 (nm) 𝑫 (m2/s) 𝝁𝑫𝑬𝑷 (m
4/V2·s) 
100 4.90×10-12 -3.32×10-22 
250 1.96×10-12 -2.08×10-21 
500 9.81×10-13 -8.31×10-21 
750 6.54×10-13 -1.87×10-20 
1000 4.90×10-13 -3.32×10-20 
2500 1.96×10-13 -2.08×10-19 
 
5.2.2. Device Fabrication 
The microfluidic devices employed were fabricated with poly(dimethylsiloxane) 
(PDMS) using standard photolithography and soft lithography techniques (Chapter 2, 
Section 2.1).259 Briefly, a silicon master wafer was patterned using SU-8 photoresist from 
a photomask containing the microchannel designs. Uncured PDMS/cross-linker was 
poured on the wafer and baked at 80°C for 4 h to polymerize. The resulting PDMS slab 
was then irreversibly sealed to a glass slide using oxygen plasma treatment to create a 
closed channel system. Reservoirs with 6 mm diameters were punched into channel ends 
to provide platinum electrodes access to the solutions in the channels. A high voltage 
source (HVS448, LabSmith, USA) controlled by Sequence software (LabSmith, USA) 
was connected to the electrodes to supply potentials to each reservoir, and a negative 
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pressure pump (MFCS-EZ, Fluigent, France) was used to maintain even solution levels 
between the outlets and inlet reservoirs to reduce hydrodynamic pressure differences. 60 
µL of each sample analyte suspension was added to the inlet reservoir prior to each 
experiment. 
 
5.2.3. Sample Preparation and Data Analysis 
Fluorescent polystyrene beads (Spherotech, USA) were suspended in 1 mM 
Pluronic F108 in water to reduce aggregation and adsorption to channel walls. The 
200 nm (λ Ex: 470 nm; λ Em: 480 nm) and 500 nm (λ Ex: 590 nm; λ Em: 620 nm) beads 
were diluted 1:1000, and the 2.5 µm beads (λ Ex: 620 nm; λ Em: 650 nm) were diluted 
1:500. PSI crystals were prepared as described previously.200 Imaging was performed 
using a fluorescence microscope (IX71, Olympus, USA) with excitation, emission, and 
dichroic filters (Semrock, USA) suitable for each fluorophore incorporated in the beads 
and PSI crystal autofluorescence. For the 200 nm/2.5 µm bead sorting experiments, an 
optical beamsplitter (Optosplit, Cairn Research, UK) was used due to their widely 
different fluorescence characteristics allowing simultaneous imaging on spatially distinct 
regions of a sensitive camera. A CCD camera (iXon, Andor, UK) captured frames using 
Micro-Manager software (ver. 1.4, UCSF, USA) which were analyzed using ImageJ 
software (ver. 1.49, NIH, USA). 
To determine sorting efficiency in the bead experiments, concentrations were 
quantified by particle counting of the microbeads and measuring average fluorescence 
intensities of the nanobeads spanning the visible “S” channel area since they are below 
the optical resolution limit of the microscope. PSI crystal size characterization was 
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performed using dynamic light scattering (SpectroSize 302, Molecular Dimensions, UK) 
of an extracted “S” outlet reservoir solution by taking 10 measurements lasting 20 s each. 
 
5.3. Results and Discussion 
5.3.1. Second-Generation Device Design Process 
The process to determine a device design for this second iteration of the 
microfluidic sorter (Figure 5.1b) entailed several criteria: (1) increase throughput, (2) 
increase channel and reservoir volume capacities, (3) reduce experimental complexity, 
and (4) minimize overall device size. 
To increase volume throughput, the original device was scaled-up 5-fold in 
channel width and 10-fold in channel height. In early development of the first sorter, we 
envisioned collecting more than two fractions in different sets of outlet channels (hence 
having five); however, it was deemed unnecessary as we learned the device could be 
tuned to one desired size fraction and more of that single fraction could be attained by 
eliminating a third fraction. Furthermore, controlling the applied potentials in four 
reservoirs versus six reduces experimental complexity and equipment needs. As such, the 
number of outlet channels was reduced from five to three (two sides and one center), and 
the width of each of the side channels (where the desired fraction is usually collected) is 
double that of the center outlet channel to increase recovery. Lastly, to reduce the needed 
applied potentials, we shortened the channel lengths to the minimum length that would 
allow for a 6 mm reservoir (dotted) with a > 100 µL solution capacity, a > 25× increase 
over the first version. Figure 5.1b summarizes the geometry based on these 
improvements. 
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Figure 5.1. Schematics of both microsorter generations. a) Device schematic of the 
first-generation microsorter with 2 mm reservoirs (dotted). The arrow indicates the fluid 
flow direction caused by EOF. b) Schematic of the final device design for the second-
generation microsorter with 6 mm reservoirs (dotted). The location of the deflection 
angle (θ) is indicated in blue. c) Zoom-in of the constriction region from (b) showing the 
computed ∇𝑬2 in the device exemplarily. A 4 order of magnitude increase in the 
maximum ∇𝑬2 occurs along the constricted channel walls compared to the pictured inlet 
region. 
 
Upscaling included the constriction region which was boosted from 30 µm to 150 
µm (Figure 5.1c). The increase in device dimensions allows for sorting larger volumes of 
sample in shorter time frames, yet since the ratio between the inlet channel and 
constriction widths was maintained, similar iDEP sorting properties were expected. 
Figure 5.1c shows the computed ∇𝑬2 within the constriction region, where high values 
(up to 1016) are found at the entrance and exit corners of the constriction (model details 
can be found in Subsection 5.2.1, and the applied potentials are discussed later). In that 
area, ∇𝑬2 increases up to 4 orders of magnitude from the inlet region shown, leading to 
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iDEP comparable to but slightly higher in generated forces than the first-generation 
design for similar particle sizes.  
As shown in Figure 5.1b and c, the angle of the side channel with respect to the 
inlet channel (θ) was chosen to be 65°. Since two of the outlet channels were removed, 
we investigated which θ values between 65° and 135° could accommodate large 
reservoirs and provided the best sorting results (see the next section for optimized sorting 
input parameters). We selected particles with diameters of 500 nm and 2.5 µm, as these 
represent sizes relevant to our application of protein crystal fractionation to isolate 
nanoparticles/crystals from microparticles/crystals. We employed DEP parameters for 
polystyrene particles exhibiting negative DEP and scaled the DEP mobility with the size 
of the particles, as previously shown to provide a suitable model for crystal sorting in 
similar size ranges and with similar DEP characteristics.259 From the calculated 
concentration distributions, sorting efficiencies were developed to gauge an effective 
sorting event. We defined the sorting efficiency (𝛴) as follows: 
 
𝛴 = [1 − (
𝐶𝑆,𝑙𝑎𝑟𝑔𝑒
𝐶𝑆,𝑠𝑚𝑎𝑙𝑙
)] × 100 (5.1) 
where 𝐶𝑆 is the normalized side channel (“S”) concentration. A sorting condition is 
defined when the normalized concentration of the smaller particle (𝐶𝑆,𝑠𝑚𝑎𝑙𝑙) is greater 
than that of the larger particle (𝐶𝑆,𝑙𝑎𝑟𝑔𝑒). Instances where 𝐶𝑆,𝑠𝑚𝑎𝑙𝑙 < 𝐶𝑆,𝑙𝑎𝑟𝑔𝑒 were not 
considered. In all cases, the center outlet (“C”) channel normalized concentration was 1. 
Further details on how concentration values were sampled can be found in Subsection 
5.2.1. 
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Table 5.2. Various geometry angles tested and their corresponding side voltages 
needed to achieve the maximum sorting efficiencies listed. 
θ VS (V) 𝜮 
65° -155 91.6% 
90° -160 90.2% 
115° -170 82.7% 
135° -190 72.9% 
 
To find a suitable baseline potential scheme, two criteria were employed: (1) a 
target sorting efficiency of ≥ 90%, as this is generally considered acceptable in separation 
applications,260-263 namely, crystal sorting for SFX, and (2) a flow rate 2 orders of 
magnitude larger than the first-generation device (≥ 75 µL/h) to reduce sorting time to 
hours. To accurately calculate the flow rate within the device, 3D modeling was 
performed (details in Subsection 5.2.1). A baseline inlet (VI) and center outlet (VC) 
voltage were established (VI = +200 V, VC = -750 V) and side outlet voltage (VS) was 
varied to achieve a maximum 𝛴 for each given θ, as shown in Table 5.2 
At the voltage schemes selected, the flow rate did not vary considerably. Two 
significant trends were observed: as θ increased, VS increased by as much as 35 V and 𝛴 
decreased by 20%. For larger θ, increasing VS to boost 𝑬 was necessary to achieve a 
nonzero 𝛴 because the corner sharpness between the constriction and side channel 
decreased, reducing the values of ∇𝑬2 found in that region. However, in these types of 
microfluidic devices applied to biological systems, the lowest possible electric field is 
desired to avoid sample damage. Consequently, the minimal possible θ of 65° to fit large 
reservoirs was selected as the optimal configuration for low electric fields and high 
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sorting efficiencies. All further studies presented in this chapter are based on this 
geometry. 
 
5.3.2. Sorting Voltage Threshold Study 
Next, we investigated optimized sorting schemes dependent on applied potentials, 
both with our numerical model and experimentally with polystyrene beads. 
Representatively, calculated concentration profiles for sorting 500 nm particles from 
2.5 µm particles (VI = +200 V, VS = -155 V, VC = -750 V) are shown in Figure 5.2a and 
b, respectively (profiles for θ = 90°, 115°, and 135° are provided in Appendix A). 
Figure 5.2a shows 500 nm particles deflecting into the side channels with a 𝐶𝑆,𝑠𝑚𝑎𝑙𝑙 > 0.9, 
and Figure 5.2b shows 2.5 µm particles mainly focusing into the center of the device with 
a 𝐶𝑆,𝑙𝑎𝑟𝑔𝑒 < 0.1, leading to a 𝛴 of 91.6%. During optimization of this potential scheme, 
we noticed a voltage threshold that occurred at the transition between DEP sorting and 
complete focusing due to “I”/“C” channel dominance by EOF. To investigate this effect 
further, we modeled varying VI between +50 and +400 V (VC = -155 V and VS = -750 V) 
to examine how voltage and maximum ∇𝑬2 influence Σ, as represented by black circles 
in Figure 5.2c. 
A sharp transition is apparent (within ~ 5 V) after which bulk flow induced 
through EOF dominates the system when VI < +200 V. This is supported experimentally 
(red symbols in Figure 5.2c) in which a similar behavior was observed when VI ~ +190 V 
for sorting a mixture of 500 nm and 2.5 µm beads by varying VI within a similar range. 
We attribute this to the fact that the inlet potential is effectively “pushing” the bulk fluid 
toward the outlets without discriminating between the sides or center. EOF into the side 
 121 
channels is dependent on the potential drop established between potential acting in the 
intersection and VI and VS. When VI is too low, this potential drop is too small to support 
EOF into the side channels; thus, particles of all sizes are mainly transported into the 
center channel. Conversely, when VI becomes too large (beyond the transition), more 
particles than necessary are pushed into the side outlet by EOF, thus decreasing Σ in a 
linear fashion. As expected, increasing VI increases the maximum realized ∇𝑬2 which 
one might expect would improve the DEP sorting effect monotonically; however, we 
show here that other significant physics such as geometric distribution of the electric field 
and EOF also play a role in governing Σ and are equally important to explain the sharp 
transition in sorting efficiency. 
 
 
Figure 5.2. Second-generation microsorter numerical modeling results. 
a) Concentration profile of 500 nm particles deflecting at the baseline voltage scheme (VI 
= +200 V, VS = -155 V, VC = -750 V). b) Concentration profile of 2.5 µm particles 
focusing at the same potentials. Color bar indicates normalized concentration values. c) 
Threshold plot comparing variations in VI to sorting efficiency (VS = -155 V, VC = -750 
V). From the model (black circles), a maximum efficiency is apparent at +200 V. A 
similar threshold was also observed experimentally (red symbols).  
 
To further confirm whether high sorting efficiencies are apparent at the optimal 
potential scheme established from the model (VI = +200 V, VS = -155 V, VC = -750 V), 
two polystyrene bead pairs were tested experimentally. Figure 5.3a shows a fluorescence  
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Figure 5.3. Experimental results of polystyrene bead sorting. a) Fluorescence 
microscopy image overlay (100 frames) of 500 nm and 2.5 µm bead sorting showing the 
microbeads (thick lines) focusing into “C” while the nanobeads (thin lines) deflect into 
“S” at the model-optimized potential scheme (VI = +200 V, VS = -155 V, VC = -750 V). 
b) Fluorescence microscopy image overlay (100 frames) of 2.5 µm beads focusing into 
“C” while (c) shows 200 nm beads deflecting into “S” under lower applied potentials 
(VI = +200 V, VS = -155 V, VC = -250 V). d) Calculated Σ for both sorting events 
indicating high levels of sorting (> 90%) in both cases. 
 
microscopy image overlay (100 frames) of the constriction region to enhance the particle 
trajectories during a sorting event for 500 nm and 2.5 µm bead sorting. The 
microparticles represented by the thicker lines focus into “C” (along the dotted yellow 
arrow) while nanoparticles (thin lines) deflect into “S” (along the dashed blue arrows), as 
expected, leading to a high Σ of 93.8 ± 0.4%. For further comparison, a second particle 
size pair was tested in the device using a slightly smaller nanoparticle (200 nm) and the 
same microparticle (2.5 µm). It was observed in this case that the potential scheme 
needed to drive sorting was lower than before (VI = +200 V, VS = -155 V, VC = -250 V), 
likely due to the greater difference in particle size requiring lower ∇𝑬2 values for sorting. 
Figure 5.3b and c shows fluorescence microscopy image overlays (100 frames) of the 2.5 
µm particles focusing and 200 nm particles (bulk fluorescence) deflecting, respectively, 
which were recorded simultaneously. Image frames were split using an optical 
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beamsplitter due to differing fluorescence properties of the beads. A similarly high Σ of 
94.8 ± 0.8% was calculated for this particle pair, which is shown in Figure 5.3d alongside 
Σ for the 500 nm/2.5 µm sorting event. 
 
 
Figure 5.4. PSI crystal sorting in the optimized design (VI = +50 V, VS = -150 V, VC 
= -100 V). a) DLS signal heat map illustrating the broad size distribution (~ 200 nm to ~ 
20 µm) of a bulk PSI crystal suspension. b) Fluorescence microscopy image of PSI 
crystals being sorted in the device where large crystals are focusing and small crystals 
deflect into “S”. c) DLS signal heat map of the “S” fraction showing a submicrometer 
size distribution is isolated from the bulk.  
 
To study our application of interest whether protein crystals could be sorted using 
this optimized device, we applied a PSI crystal sample with a heterogeneous size 
distribution of ~ 200 nm to ~ 20 µm, as characterized by dynamic light scattering (DLS) 
in Figure 5.4a. Figure 5.4b shows a fluorescence microscopy snapshot of the sorting 
event (VI = +50 V, VS = -150 V, VC = -100 V) illustrating large crystals centrally 
focusing in the device while smaller crystals deflect (bulk fluorescence indicates small 
nanocrystals and a few large nanocrystals and small microcrystals can be resolved). 
Interestingly, lower overall potentials were required for sorting, likely due to an 
electrophoretic component from the charged protein. Because of the more continuous size 
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distribution, a similar quantitative analysis, as in the bead case, cannot be applied. 
Therefore, we again employed DLS to measure the size distribution of the deflected “S” 
fraction after recovery of the reservoir volume. Figure 5.4c shows a DLS signal heat map 
of this fraction indicating a submicrometer size distribution is attained as desired, with a 
major contribution lying between ~ 400 nm to ~ 800 nm. Some microcrystals are also 
detected, which is expected as the sorting efficiency is expected to be around 90% as 
previously observed in the bead experiments. As these sorted crystals were extracted for 
DLS measurement, they can also be directly loaded into a sample injector21 and delivered 
to the XFEL beam for SFX experimentation. 
 
5.3.3. Effect of Constriction Width 
A main requirement of iDEP is the appearance of high ∇𝑬2 regions, which in our 
device is accomplished by converging the electric field from the inlet into a constriction 
region. The ratio between these widths was 3.3:1 in the first-generation device and was 
maintained during upscaling. Because the device volume expanded, the applied potentials 
also increased accordingly to maintain similar ∇𝑬2 generation and thus DEP sorting 
effects. In the previous micro/nanosorting example, this increase was reasonable for 
biological applications. However, for smaller samples with smaller DEP mobilities (i.e., 
within the nanoregime) where ∇𝑬2 needs to be much higher for a DEP effect to be 
realized, alternatives to increasing voltage need to be considered. 
One way to do this is to increase the width ratio between inlet and constriction. 
Figure 5.5a and b illustrates one example where we reduced the constriction width by a 
factor of 3 from 150 to 50 µm (10:1 inlet width/constriction width) and modeled ∇𝑬2 in 
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that area using the optimized sorting potentials discussed in the previous section. A 
cutline was drawn spanning 300 µm along the constriction wall, with corresponding ∇𝑬2 
values given in Figure 5.5c. A significant difference arises between the two constriction 
types with a nearly 1 order of magnitude increase in ∇𝑬2 for the 50 µm constriction 
versus the 150 µm constriction, leading to a 6.5-fold increase in magnitude between the 
pictured inlet and constriction in Figure 5.5a. Additionally, the region of higher ∇𝑬2 
values broadens (peak area increases) and a greater displacement between the two peak 
maxima occurs (60 to 80 µm) because the corner connecting the right constriction edge 
and side outlet shifts inward, leading to a slight lengthening of the constriction channel. 
Combined, these effects increase 𝑭𝐷𝐸𝑃 to improve sorting. 
To examine the improvement in sorting, we tested whether 1 µm particles could 
be sorted from 100 nm particles with the 50 µm wide constriction. A potential scheme 
was developed to achieve a 𝛴 of 92% (VI = +600 V; VS = -585 V; VC = -2250 V) and 
resulting concentration profiles are shown in Figure 5.6a and b for 100 nm and 1 µm 
particles, respectively. It should be noted that while potentials still had to be increased to 
achieve this level of sorting, the electric field remains nondestructive in magnitude for 
proteins.264 Furthermore, this voltage increase was still 2.5 times less than that required to 
achieve a 𝛴 > 90% for sorting 100 nm from 1 µm particles using the larger 150 µm 
constriction device. At the potential scheme yielding a 𝛴 > 90% with the 50 µm 
constriction, the 150 µm constriction (Figure 5.6c,d) showed significant deflection of 1 
µm particles and 𝛴 declined to 62%. For both constrictions, we also examined sorting 
four intermediate particles sizes with respect to the 1 µm particles to study resolution 
(concentration profiles for 250, 500, and 750 nm are shown in Appendix A). Figure 5.6e  
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Figure 5.5. Comparison of two constriction widths. a,b) Models of 𝛻𝑬2for the 50 and 
150 µm constriction designs, respectively. c) Plot of 𝛻𝑬2sampled from the dotted lines in 
(a) and (b) showing a significant difference in maximum values nearing 1 order of 
magnitude. 
 
presents the calculated 𝛴 for each particle sorting pair using the same potential scheme. 
As indicated, an acceptable 𝛴 > 90% is obtained for 100 and 250 nm particles; however, 
it declines to 85% and 66% for 500 and 750 nm particles, respectively, indicating smaller 
differences in DEP mobility would need to be addressed with other geometries. 𝛴 of 
these intermediate particle sizes was also calculated for the 150 µm constriction whereby 
no particles had an acceptable value as expected (maximum was 62% for 100 nm 
particles down to 35% for 750 nm particles). In both cases, the relationship between 𝛴  
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Figure 5.6. Comparison of the nanoparticle sorting ability for both constriction 
widths. Concentration profiles showing (a) 100 nm particles deflecting and (b) 1 µm 
particles focusing in the 50 µm constriction under the same applied potentials (VI = 
+600 V; VS = -585 V; VC = -2250 V). Under the same scheme, (c) and (d) show 
concentration profiles of each particle size in the 150 µm constriction. Through this wider 
constriction, the 1 µm particles exhibit a greater deflected concentration. e) Shows the 
sorting efficiencies of various particles sizes with respect to the 1 µm particles. In the 50 
µm constriction, 100 and 250 nm particles give acceptable sorting efficiencies (𝛴 > 90%), 
whereas in the 150 µm constriction, no particles sizes are sorted efficiently (𝛴 < 90%). 
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and particle size could be fit exponentially (R2 = 0.99), indicating that the degree of 
sorting between two particle sizes can be predicted for a given voltage scheme and device 
geometry. Note that Appendix A (Figure A-3) further discusses trends between VI and VS 
for both micro/nanosorting and nanosorting, which can also be studied with this model. 
 
5.4. Conclusions 
We have presented a detailed optimization strategy and procedure to develop a 
high-throughput microfluidic sorter based on iDEP. Initially, several aspects of the 
second-generation geometric design were finalized including channel width and length, 
angles between channels, and reservoir size. Physical limitations (e.g., reservoir 
crowding) were first considered, then a calculated sorting efficiency was used to optimize 
specific geometric parameters by testing the sorting mechanism at a baseline potential 
scheme. Voltage thresholds to give the best sorting result were presented, whereby the 
importance of voltage tuning was demonstrated to achieve the highest efficiency. The 
optimized design exhibited high theoretical and experimental sorting efficiencies of 
91.6% and 93.8%, respectively, to sort 500 nm particles from 2.5 µm particles at the 
discovered optimal potential scheme. The possibility to sort smaller particles (100 nm 
from 1 µm) was also discussed, which can be accomplished with changes in geometry 
(constriction width) and further tuning of applied potentials. Lastly, it was shown that the 
optimized sorter can also be applied for isolating submicrometer fractions of PSI crystals, 
allowing us to provide an ideal sample for efficient and high quality SFX 
experimentation, noting that sample injection for SFX at XFELs is constantly improving 
toward accommodating sample volumes that the high-throughput sorter is capable of 
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processing in an hour. Furthermore, using the described methodology, we envision size 
fractionation of other impactful samples such as natural or artificial DNA or carbon 
nanotubes, which could also be investigated by similar theoretical and experimental 
processes covered in this study. 
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CHAPTER 6 
APPLYING MICROFLUIDIC PROTEIN CRYSTAL SORTING TO SERIAL 
FEMTOSECOND CRYSTALLOGRAPHY 
 
6.1. Introduction 
X-ray free-electron laser (XFEL) technology has become popular over recent 
years in the field of protein crystallography.21, 199, 265 This technology was proposed to 
facilitate structural studies of difficult-to-crystallize proteins23, 194, 266 that failed to 
produce crystals large enough for traditional synchrotron-based crystallography where 
the crystal is exposed to the X-ray beam for durations longer than the onset of detrimental 
radiation damage. Smaller crystals grow more readily from these complex proteins and 
feature a low degree of long range disorder, yet are damaged by the X-ray radiation dose 
required to collect full, high-resolution datasets using conventional methods. XFELs 
outrun radiation damage with pulses lasting tens of femtoseconds and thereby enable 
“diffraction before destruction” to solve such protein structures.18, 200, 267 As the crystals 
are destroyed by the extremely intense XFEL pulse (after producing a useful diffraction 
pattern), the sample must be very rapidly replenished in order to collect a full dataset in a 
reasonable amount of time. The serial femtosecond crystallography (SFX) method has 
now been applied to solve the structures of many proteins,268-271 and continued success is 
expected in the realm of virus complexes in the future.272-274 However, to ensure such 
success, this nascent methodology requires considerable further development, from 
sample optimization and delivery, to detector technology and data analysis. 
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Two sample characteristics that significantly impact SFX data quality are crystal 
size and dispersity. Protein crystals smaller than the X-ray beam (generally 
submicrometer) can generate diffraction patterns with “shape transforms” or interference 
fringes between the Bragg spots,275 which can be used for a novel, direct phasing 
method.276-278 Because SFX is a serial method where a new crystal is brought into the X-
ray interaction region for each X-ray pulse, patterns from many different crystals must be 
indexed and their structure factors merged to reconstruct the electron density map of the 
molecules in the unit cell. This analysis effectively performs a Monte Carlo integration 
over a (typically) heterogeneous distribution of crystal sizes, shapes, and orientations, as 
well as the stochastically varying XFEL pulse intensity and spectrum.24 Narrowing the 
distribution of any of these fluctuating parameters would narrow the distribution of 
intensity samples (which are mostly partial reflections) measured for each reflection in 
each snapshot, to different degrees. A narrow crystal size distribution is expected to 
significantly decrease the number of patterns required for the determination of accurate 
structure factors.  
Microfluidic platforms have the potential to optimize protein crystal size for 
SFX259, 279 since they are capable of handling small volumes of sample and allow for their 
manipulation in ways in which macroscale methods cannot, such as fine-tuned 
separations and control of chemistry. We previously demonstrated a proof-of-principle 
microfluidic device that can sort polystyrene particles and photosystem I (PSI) protein 
crystals into submicrometer size fractions with a narrowed size distribution.259 The 
sorting principle is based on DEP,45, 46 which has been extensively employed to 
manipulate particles for various applications such as size sorting,212, 213, 258 particle 
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trapping,228, 256, 257, 280 and concentration.71, 224, 255 Revisiting Chapter 2, Subsection 2.2.4, 
to induce DEP, an inhomogeneous electric field is applied to the solution, whereby 
gradients of the electric field (𝑬) are formed generating a DEP force (Eq. (2.15))281 
In microfluidic devices, creative electrode patterning or the design of nonlinear channels 
in an insulating material such as polydimethylsiloxane (PDMS) can create ∇𝑬2 regions 
where DEP acts on particles flowing through.70, 254 The latter method, known as insulator-
based DEP (iDEP), is employed here as it enables simpler device fabrication for rapid 
replication, cost reduction, and a uniform ∇𝑬2 along the entire channel height.212, 228, 255, 
258 Once a DEP region is established by creating areas of high ∇𝑬2, each particle needs to 
have an inherently unique 𝑭𝐷𝐸𝑃 in order for differential manipulation to occur for sorting. 
In Eq. (2.15), the dependence of 𝑭𝐷𝐸𝑃 on particle radius indicates that large particles 
exhibit a greater 𝑭𝐷𝐸𝑃 response, enabling size-dependent sorting (assuming 𝑓𝐶𝑀 is 
constant for particles with similar physicochemical properties). For protein crystal 
sorting, conditions are established to facilitate negative DEP,212, 213, 259 whereby larger 
particles experiencing a higher 𝑭𝐷𝐸𝑃 are repelled from high ∇𝑬
2 regions more than 
smaller particles (details on device design can be found in Section 6.3). 
Since the aforementioned first-generation microsorter259 showed the first proof-
of-principle device, volume throughput was low, making it inefficient at providing the 
minimum sample volume (~ 300 µL) needed for current XFEL liquid jet-based sample 
delivery methods.282, 283 To collect XFEL data using a liquid jet injector, we scaled up the 
size of the microsorter to increase volume throughput from ~ 3 µL/h to ~ 150 µL/h, 
which significantly reduced the time required to sort larger volumes of crystal 
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suspensions. The particle fractions obtained were then delivered into the path of the Linac 
Coherent Light Source (LCLS) X-ray beam at SLAC National Accelerator Laboratory.  
This paper focuses on crystal size optimization and its potential for improving 
data quality and facilitating new phasing methods. We further describe the second-
generation microfluidic sorting device, provide a detailed sorted sample characterization 
using several methods, including dynamic light scattering (DLS), NanoSight particle 
tracking, and electron microscopy (EM), and examine diffraction patterns obtained from 
sorted protein nanocrystals. Additionally, simulations of SFX datasets with different 
levels of crystal size dispersity representing the unsorted and experimentally attained 
sorted crystal fractions are presented to illustrate the benefits of a narrow crystal size 
distribution on SFX data analysis, by comparing correlation coefficients (CC*), 
multiplicities, and signal-to-noise ratios (SNRs) of merged reflections. 
 
6.2. Methods 
6.2.1. Materials and Chemicals 
For protein preparation and crystallization, n-Dodecyl-β-D-maltoside (β-DDM) 
was purchased from Glycon, Germany. 2-(N-Morpholino)ethanesulfonic acid (MES), 
MgSO4, CaCl2, MgCl2, and phenylmethanesulfonyl fluoride (PMSF) were purchased 
from Sigma Aldrich, USA. For sorting, platinum wire was purchased from Alfa Aesar, 
USA, polydimethylsiloxane (PDMS) (Sylgard 184) from Dow Corning, USA, and Tygon 
(1/16 in. inner diameter) and fluorinated ethylene propylene (1/32 in. inner diameter) 
tubing were purchased from Cole Parmer, USA. 
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6.2.2. Photosystem I Purification and Crystallization 
All steps of isolation, purification, and crystallization were carried out in dim 
green light and at 4 °C. PSI was isolated and purified from Thermosynechococcus 
elongatus as described previously,194 with modifications. Cells were broken with an M-
110L microfluidizer processor (Microfluidics Inc., USA) and inhibition of proteases was 
implemented by maintaining a concentration of 50 µM PMSF at all steps prior to 
isolation of PSI by anion exchange chromatography. Crystallization was used as a final 
purification step as described in Hunter et al.18 The PSI-containing high-performance 
liquid chromatography (HPLC) fractions (which contain 20 mM MES, pH 6.4, 0.02% β-
DDM, and 140 mM MgSO4) were concentrated to approximately 5 mL (corresponding to 
10 mM chlorophyll) and diluted with buffer without salt (5 mM MES, pH = 6.4, and 
0.02% β-DDM) to obtain a concentration of 8 mM MgSO4. Crystal growth is induced by 
concentrating the sample in an ultrafiltration cell. Crystals were then harvested and 
washed in buffer with 6 mM salt (5 mM MES, pH = 6.4, 6 mM MgSO4, and 0.02% β-
DDM) and stabilized in buffer without salt (5 mM MES, pH = 6.4, and 0.02% β-DDM). 
The crystal suspension was coarsely fractionated by sedimentation as follows: the 
suspension was aliquoted into several microcentrifuge tubes and allowed to settle for 
sequential steps of 10, 20, 30, and 40 min, each time removing the supernatant. All 
crystals were prepared within 10 days of fractionation and stored at 4 °C in the dark. 
 
6.2.3. Microfluidic Device Fabrication and Photosystem I Crystal Sorting 
The microfluidic sorter was fabricated using standard photolithography and soft 
lithography techniques (Chapter 2, Section 2.1).33, 245 Briefly, a printed photomask 
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containing the channel outlines was designed using AutoCAD software (AutoDesk, 
USA) and printed at high-resolution (CAD/Art Services, Inc., USA). This mask was then 
patterned on a silicon wafer with SU-8 negative photoresist (MicroChem, USA) using a 
mask aligner (System III, Hybrid Technology Group, USA). The wafer was silanized and 
a 10:1 mixture of PDMS/cross-linker was poured on the wafer and cured at 80 °C for 4 h 
to form a negative relief of the structures. The PDMS structure was cut off the wafer and 
plasma treated with a glass microscope slide to form a sealed channel system. 6 mm 
diameter circles were punched at channel ends to form reservoirs. Platinum wire 
electrodes were placed in each reservoir to facilitate connection to a high voltage source 
(HVS448, LabSmith, USA), and rigid tubing was placed in outlet reservoirs for 
connection to a negative pressure pump (MFCS-EZ, Fluigent, France) to extract sorted 
fractions. ~ 100 µL of PSI crystal suspension (30 or 40 min settled fraction) were added 
to the inlet reservoir, and 500 V peak-to-peak AC potential at a frequency of 250 Hz was 
applied across the device with negative pressure applied to all outlet reservoirs to initiate 
the sorting process and maintain sample flow and extraction. Monitoring and 
fluorescence imaging of experiments performed at Arizona State University were done 
with a fluorescence microscope (IX71, Olympus, USA) equipped with appropriate 
bandpass filters (exciter: 470 nm, Semrock; emitter: 690 nm, Chroma) and attached CCD 
camera (iXon, Andor Technology, UK) controlled by Micro-Manager acquisition 
software (ver. 1.4, UCSF, USA). Monitoring of experiments performed at LCLS was 
facilitated with a portable microscope (SVM340, LabSmith, USA) equipped with an EPI-
fluorescence camera module (476 nm excitation) and installed emission filter (675 nm, 
Edmund Optics, USA), controlled by LabSmith µScope software (ver. 1.04). 
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6.2.4. Sample Characterization 
To measure sample size distribution, dynamic light scattering measurements were 
performed using a droplet-based instrument (Spectro Size 302, Molecular Dimensions, 
UK) and a cuvette-based instrument (DynaPro Nanostar, Wyatt Technologies, USA). For 
the former, 3 µL of sample was pipetted on a siliconized glass coverslip and placed in a 
hanging drop-mode on top of the well of a 24-well plate, with each well containing 500 
µL of buffer without salt to prevent the drop from evaporating during the DLS 
measurement. The sample drop was aligned to the laser and 10 DLS scans lasting 20 s 
each were recorded. For the latter, 60 µL of sample was placed in a UV-transparent 
plastic cuvette and set in the instrument from which 20 measurements lasting 10 s each 
were recorded. Further sample size distribution measurements were performed using a 
NanoSight instrument (LM10-HS, 405 nm laser, Malvern Instruments, UK), in which 
300 µL of sample at a concentration of approximately 108 particles/mL was injected into 
the sample holder cell and measured using Nanoparticle Tracking Analysis (NTA) 
software. 
Transmission electron microscopy (TEM) imaging of PSI crystals was performed 
as described previously.284 Briefly, 25 µL aliquots of PSI crystal sample were collected in 
their native buffer. The aliquot was concentrated and 8 µL of sample was applied to a 
pre-discharged square mesh copper grid (Electron Microscopy Sciences) and incubated 
for 30 s before blotting and staining with 2% (w/v) uranyl acetate. TEM images were 
acquired using an FEI Tecnai T12 electron microscope operating at 120 kV equipped 
with a Gatan UltraScan 1000 CCD camera. 
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6.2.5. Serial Femtosecond Crystallography Experiments 
Sorted PSI nano- and microcrystal fractions were prepared for SFX experiments 
at LCLS by first concentrating them 3-4 fold by centrifugation (< 300 rpm). This sample 
was then loaded into a stainless steel reservoir, which was then connected to the Gas 
Dynamic Virtual Nozzle (GDVN)282, 283 injector sample line (75 μm ID) controlled by an 
HPLC pressure pump. Gas to the GDVN was provided by an in-house helium gas supply 
at 450 psi. The sample was delivered at an average rate of 15 µL/min and jetted out of the 
GDVN in a stream positioned perpendicular to the XFEL beam direction (for further 
details on liquid-jet sample delivery, see DePonte et al.282 and Weierstall et al.283). SFX 
data were collected at the Coherent X-ray Imaging (CXI) instrument at LCLS from sorted 
and unsorted PSI nano/microcrystal suspensions, with the latter serving as a reference 
sample to test the experimental conditions. Two Cornell-SLAC Pixel Array Detectors 
(CSPADs)285 were arranged in series, for high spatial resolution on the front detector (z = 
88 mm) and high angular resolution on the back detector, at very low scattering angles (z 
= 2.1 m). We used 9.48 keV X-ray pulses, lasting ~ 40 fs each, with an average pulse 
energy of ~ 2.2 mJ (1.4 × 1012 photons/pulse), at a 120 Hz pulse repetition rate. 
 
6.3. Results and Discussion 
6.3.1. Microfluidic Crystal Sorting 
Our XFEL crystal size optimization is based on sorting a bulk PSI crystal 
suspension by size to isolate submicrometer fractions with reduced size dispersity using 
microfluidics. Figure 6.1a shows a schematic drawing of the microchannel design 
employed, which is a second-generation, scaled-up version of a microsorter we 
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developed previously.259 The device operates on the basis of DEP, whereby 
inhomogeneous electric fields form when potentials are applied across wide channels 
connected by a thinner constriction region. These inhomogeneities create areas of high 
∇𝑬2 within the constriction region shown in Figure 6.1b, whereby a DEP force is induced 
as described in Eq. (2.15). Because negative DEP prevails under the operating conditions, 
particles are repelled from constriction channel walls to an extent proportional to their 
radius (𝑭𝐷𝐸𝑃 ∝  𝑟
3). Consequently, for sorting, large particles are focused centrally, 
whereas small particles do not experience significant repulsion and deflect into side 
channels, effectively separating the size fractions. 
This second-generation microsorter was developed to greatly increase throughput 
compared to the first-generation device. With the current XFEL liquid jet injection 
system,282, 283 the minimum loading volume is ~ 300 µL which was difficult to produce 
with the first-generation device running at a few µL/h. We therefore targeted a large 
volumetric flow rate of > 150 µL/h by increasing channel widths by 5× and channel depth 
by 10× in order to reduce experimentation time from weeks to days. The channel design 
was also simplified, whereby only two wide side channels ([S]) were formed in order to  
collect large amounts of the desired deflected submicrometer particles. Figure 6.1c shows 
a fluorescence microscopy snapshot of a sorting event, where large protein crystals are 
seen focusing into the [C] outlet, while small submicrometer crystals (mainly identified 
by optically unresolvable bulk fluorescence) deflect into the two [S] outlet channels. 
These fractions were extracted and collected for further characterization and SFX 
experimentation. The [C] channel crystal fraction can also be recovered from the sorting 
device such that virtually all crystals passing through can be collected. This fraction  
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Figure 6.1. Second-generation photosystem I crystal sorting. a) Microfluidic sorting 
device schematic with labeled channels ([I] = inlet, [S] = side outlet, and [C] = center 
outlet). b) Close up of the central region showing simulated ∇𝑬2 values and differential 
particle deflection based on size. The DEP-active region is indicated within the 
constriction channel where large ∇𝑬2 values are apparent. c) Fluorescence microscopy 
imaging showing PSI crystals flowing through the device. Large crystals are seen focused 
into [C] and small crystals deflect into [S]. Particles flow from left to right. 
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could then be resorted iteratively to pull out nearly all of the submicrometer crystals from 
the initial heterogeneous mixture, and the larger crystals could be dissolved and 
recrystallized to obtain more submicrometer crystals, increasing the amount of sorted 
crystal sample available for an SFX experiment. In principle, raw protein is not wasted 
during sorting due to the non-destructive, sample-conserving nature of the microfluidic 
sorter. 
 
6.3.2. Sorted Crystal Size Characterization 
Size distributions of the crystal suspensions obtained from the sorting process 
were characterized using two methods: DLS and NanoSight NTA. The two techniques 
operate on size-dependent diffusion of particles but use different detection methods: DLS 
quantifies the size of particles from their diffusion coefficients by autocorrelating signal 
changes due to Brownian motion over time and NanoSight uses light scattering and 
image analysis software to individually track and monitor the scattered light from 
diffusing particles frame by frame to quantify size information.286 We used both types of 
instruments as complementary techniques to confidently determine the size distributions 
of each crystal fraction (both provide size distribution and NanoSight can estimate 
particle concentration). 
Figure 6.2 shows DLS data obtained from a sample droplet of the inlet PSI 
suspension and obtained sorted [S] fraction in the form of signal heat maps (blue = 
lowest, red = highest), (a) and (b), and particle count histograms, (c) and (d). From the 
bulk (Figure 6.2a and c), a wide crystal size distribution is present as expected, ranging 
from ~ 200 nm to ~ 20 μm. In contrast, the fraction that passed through the sorter and was  
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Figure 6.2. Sorted fraction size characterization by DLS. DLS heat map of (a) the PSI 
crystal suspension prior to fractionation, indicating a wide size distribution (~ 200 nm to 
~ 20 µm), and (b) a PSI crystal fraction collected from the [S] channels indicating a 
narrowed submicrometer size distribution (~ 200 nm to ~ 600 nm). Signal increases from 
blue (lowest) to red (highest). (c) and (d) show DLS histograms corresponding to (a) and 
(b), respectively. (e) and (f) show DLS histograms of the PSI suspension prior to sorting 
(~ 200 nm to ~ 10 µm) and an [S] channel fraction (~ 150 nm to ~ 550 nm), respectively, 
measured using a cuvette-based instrument for comparison with (a)-(d), confirming the 
differences in the size distribution. 
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collected from the [S] channel reservoirs shows a narrower, submicrometer size 
distribution (Figure 6.2b and d) with crystals ranging in size from ~ 200 nm to ~ 600 nm 
indicating that the broad bulk crystal size distribution was reduced modally and narrowed 
as desired (signal below 100 nm is likely from free PSI trimers and very small 
nanocrystals). A second cuvette-based DLS instrument was also used to measure the 
particle size of a sorted fraction, to confirm the droplet-based DLS results. As shown in  
Figure 6.2e, the PSI suspension prior to sorting was again found to have a wide 
crystal size distribution (~ 200 nm to ~ 10 μm), whereas the sorted fraction (Figure 6.2f) 
indicated similar trends as before with a crystal size range between ~ 150 nm and ~ 550 
nm. Any discrepancies in size measurement between the two DLS instruments most 
likely arise from (i) the order of magnitude difference in sample volume measured giving 
differences in population size and particle settling effects and/or (ii) differences in the 
proprietary software algorithms correlating the raw signal to an assigned particle size. 
NanoSight NTA was also used as a supporting method to further confirm that the 
modal size and size distribution of the sorted [S] fraction were reduced compared to the 
bulk suspension shown previously. Figure 6.3a illustrates data obtained from this method 
as absolute particle counts versus particle diameter averaged for three scans. As shown 
with the DLS data, the size distribution is further confirmed to be submicrometer, with a 
major peak designating a size range of ~ 125 nm to ~ 300 nm and contributions up to ~ 
650 nm. The NanoSight detects and counts the scattered light from individual particles, 
where images of particle scattering can be obtained to confirm the presence of actual 
particles, as shown in Figure 6.3b.  
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Figure 6.3. Size characterization by NanoSight NTA of the [S] channel fraction. a) 
Averaged particle size distribution for three measurements indicating a submicrometer 
size range between ~ 100 nm and ~ 650 nm with the majority being < 300 nm. b) Image 
taken of the suspended particles diffracting as they are measured by the instrument 
illustrating low size dispersity. Not appreciable in the image is the small particle size, 
which is evident in the distance traversed per frame as measured in (a). 
 
6.3.3. Sorted Crystal Quality Characterization 
Two modes of characterization were performed to determine whether the sample 
maintained crystallinity after passing through the microfluidic channels under the applied 
voltage. First, second-order nonlinear imaging of chiral crystals (SONICC) was utilized 
due to the fact that it can exclusively detect chiral crystals (i.e., the majority of protein 
crystals) in a sample.232, 233 Protein molecules and amorphous precipitate are not SONICC 
active and thus do not emit a signal. This method is also useful for detecting crystals 
below the size limit of a standard optical microscope (i.e., nanocrystals) with SNRs 
enabling high contrast imaging. Figure 6.4a shows a bright-field image of an [S] channel-
collected fraction and Figure 6.4b shows a corresponding SONICC image clearly 
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containing a bright signal from the protein crystals in solution. This signifies that the 
sorted fractions contain protein crystals after passing through the microfluidic device. 
 
 
Figure 6.4. PSI crystal characterization post-fractionation. a) Bright-field image of a 
droplet of the [S] channel fraction. b) SONICC image of the same droplet, indicating that 
crystallinity is maintained. 
 
Second, TEM was used to examine crystal lattice quality after sorting and as a 
further measure to confirm the existence of protein nanocrystals in the sorted fractions.284 
Figure 6.5a shows an electron micrograph of heterogeneously-sized PSI crystals from the 
bulk sample, with further magnification and corresponding fast Fourier transform (FFT) 
analysis (Figures 6.5b and c, respectively) exhibiting the lattice structure and Bragg spots 
from the crystal designated with an arrow. Images were also taken of a representative 
submicrometer crystal from an [S] channel fraction (Figure 6.5d) for comparison after 
passing through the microfluidic device where the lattice can readily be observed. Further 
magnification (Figure 6.5e) clearly shows the well-ordered unit cells, while the FFT 
(Figure 6.5f) also features Bragg spots confirming that the well-ordered structure is 
maintained. Other crystals in this sample were also observed by TEM and ranged in size 
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from ~ 300 nm to ~ 600 nm, which is in agreement with the size characterizations 
discussed previously. 
 
 
Figure 6.5. TEM imaging of photosystem I crystals. a) TEM image of PSI crystals 
from the bulk sample. b) High magnification TEM image of a portion of this group, 
showing an intact, well-ordered lattice structure. c) FFT from the crystal marked by the 
arrow in (a) and (b) illustrating a well-ordered lattice. d) TEM image of a submicrometer 
PSI crystal from the [S] fraction. e) Enlargement of (d), showing the well-ordered 
crystalline lattice is maintained. f) Corresponding FFT with Bragg spots from the ordered 
lattice. 
 
6.3.4. Serial Femtosecond Crystallography on Sorted Crystals  
Sorted PSI crystal fractions were delivered into the XFEL for SFX experiments at 
LCLS as described in Section 6.2. Sharp diffraction spots to 4 Å resolution were obtained 
from a sorted crystal fraction (Figure 6.6a) containing a submicrometer crystal size range 
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as described previously, further indicating that the fragile membrane protein crystals were 
not damaged and remained crystalline during the sorting process. From this same crystal, 
shape transforms were also observed (Figure 6.6b), indicating a small crystal size and the 
ability to obtain shape transforms from sorted crystals, which could facilitate new 
phasing methods for SFX.276-278  
 
 
Figure 6.6. Serial femtosecond crystallography results. a) Diffraction pattern on the 
front CSPAD (at a distance of ~ 88 mm) from a sorted PSI crystal showing sharp spots 
and low mosaicity, with (b) corresponding shape transforms on the inner part of the back 
CSPAD (at a distance of ~ 2 m), indicating a small crystal. 
 
We note that hit rates were very low (< 1%) for the sorted samples, and patterns 
were indexable with the expected PSI unit cell parameters. We attribute the low hit rate to 
low sample concentration, and the low SNR from nanocrystals (with very large unit cells) 
in solution. Even in the close-to-ideal conditions simulated (details below), only half of 
the simulated diffraction patterns from the sorted (submicrometer) crystals were 
indexable. Future experiments can be optimized for data collection from submicrometer 
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crystals (higher sample concentration, thinner liquid jet, softer X-rays) and would benefit 
from a more intense beam (i.e., at future XFELs). 
 
6.3.5. Potential for Investigating Crystal Quality 
The ability to manipulate the size distribution of protein nano- and microcrystals 
will enable quantitative studies of the relationship between protein crystal size and 
diffraction quality. Membrane protein crystals on the nanometer scale are assumed to be 
of superior quality to large membrane protein crystals by virtue of being smaller than a 
mosaic block and thus not prone to long-range disorder.287, 288 However, the increased 
number of surface unit cells (partial or full) to inner-crystal unit cells may lead to a limit 
in the quality improvement of crystallinity as a function of decreasing crystal size. This 
cannot be probed with a broadly disperse crystal suspension by SFX, as it is impossible to 
distinguish diffraction patterns from a small crystal in the center of the beam from 
diffraction patterns from large crystals only partially intercepted by the beam using 
intensity alone (i.e., without clear shape transforms to determine crystal size). Pre-sorting 
protein crystals with a microfluidic device will be an ideal method to answer this question 
by enabling systematic studies of crystal quality as a function of crystal size.  
 
6.3.6. Potential for Facilitating High Intensity Radiation Damage Induced Phasing 
The brilliance available at LCLS can also be used for high-intensity radiation-
damage-induced phasing (HI-RIP).289, 290 In HI-RIP, the different degrees of ionization of 
heavy atoms, in particular, compared to a low-fluence dataset, provides a novel method 
for finding the molecular substructure (akin to a single-wavelength anomalous dispersion 
 148 
experiment). HI-RIP SFX requires the whole crystal to be exposed to sufficiently high 
intensity for multiple ionizations, which is difficult to achieve experimentally due to the 
XFEL beam with broad, low-fluence tails. By using a narrow size distribution of nano- or 
microcrystals matched to the size of the XFEL beam focus, it becomes much simpler to 
separate high intensity from low intensity data to maximize the radiation damage-induced 
contrast at the heavy atom positions and thus facilitate phasing.  
 
6.3.7. Efficient Use of Crystals in SFX Data Collection by Microfluidic Sorting 
We investigated the effect of crystal size distribution on merged SFX data quality 
by simulating PSI nano/microcrystal distributions with varying levels of size 
heterogeneity. PSI diffraction patterns were simulated using pattern_sim, a program in 
the CrystFEL software suite,291 considering crystals as rectangular prisms with integer 
numbers of unit cells, where each side length is chosen independently from a top-hat 
distribution between user-specified size limits. Distribution (a) was comprised of a very 
broad range of crystal side lengths between 0.1 and 10.0 µm, representing the unsorted 
fraction, and (b) comprised of crystals with side lengths of 150 – 550 nm, representing 
the sorted fraction. A histogram of simulated crystal volumes for dataset (b) is shown in 
Figure 6.7a. The simulations used 9.5 keV X-ray pulses with a fixed flux of 6×1011 
photons/pulse, no divergence, and 1% bandwidth. (This does not reflect the shot-to-shot 
fluctuations in wavelength and X-ray flux at LCLS, which were ~ 0.2% and ~ 30%, 
respectively, for the SFX experiment in this study.292) The detector, representing a 
CSPAD, had 1764 × 1764 pixels, each 110 × 110 µm2, positioned at a working distance 
of 0.21 m (3 Å at the edge), with a two-photon, Poisson-distributed, uniform background. 
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Scattering from the liquid jet was not included. PSI structure factors were calculated from 
1JB0.pdb20 (a = b = 281, c = 165.2 Å; α = β = 90°, and γ = 120°; in space group P63), 
using sfall, from the Collaborative Computational Project Number 4 (CCP4).291, 293, 294 
Three datasets were simulated, indexed, and merged: two contained 10,000 diffraction 
snapshots for both crystal size distributions and one contained 5,000 diffraction snapshots 
for the “unsorted”, wide size distribution. Over 99 % of the wide size distribution datasets 
were indexed, while only 48 % of the sorted crystal size distribution dataset could be 
indexed due to low intensities/number of Bragg spots.  
A robust measure of the quality of the merged reflection lists is CC*, which is an 
estimate of the value of CCtrue (the measure of correlation between an averaged data set 
with a noise-free true signal that may be unknown). CC* reflects the degree of reliability 
of the merged reflection list and is used to determine the resolution of crystallographic 
datasets.295 CC* was calculated by splitting the simulated dataset into two datasets, then 
comparing their independently merged reflection lists with results shown in Figure 6.7b. 
The merged dataset from the sorted crystal fraction (5,000 indexed patterns from ~ 
10,000 simulated patterns) has significantly higher CC* values (orange, Figure 6.7) than 
the unsorted crystal distribution with the same number of indexed patterns (blue, Figure 
6.7). This is true even when comparing to twice the number (10,000) of indexed patterns 
from unsorted crystals (green, Figure 6.7) until resolutions higher than ~ 4.5 Å where the 
multiplicity (the average number of times a reflection was measured) of the sorted crystal 
fraction drops significantly from insufficient scattering signal (Figure 6.7c). Figure 6.7d 
shows the average SNR of the reflections in each resolution shell, respectively, for each 
simulated dataset. Interestingly, despite an order of magnitude higher multiplicity 
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(Figure 6.7c) and higher SNR in the medium resolution bins for the unsorted crystal size 
distribution compared to the sorted crystal size distribution, the CC* values in the latter 
dataset are significantly higher.  
 
 
Figure 6.7. Comparison of SFX data quality by simulated diffraction from PSI 
crystals with size distributions representing the unsorted and sorted crystal fractions. (a) 
Crystal volumes from the simulated narrow submicrometer crystal dataset. (b) CC*295 of 
merged reflections from 5,000 and 10,000 crystals with side lengths of 0.1-10 µm (blue 
and green, respectively), and of 5,000 merged, indexable patterns from ~ 10,000 crystals 
with side lengths of 0.15 – 0.55 µm (orange). (c) Average multiplicity and (d) SNR of 
reflections in each resolution shell. A significantly smaller amount of protein is required 
for high quality reflection lists if the crystal size distribution is narrowed. The drop in 
quality at high-resolution for the 0.15 – 0.55 µm crystal dataset is due to low signal 
strength at that resolution. 
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Importantly, the amount of protein that would be used in the sorted crystal 
fraction would be significantly lower than the unsorted fraction and could be tuned 
experimentally based on a target size range. In these simulations, the total volumes of 
crystals in samples (a) and (b) were 6.31 ×105 µm3 and 176 µm3, respectively, which 
corresponds to a ~ 3,500-fold decrease in protein use in the sorted fraction. These 
simulations demonstrate that reduced crystal size variation increases the accuracy of the 
merged intensities, requiring smaller datasets for accurate structure factors, while making 
much more efficient use of precious protein.  
Experimentally, shot-to-shot fluctuations in the beam intensity and the random 
position of the crystal with respect to the beam inflate the distribution of intensities 
measured for each reflection, requiring even more data for accurate structure factors. 
These variations were not taken into account in these simulations, so the improved 
accuracy from narrowing the crystal size distribution may have a less significant effect on 
experimental data. However, sorting submicrometer crystal fractions can reduce the 
impact of crystal positioning in the beam path as larger micrometer crystals that match or 
exceed the beam diameter have a greater chance of being partially illuminated by the 
beam. 
 
6.4. Conclusions 
We have demonstrated a method to isolate submicrometer PSI protein crystal size 
fractions for SFX studies at an XFEL. The samples processed were awarded beam time at 
the LCLS XFEL at SLAC in which we were able to obtain diffraction from fractionated 
crystals. Several sample characterization methods were presented to study size 
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distribution and crystal quality. Using DLS, we measured our sample sizes in the 
submicrometer regime, with a major range of ~ 150 nm to ~ 600 nm. NanoSight NTA 
was also used to support this data, whereby similar submicrometer size ranges were 
observed. In all cases, sample dispersity was narrowed and the size range of the bulk 
crystallization products (~ 200 nm to ~ 20 μm) was reduced to the submicrometer regime. 
SONICC images confirmed that protein crystals remained intact in solution after 
fractionation. TEM was used to examine the individual crystal lattices demonstrating that 
crystals remained well-ordered and of diffraction quality after fractionation. SFX data 
from fractionated crystals showed diffraction to ~ 4 Å, with no evidence of damage to the 
crystals due to sorting, and concomitant shape transforms confirmed a small crystal size. 
Simulations show that a narrow size distribution improves the quality of SFX datasets, 
requiring smaller datasets. Moreover, targeting smaller crystals with microfluidic 
platforms that allow crystals not selected for SFX to be recovered for follow-up 
experiments preserves and reduces consumption of precious protein sample. Since hit 
rates and indexing rates are continually improving for SFX analysis (averaging 10% and 
up to 80%, respectively), we envision microfluidic sorting as a promising method to 
obtain protein crystal samples with desired size characteristics to improve data analysis 
efficiency (by narrowed size dispersity) and capability (small-crystal shape transforms for 
shape transform-based phasing). Further optimization and development of the current 
device will broaden its applicability and enhance its impact. 
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CHAPTER 7 
CRYSTALLIZATION OF THE LARGE MEMBRANE PROTEIN COMPLEX 
PHOTOSYSTEM I IN A MICROFLUIDIC CHANNEL 
 
7.1. Introduction 
Protein crystallization can be a daunting task and often takes years to optimize for 
a given protein. Typically, a screening process is employed in which many conditions of 
various protein concentrations and buffers are tested separately until an optimal 
combination initiates crystallization.73, 296-298 Crystallization is a necessary precursor of 
crystallography, which is the most commonly used method to elucidate protein structure, 
requiring highly ordered protein crystals in order to obtain high-resolution X-ray 
diffraction patterns to analyze the atomic arrangement of a protein.17 Usually, the chosen 
X-ray beam technology governs the types and quality of crystals desired leading to 
further crystallization screening and optimization for a specific crystal characteristic. In 
traditional crystallography, the high dose of X-ray radiation requires large crystals to 
avoid damage before diffraction and to provide suitable electron density.18  
Many complex proteins such as membrane proteins pose even greater difficulties 
during crystallization method development and in many cases are nearly impossible to 
crystallize at sizes suitable for traditional crystallography, which is why less than 400 out 
of the 80,000+ protein structures determined to date comprise membrane proteins.20 The 
main reason for this is that membrane proteins have large unit cells dominated by solvent 
(> 70%) where solvent-protein interactions dominate, leaving few contact areas for 
protein-protein interactions. Consequently, increased disorder arises in the unit cell 
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arrangement, eventually preventing ordered crystal formation.194 For example, it took 12 
years to determine the structure of photosystem I (PSI) at atomic resolution with the 
majority of this time being spent developing a crystallization method to provide suitable 
crystals.20 This was a significant accomplishment as PSI is the largest and most complex 
membrane protein crystallized to date consisting of 36 proteins to which 381 cofactors 
(chlorophylls, carotenoids, quinones, and 4Fe4S clusters) are noncovalently attached.20 
One can imagine that the ability to easily grow membrane protein crystals would 
drastically expedite structure determination. However, an alternative route is the current 
development of femtosecond nanocrystallography which is tailored for complex 
membrane protein structure determination where smaller, ideally nanometer-sized 
crystals can be utilized to provide diffraction patterns.21, 199 Yet femtosecond 
nanocrystallography still imposes some desired crystal characteristics such as a 
monodispersed suspension of nanocrystals, thus it is imperative to optimize 
crystallization conditions to obtain such samples as well as to develop methods to 
characterize sample size distributions.200 
Microfluidic devices have become widespread in their application toward 
biochemistry245 including areas such as electrophoresis,68, 299, 300 PCR,185, 188, 189 
immunoassays,301-303 biosensors,304-306 and more.91, 307-309 Protein crystallization has also 
been demonstrated in capillaries77, 310, 311 and a microfluidic device312 by means of 
counter-diffusion313 in which lysozyme and insulin, among others, have been crystallized. 
In these experiments, protein and crystallization buffer concentration gradients form 
along a channel in which many conditions can be realized in one experiment. Controlled 
mixing of two reagents by microfluidic droplet generation314 has also been employed for 
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crystallization screening81 in which protein and buffer are interspersed within a droplet. 
These methods have been applied to the more common high ionic strength “salting-out” 
procedures for proteins with well-known crystallization characteristics where a separate 
saline buffer or buffer containing precipitants like polyethylene glycol come into contact 
with protein solution. Low ionic strength crystallization which lacks any precipitant, such 
as that employed for the membrane protein complex PSI,194 has not yet been 
demonstrated in a microfluidic device to the best of our knowledge. 
The reason behind this alternate crystallization pathway for PSI is due to the 
many factors influencing the solubility of proteins including ionic strength, pH, and 
precipitant concentration, among others. In typical “salting-out” crystallization 
procedures, protein solubility is generally highest at medium ionic strength and decreases 
at high ionic strength due to competition between ions and protein for the solvent water. 
However, solubility is also decreased at very low ionic strength as the charged groups on 
the surface are depleted of counterions, thereby facilitating crystal contact formation 
between oppositely charged groups on nearby protein molecules. This latter effect is 
referred to as the “reverse of salting-in” and occurs with PSI.193 Specifically, the salt 
(MgSO4) and the protein coexist in one solution and microfluidic crystallization is 
accomplished by diffusion of the salt ions (Mg2+ and SO4
2-) at a faster rate than the 
protein. This is possible due to the large difference in diffusion coefficients between the 
salt ions and protein, resulting in a temporal ionic strength gradient within the protein 
solution capable of probing various conditions in a crystallization phase diagram within 
one experiment. 
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Establishing a salt gradient within the microchannel requires the presence of a 
large reservoir to accept the diffusing salt ions, thus reducing the salt concentration of the 
protein solution. A crystallization buffer free of MgSO4 is brought into contact with the 
salt-containing protein solution at a defined interface in a similar fashion as the 
introduction of a high ionic strength buffer in the “salting-out” crystallization regime. In 
either case, direct mixing of the two solutions would cause rapid changes in protein and 
salt concentration that are beyond the kinetics of crystallization causing the protein to 
“crash out” of solution and form an amorphous precipitate.315 Defined initial conditions, a 
stable interface, and convection-free conditions are thus important for microchannel 
crystallization experiments to establish optimized and reproducible crystallization 
conditions. Furthermore, quantitatively modeling concentration changes of participating 
ions becomes difficult when convection occurs as it can be caused by a variety of factors 
such as density gradients and evaporation. 
Most capillary crystallization experiments employing diffusion-based 
crystallization methods implement gels to reduce convection312, 316-318 usually by adding a 
low concentration of gel to the protein solution to increase viscosity. However, this alters 
the crystallization conditions in a way that could pose problems when translated to 
macroscale crystallization experiments when large amounts of crystals are needed. To 
avoid this, the gel acupuncture method (GAME)319, 320 has been developed for capillary 
counter-diffusion crystallization. In this method, the capillary is filled with protein 
solution and partially punctured into a gel base saturated with crystallization buffer, thus 
establishing a porous barrier between the crystallization buffer and protein solution to 
effectively reduce convective mass transport. Here, we have adapted this method to a 
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microfluidic channel in which the protein solution in the channel forms an interface with 
a gel-filled reservoir at the opposing channel end where salt-free buffer is added. Over 
time, salt ions diffuse out of the microchannel, forming an ionic strength gradient to 
induce crystallization at points along the channel where optimal conditions are met. 
In this work, we demonstrate the ability to crystallize the membrane protein 
complex PSI using a gel barrier and diffusion of salt and protein within a microfluidic 
device. Furthermore, we have incorporated a hydrophobic valve to set up a discrete 
crystallization zone, making quantitative analysis possible. Crystal formation along a 
microchannel was investigated with both bright-field microscopy as well as an effect 
known as second harmonic generation using second order non-linear imaging of chiral 
crystals (SONICC). To the best of our knowledge, SONICC was applied for the first time 
to the imaging of a protein crystallization process within a microfluidic channel, where 
we exhibit the capability of this technology to detect PSI crystals in the micrometer- and 
nanometer- size domains. Lastly, by correlating numerical models of the protein and salt 
concentrations along the channel to crystals imaged with SONICC, we illustrate the 
potential for efficient crystallization phase diagram development by producing a portion 
of the PSI phase diagram. 
 
7.2. Theory 
An important aspect of this method is quantitative analysis to determine the actual 
concentrations of protein and salt that induce spontaneous nucleation (initial formation of 
stable protein clusters) and crystallization as well as a successful piecing together of the 
crystallization phase diagram of a protein. In our channel layout, two reservoirs are 
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present at both channel ends (see Figure 7.1a). Initially, protein solution flows into the 
channel via capillary action (Chapter 2, Subsection 2.2.1). For quantitative analysis, a 
discrete, consistent crystallization zone is necessary, which is provided by the linear 
channel. Furthermore, leakage of protein solution into the opposing reservoir would 
cause variable concentrations of protein and salt in that reservoir that cannot be 
quantified. To overcome this, a hydrophobic valve was developed at the channel/gelled 
reservoir interface. At the valve, capillary action is halted since it is driven by surface 
tension (𝛾) along the hydrophilic channel.321, 322 The Young-Laplace equation323 
describes the relationship between surface tension, capillary pressure (𝑝𝑐), and surface 
contact angle (𝜃): 
 
𝑝𝑐 =
2𝛾 𝑐𝑜𝑠𝜃
𝑟
 (7.1) 
where (𝑟) is the radius of the fluid meniscus. At hydrophobic contact angles (> 90°), 𝑝𝑐 
becomes negative; thus placing the valve at the channel end effectively halts capillary 
flow of the protein at the interface of the gelled reservoir to establish a discrete 
crystallization region within the channel. 
The concentrations of salt and protein within the microfluidic channel are 
determined by numerical modeling using the representative geometry and considering the 
diffusion coefficients (𝐷) of the salt ions324 (Mg2+: 7×10-10 m2/s, SO42-: 1×10-9 m2/s) and 
protein (in channel: 2×10-11 m2/s, in gel325: 9×10-12 m2/s). A smaller PSI diffusion 
coefficient was considered in the gelled reservoir due to the large size of PSI and was 
calculated based on a theoretical model given by Boyer and Hsu that accounts for protein 
mass and agarose concentration.325 The diffusion coefficients of the salt ions were 
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assumed to have a negligible change in agarose gel. The numerical models are based on 
Fick’s second law for time-dependent diffusion:326  
 𝜕𝑐
𝜕𝑡
= 𝐷∇2𝑐 (7.2) 
where 𝑐 is concentration, 𝑡 is time, and ∇ is the gradient operator. The discrete 
crystallization region along the channel was modeled, and concentration profiles were 
obtained spanning the entire channel length for various experimental durations. When the 
actual experiment was imaged, various locations along the channel where crystals were 
observed were correlated to the numerical model that corresponds to the duration of the 
experiment at hand. Our aim was to use this quantitative information to form a phase 
diagram (Chapter 2, Subsection 2.4.2) for PSI which compares protein concentration to 
salt concentration and assigns these concentrations to the various crystallization phases: 
undersaturated where salt concentration is too high and crystallization does not occur, 
metastable where crystallization can occur nonspontaneously, nucleation where 
crystallization is spontaneous, and precipitation where salt concentration is so low that 
protein precipitates rapidly and forms amorphous precipitate.76  
 
7.3. Methods 
7.3.1. Materials and Chemicals 
SU-8 photoresist was purchased from MicroChem, USA. n-Dodecyl-β-D-
maltoside (β-DDM) was from Glycon Biochemicals, Germany. 2-(N-
Morpholino)ethanesulfonic acid (MES), magnesium sulfate (MgSO4), and low gelling 
temperature agarose were from Sigma-Aldrich, USA. Poly(dimethysiloxane) (Sylgard 
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184) was from Dow Corning, USA, and glass microscopy slides were purchased from 
Fisher Scientific, USA.  
 
7.3.2. Device Fabrication 
The microfluidic channels were fabricated using standard photolithography and 
soft lithography as reported previously (Chapter 2, Section 2.1).224 Briefly, AutoCAD 
software (Autodesk, USA) was used to design the microchannel structure that was 
transferred to a chrome mask (Photosciences, USA). The mask was then used to create a 
silicon master wafer by patterning structures with a negative photoresist via 
photolithography. A polydimethylsiloxane (PDMS) mold was cast using the master wafer 
as a template in which the negative relief of the structure formed the linear microchannels 
in the polymer. The resulting channels measured 3 cm in length with a cross-sectional 
width of 50 µm and depth of 35 µm. The microchannel was cut out of the mold and 
oxygen plasma treated to render the PDMS surface hydrophilic and with exposed silanol 
groups. Reservoir holes were then punched into channel ends postexposure in order to 
maintain a hydrophobic surface along the reservoir walls to form the valve interface. The 
PDMS slab was then irreversibly bonded to an oxygen plasma-treated glass microscope 
slide to create a sealed channel system. 
 
7.3.3. PSI Purification 
PSI was isolated and purified as previously described.194 Briefly, thylakoids 
isolated from cell cultures of the cyanobacterium Thermosynechococcus elongatus were 
incubated in 0.6% β-DDM to solubilize PSI. PSI was further purified by anion-exchange 
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chromatography on a Q sepharose HP column. The column was equilibrated using a 
buffer containing 20 mM MES, 0.02% β-DDM, and 50 mM MgSO4 (pH 6.4) at 4°C. The 
salt concentration was then increased to 100 mM MgSO4 to elute photosystem II and PSI 
monomers and further increased to 150 mM MgSO4 to finally elute trimeric PSI. The 
protein solution was diluted to 6 mM salt, then concentrated to 10 mM chlorophyll using 
ultrafiltration to precipitate PSI in the form of small crystals. The final solution was made 
by completely dissolving the PSI microcrystals in a buffer containing 50 mM MgSO4 (5 
mM MES, 0.02% β-DDM, pH 6.4) to a chlorophyll concentration of 20 mM. This PSI 
solution was used for the microfluidic crystallization experiments described next. 
 
7.3.4. PSI Crystallization and Imaging 
3 µl of PSI solution was pipetted into one empty reservoir of the microfluidic 
device to fill the microchannel by capillary action. Agarose was dissolved in an MgSO4-
free buffer containing 5 mM MES and 0.02% β-DDM at pH 6.4 (Buffer A) to a 
concentration of 1% (w/v) by heating. 5 µl of the 1% (w/v) molten agarose buffer was 
pipetted into the second empty reservoir and allowed to cure at 4 °C for 15 min. 10 µl of 
Buffer A was then pipetted onto the gelled reservoir. The chip was placed in a dark 
humidity chamber to avoid PSI degradation and solution evaporation and allowed to 
incubate at ambient temperature for crystallization to proceed. Three separate 
experiments were performed with 3, 6, and 10 day incubation periods. In each case, the 
chip was then removed from the humidity chamber, and the microchannel was imaged 
with bright-field microscopy and second harmonic generation microscopy via SONICC 
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(Formulatrix, USA). To capture the entire microchannel, the SONICC software was 
programed to acquire consecutive images along the microchannel. 
 
7.3.5. Numerical Modeling 
COMSOL Multiphysics 4.3 software was used to quantify the concentrations of 
both salt ions (Mg2+ and SO4
2-) and PSI along the microchannel. This was done by 
modeling diffusion of all three species within the microchannel and reservoir. The device 
geometry drawn in the software was an exact replicate of the microfluidic channel system 
used experimentally. The Transport of Diluted Species module incorporated the diffusion 
coefficients of both salt ions and PSI with values presented in Section 7.2. The diffusion 
coefficients of the ions were obtained from literature measurements in water, and the PSI 
diffusion coefficient in solution was estimated from the Stokes-Einstein relationship for a 
trimer size of 10 nm.230 The diffusion of each species was then modeled over several time 
periods of 3 days, 6 days, 10 days, and 14 days, which allowed for the transport of the 
particles to be calculated. The obtained numerical solution was then used to obtain 
concentration profiles of the salt ions and PSI spanning the entire microchannel at the 
previously mentioned time points. 
 
7.4. Results and Discussion 
The working principle of the microfluidic crystallization device is first discussed. 
Figure 7.1a shows a longitudinal cross section of the channel and two reservoirs where 
PSI and Buffer A (see Section 7.3) were added. The channel was rendered hydrophilic by 
oxygen plasma treatment which facilitated filling of the channel with aqueous protein  
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Figure 7.1. Microfluidic crystallization channel with valve. a) Cross section of the 
microfluidic channel used for crystallization. Two reservoirs are located at channel ends 
where solutions can be introduced. The saline protein solution is injected into the channel 
from the reservoir on the right and fills via capillary action. The hydrophobic valve is 
placed at the left channel end to stop protein flow, effectively setting up a discrete 
crystallization zone. Hydrophobic surfaces are indicated in red and blue designates 
hydrophilic regions. On the left side of the image, the reservoir containing the Buffer A 
gel plug is shown. b) Photograph of the Buffer A reservoir/channel interface without the 
hydrophobic valve illustrating leakage of protein out of the channel and into the reservoir. 
c) Photograph of the same interface with the hydrophobic valve showing impeded protein 
flow and no leakage out of the channel. 
 
solution via capillary action. Because the opposing reservoir was punched postplasma 
treatment, the reservoir walls remained hydrophobic. Our fabrication technique is 
beneficial compared to chemical surface treatments, avoiding an added fabrication step 
and possible adverse reactions with the sample. As the protein fills the channel via 
capillary pressure, it eventually meets hydrophobic regions in the reservoir which halt the 
flow, acting as a hydrophobic valve.327 Figure 7.1b illustrates a channel/reservoir 
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interface without this valve where protein leaks into the reservoir as opposed to Figure 
7.1c, which shows the valve effectively impeding protein flow. This barrier was 
necessary in order to eliminate leakage of the protein solution into the opposing reservoir 
where mixing could occur with Buffer A/agarose during initial filling of the device. 
Furthermore, initial experiments demonstrated that the pipetting steps for filling both 
reservoirs could not be performed in a synchronized manner to ensure defined initial 
conditions for the microfluidic crystallization experiment, fortifying the need for a valve 
barrier. Once the channel was filled, the empty second reservoir was filled with molten 
agarose that was gelled and saturated with Buffer A to aid in the depletion of salt in the 
channel. Without a gel barrier, convective mixing was observed in which Buffer A 
flowed rapidly into the channel and depleted the protein solution without crystallization 
(not shown). To reduce this effect, it is common practice to gel the protein solution 
during diffusion-based microfluidic crystallization;312, 316-318 however, our method 
eliminates the need to alter the protein solution (which can influence crystallization) by 
using a stand-alone gel plug. 
Figure 7.2 shows a top-down perspective of the channel with drawn hexagonal 
PSI crystals of various sizes and abundance at their expected locations along the channel. 
Due to diffusion, ionic strength and protein concentration gradients form. As shown by 
the triangular scale, these two gradients decrease toward the gelled, initially protein-free 
reservoir, as indicated by the black to white color gradient. At the lowest ionic strength 
(white region of the scale), proteins precipitate out of solution rapidly and form 
amorphous precipitate instead of crystals. In the direction toward the protein reservoir 
(black region of the scale), crystal size increases and abundance decreases as 
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crystallization kinetics change based on the salt and protein concentrations. At higher salt 
concentrations, the loss of interaction between the PSI trimers and salt ions is less 
extensive, thus a single crystal can build upon itself as less new nucleation events occur. 
The opposite occurs at lower salt concentrations because more free PSI trimer is present, 
thus the chance for new nucleation events is greater. 
 
 
Figure 7.2. Top-down view of the channel structure, laid out similarly to that in 
Figure 7.1. PSI crystal characteristics are drawn within the channel as hexagons, 
indicating expected changes along the channel. At the gel/channel interface, salt 
concentration is the lowest; therefore, protein rapidly precipitates out of solution and 
forms amorphous precipitate (small dots). Moving toward the protein solution reservoir, 
crystal size increases and abundance decreases. In terms of the phase diagram, each phase 
can be mapped out along the channel beginning with precipitation near the gel/channel 
interface and transitioning toward undersaturated at the opposite end of the channel. 
 
7.4.1. Numerical Modeling 
In order to determine the concentrations of salt and protein along the channel, 
numerical modeling was employed. The model considered diffusion of both salt ions 
(Mg2+ and SO4
2-) and PSI spanning the entire channel geometry which was replicated 
identically to that used experimentally. Diffusion was based on Fick’s laws, and diffusion 
coefficients of the salt ions and proteins were considered as described in Section 7.2. 
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Because diffusion out of the channel occurred into the gelled reservoir, the diffusion 
coefficient of PSI in agarose was calculated based on a relationship between its estimated 
diffusion coefficient in water and the concentration of the agarose that it diffuses into, as 
developed by Boyer and Hsu.325 It was assumed that diffusion of the salt ions was not 
influenced by the gel; therefore, their diffusion coefficients remained the same in the gel. 
The numerical models were solved as a time-dependent study, and four time 
durations were studied: 3, 6, 10, and 14 days. Concentration profiles of both salt ions 
(Figure 7.3a and b) and protein solution (Figure 7.3c) were developed. At 3 days, the 
concentration profiles of both salt ions show a slightly curved trend with the lowest 
concentration near the gelled reservoir (0 cm) and increasing concentration as the protein 
reservoir (3 cm) is approached, as shown in Figure 7.3a and b. As time increases to 6 
days and greater, the salt ions develop a linear concentration profile with a decreasing 
slope. At very long durations, > 4 months (not shown), the concentration profile becomes 
completely horizontal, indicating a homogeneous, equilibrated concentration distribution 
spanning the entire microchannel with a concentration of half the initial value. The 
profiles of both ions are comparable due to the similarity of their diffusion coefficients; 
however, the protein concentration profile differs significantly due to its diffusion 
coefficient being 1-2 orders of magnitude lower. Figure 7.3c shows the PSI concentration 
profile that maintains a hyperbolic type trend over all time durations plotted. At a much 
longer time compared to the salt ions (> 10 years), the protein concentration profile does 
equilibrate in a similar fashion; however, this time duration is beyond the scope of any 
crystallization experiment that would be utilized for applications such as femtosecond 
nanocrystallography. It is important that the protein diffuses slowly, and its concentration 
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remains high along a greater portion of the channel compared to that of the salt ions so 
that enough protein is available to crystallize. If both solutions were depleted, no crystals 
would form because there is simply not enough starting material. An ideal scenario would 
involve salt depletion along the channel in a linear gradient with minimal protein 
depletion to minimize interactions between the salt ions and PSI trimers, resulting in self-
stabilization of the trimers by forming crystals. 
 
 
Figure 7.3. Modeling relative concentration profiles of protein and both salt ions 
along the microfluidic channel. Distance on the x-axis is the location relative to the 
gel/channel interface (0 cm). The models consider spatial and time-dependent diffusion 
of Mg2+ (a), SO4
2- (b), and PSI (c). Each plot shows the concentration profiles at four 
different time points ranging from 3 to 14 days. At 3 days, the ions exhibit a slightly 
curved trend that becomes linear at later time points. The PSI curves show a hyperbolic 
trend due to its lower diffusion coefficient compared to the ions. The 10 day profile given 
by the solid bold line corresponds to the experimental data shown in Figure 7.4. 
 
7.4.2. Photosystem I Crystallization 
Crystallization of PSI within a microfluidic channel was performed successfully 
using the “reverse of salting-in” diffusion method. After 3, 6, and 10 days of incubation, 
the channels were imaged using second harmonic generation via SONICC. This 
technology is based on the excitation of two photons which combine and emit as a single 
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high-energy photon, a phenomenon that only occurs in noncentrosymmetric (lacking an 
internal plane of symmetry) species such as various protein crystals.232, 233 Individual 
protein molecules, amorphous precipitate, and the majority of salt crystals (including 
MgSO4) do not possess this capability, thus this imaging technique can exclusively obtain 
a high contrast signal from protein crystals in complex mixtures or suspensions. A 
powerful imaging technique such as SONICC is crucial for our microfluidic 
crystallization experiments as the crystals in the channel were not isolated for further 
examination and were imaged directly on-chip. We were thus able to use SONICC to 
confirm the presence of crystals in the channel (and therefore a successful crystallization 
process) despite the dark green protein solution masking them under bright-field optical 
microscopy. Furthermore, SONICC provides the ability to detect small nanocrystals (< 
500 nm) that would be unresolvable with bright-field microscopy. This is a major 
advantage for femtosecond nanocrystallography applications since we can determine 
crystallization conditions where nanocrystals are formed using our microfluidic platform 
in tandem with SONICC imaging. Figure 7.4 illustrates this ability, as the top sequence 
shows a bright-field image of the channel and the bottom sequence shows the 
corresponding SONICC image of a 10 day crystallization experiment. While the bright-
field frames do not show crystals, the SONICC frames represent high contrast images 
clearly showing a strong signal from the PSI crystals present along the channel. 
The SONICC detection in Figure 7.4 also illustrates the expected crystal growth 
trends previously mentioned and drawn out in Figure 7.2. The channel position closest to 
the gelled reservoir (P1) shows no signal most likely due to nonspontaneous nucleation 
(metastable) at the region of lowest protein concentration. Moving toward the protein 
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reservoir to P2, a large number of small crystals are observed, indicating many nucleation 
events occurring at low ionic strength, yet at this point, the PSI trimer concentration is 
great enough to provide adequate starting material for crystallization to occur. Moving 
along further toward points P3-P6 illustrates a decrease in crystal abundance and an 
increase in crystal size as expected when the ionic strength increases, and more salt-
protein interactions are present that reduce the number of nucleation events. We suspect 
the signal at the walls throughout the channel are a result of some pervaporation through 
PDMS causing small concentration changes at the walls when the chip was removed 
from the humidity chamber during the time needed for SONICC imaging. A SONICC 
signal was not observed at the earliest viewing of the device yet intensified as time 
passed. Consequently, we used the central region of the channel to determine crystal 
growth for further analysis. 
 
 
Figure 7.4. Microfluidic device dimensions with a zoomed in region showing 
SONICC and bright-field images of the microchannel. The capability of SONICC for 
detection is illustrated as a high contrast image compared to the bright-field image where 
crystals are not detectable in the dark protein solution. Only a small portion of the 
channel (3 mm) is shown where crystals were detected as further downstream conditions 
did not favor crystallization. Six positions are marked (P1-P6) corresponding to the labels 
shown on the phase diagram in Figure 7.5. The region depicted beyond P6 is 
representative of the remainder of the microchannel, which did not exhibit PSI crystals 
within the channel. 
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It is also important to note that the SONICC instrument is capable of detecting 
nanometer-sized crystals with a spatial resolution of ~ 4 µm. We thus postulate the 
existence of nanocrystals around P2, and the upper limit crystal size range spanning to P6 
is ~ 4 µm to 15 µm. Our study showed that spontaneous crystallization conditions are 
only present along a very small portion of the channel (~ 3 mm of the total channel length 
of 3 cm), indicating that optimal crystallization conditions are met under narrowly 
specific ionic strengths and protein concentrations as expected for membrane proteins 
such as PSI. Theoretically, this region could be spread out and shifted based on the initial 
protein and salt concentrations; for example, applying half the initial salt concentration 
used experimentally (25 mM MgSO4) to the numerical model would place the observed 
10 day nucleation region 9.5 - 14.8 mm away from the gelled reservoir. However, this 
was not further examined due to the strict crystallization conditions adhered to by PSI; 
thus known, stable initial conditions were employed. Furthermore, crystals were not 
observed in the channel region further downstream of P6, indicating that the ionic 
strength was too high for spontaneous crystallization to occur as the solution has not 
reached the nucleation zone. As an additional confirmation of favorable crystallization 
conditions, a control experiment was performed where buffer containing 50 mM MgSO4 
was added to the gelled reservoir, maintaining a high salt concentration throughout the 
device. As expected, since the solution was in the undersaturated zone, PSI crystallization 
was impaired and did not occur as confirmed by a lack of SONICC signal throughout the 
entire microchannel. 
To further confirm the capabilities of this device, we also performed 
crystallization experiments with two other proteins, lysozyme and phycocyanin, using a 
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different precipitant for both. Conditions were similar to the PSI experiment such that the 
channel was filled with precipitant and protein solution, and diffusion of precipitant out 
of the channel established concentration gradients. For both proteins, we observed 
crystallization at nucleation conditions that are in excellent agreement with previously 
reported conditions for these proteins. Further detail can be found in Appendix B. 
 
7.4.3. Phase diagram 
Experimental and model data can be combined to develop portions of a 
crystallization phase diagram. Experimentally, one can observe locations along the 
channel where crystallization occurs for specific incubation times, and the entire 
nucleation zone can even be visualized based on known initial conditions, as shown in 
Figure 7.4. At each point, crystal size can also be measured if size is an important 
characteristic for the application at hand. For example, in femtosecond 
nanocrystallography, small, monodispersed nanocrystals in solution are desired. 
Accordingly, determining the crystallization conditions at the channel location nearest to 
the gelled reservoir where crystals are still detectable (P2) would be a good starting point 
to make the smallest crystals. On the other hand, traditional X-ray crystallography 
requires large crystals to avoid X-ray damage so one could study the conditions where 
larger crystals are detected (i.e., in the P6 region). 
To accomplish such a quantitative analysis, the results of the numerical models 
were correlated to those observed experimentally. The concentration profiles developed 
in Figure 7.3 provide the concentration of the salt ions and protein (in this case Mg2+ and 
SO4
2- for PSI) at any point along the channel. Furthermore, while we only modeled four 
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time points, any duration of time can be studied. The experimental result presented in 
Figure 7.4 represents a 10 day experiment which is shown as a thick solid black line in 
the modeled concentration profiles. From chosen points along the channel where crystals 
were observed, we calculated the model-derived concentrations of PSI, Mg2+, and SO4
2-. 
We chose six points labeled as P1-P6 in Figure 7.4, which were assigned to the 
metastable region (P1) and spanned the nucleation zone with increasing ionic strength 
and protein concentration (P2 to P6). 
A crystallization phase diagram conventionally compares protein concentration on 
the y- axis to salt concentration on the x-axis and describes the four zones of the 
crystallization process: precipitation, nucleation, metastable, and undersaturated. Figure 
7.5 illustrates these zones as various shades of gray and black with assigned ranges of salt 
and protein concentration. In the case of the 10 day experiment, the metastable zone was 
realized at the area closest to the gelled reservoir where no SONICC signal was obtained 
(P1). While this lack of SONICC signal could represent either the metastable or 
undersaturated zone, we assigned the metastable zone to this region as the small 
calculated difference in salt concentration between P1 and P2 would unlikely cause a 
jump from the nucleation to the undersaturated zone. In a follow-up experiment, this 
assignment could be confirmed by screening conditions for metastable characteristics 
using a seeding procedure that induces crystallization in this zone. Because the chip was 
imaged directly as-is with no sample extraction, we did not perform such a test.  
Despite this, determining the nucleation zone of a protein is usually most sought 
after and was demonstrated in this experiment. Positions P2-P6 fall within the PSI 
nucleation zone where SONICC signal was observed and thus can be placed accordingly  
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Figure 7.5. Possible phase diagram for PSI based on experimental and modeling data. 
Positions along the microchannel were correlated with modeling data to determine salt 
and protein concentration assignments for each phase. For the 10 day experiment, 
positions are labeled according to Figure 7.4 (P1-P6). At position P1, protein 
concentration was lowest and crystals were not observed, likely indicating the metastable 
region. P2-P6 are positions where crystals were observed, indicating conditions of the 
nucleation zone. Additionally, 3 (▲) and 6 (■) day experiments were performed in a 
similar way, and corresponding salt and protein concentrations were extracted from the 
numerical models. For those experiments, crystals were observed at each corresponding 
data point indicating nucleation zone conditions. Negligible variation (~ 0.15 mM 
MgSO4) was observed based on duplication of the 10 day trial; thus error bars are 
encompassed by the marker size. 
 
on the phase diagram in Figure 7.5. To our knowledge, SONICC has not been used thus 
far in any capillary or microfluidic crystallization procedures previously reported. This 
analysis methodology is extremely beneficial as the crystallization conditions tailored for 
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small crystals such as nanocrystals can be quantified and assigned to the appropriate 
region of the phase diagram to aid in future crystallization trials for nanocrystallography 
applications. From this single experiment, a large portion of the nucleation zone was 
uncovered unlike in a single crystallization trial where one set of conditions (protein and 
salt concentrations) is screened. Specifically around position P2, the smallest crystals 
were observed, and due to the powerful resolving power of SONICC, likely relate to 
nanometer-sized crystals desired for femtosecond nanocrystallography. We also 
performed 3 and 6 day crystallization experiments in a similar way to further develop the 
nucleation zone (see triangle and square symbols in Figure 7.5). These results showed 
similar trends compared to the 10 day experiment such that all three experiments span the 
nucleation zone on the phase diagram. When these specific experiments utilizing PSI 
were combined, the nucleation zone fell within a MgSO4 concentration of ~ 5-13 mM 
and PSI concentration of ~ 4-30 µM which is in agreement with values of previously 
determined crystallization conditions for PSI where 6-9 mM MgSO4 was reported.
194 It 
should be noted that the 10 day trial was duplicated and negligible variation was observed 
between trials (~ 0.15 mM MgSO4).  
We envision this microfluidic crystallization device to be applicable to a wide 
range of proteins and buffer solutions due to the ability to apply the sample as-is. We 
demonstrated this by successfully analyzing three different proteins crystallized under 
very different conditions: decreasing ionic strength for PSI and increasing ionic strength 
for lysozyme and phycocyanin using two different salts (NaCl and ammonium sulfate, 
respectively). Moreover, the nucleation conditions determined for all three proteins are in 
excellent agreement with those previously reported (see Appendix B for details on the 
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crystallization of lysozyme and phycocyanin). The matching of experimental and 
literature nucleation zones for the three proteins is also an excellent justification for the 
numerical model used. We also emphasize that similar diffusion models have been used 
which agreed with experimental crystallization events as evidenced by others.313, 328  
Lastly, as mentioned previously, an added benefit of our novel method over 
diffusion-based capillary crystallization methods that generally employ a gelled protein 
solution312, 316-318 is the incorporation of a gel without altering the protein solution. We 
illustrated the versatility of this device by crystallizing PSI using the unique “reverse of 
salting-in” procedure, which has not been performed within a capillary or microfluidic 
crystallization device utilizing diffusion until now. Additionally, simple parallelization of 
several microfluidic channels with various starting conditions can also be enacted to 
encompass a larger portion of a protein’s phase diagram, leading to rapid screening of 
proteins with unknown crystallization conditions. This is advantageous as more 
conditions can be screened in fewer experiments compared to traditional approaches. 
Furthermore, sample consumption in such a device is minimal (on the order of nanoliters) 
which is favorable for a precious protein sample where starting material is scarce. 
Combined, the demonstrated device can be fostered into a powerful protein 
crystallization tool for initial method development to determine optimal crystallization 
conditions of a given protein. 
 
7.5. Conclusions 
We demonstrated a novel microfluidic protein crystallization method for the 
membrane protein PSI. Crystallization of this protein is unique in that salt and protein 
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coexist in solution initially, and salt is depleted to facilitate crystallization. This 
previously developed “reverse of salting-in” crystallization method for PSI was 
successfully incorporated into a microfluidic device where salt and protein concentration 
gradients were established by diffusion. Crystallization of PSI was realized in 3, 6, and 
10 day experiments as confirmed by second harmonic generation imaging via SONICC, 
in which expected crystal growth trends were also observed. At low ionic strength 
regions, PSI was found as abundant small crystals, and as ionic strength increased, crystal 
size increased and abundance decreased. Numerical modeling provided quantification of 
salt ions (Mg2+ and SO4
2-) and protein (PSI) concentration along the entire channel for 
various experimental durations. A portion of the PSI phase diagram could be constructed 
from the computed concentration values at specific time points and crystal formation 
imaged with SONICC at designated points along the microchannel. The nucleation zone 
observed with this method was in the range of that previously determined for PSI. To 
further support our method, we also achieved similar success with lysozyme and 
phycocyanin. 
In the future, proteins with unknown phase diagrams and crystallization 
conditions can be studied with this methodology due to the versatility of the procedure 
where protein can be applied natively without gelling. A single microchannel experiment 
can encompass the entire nucleation zone of a protein for a certain starting condition. 
Parallel experiments can be performed to increase efficiency, and once optimal 
conditions are determined, they can be applied to macroscale methods for high-
throughput production of crystals with desired characteristics. Collectively, an entire 
protein crystallization phase diagram could be pieced together more efficiently using low 
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volumes of precious sample to better understand proteins that are not well studied. This, 
in tandem with highly sensitive imaging, provides a unique capability to newly 
developing technologies for protein studies such as femtosecond nanocrystallography 
where nontraditional crystallization characteristics are desired. 
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CHAPTER 8 
PROTEIN CRYSTALLIZATION IN AN ACTUATED MICROFLUIDIC NANOWELL 
DEVICE 
 
8.1. Introduction 
X-ray crystallography is the leading method to determine the structure of proteins 
and contributes to the vast majority of entries submitted to the Protein Data Bank.  
Protein crystals are needed because X-ray sources do not yet provide enough brilliance to 
produce detectable diffraction from a single protein molecule and the success of X-ray 
crystallographic studies depends on the quality of the crystals. Traditional X-ray sources 
(e.g. synchrotrons) have made great progress in beam flux where data can be collected on 
crystals as small as ~ 20 μm at microfocus beamlines under cryogenic conditions for 
protein crystals with small unit cells. However, X-ray damage is severe and limits the 
minimal size of crystals from which useful X-ray diffraction data can be collected.329 
Advancements in X-ray accelerator technology and the advent of X-ray free-electron 
lasers (XFELs) are circumventing the X-ray damage problem with ultrashort pulse 
durations, allowing the study of complex protein structures that were previously unable to 
be determined by X-ray crystallography.195, 199, 330, 331 XFELs produce extremely short 
(femtosecond) and highly brilliant X-ray pulses capable of outrunning X-ray damage 
processes. Consequently, diffraction can be attained from crystals as small as 200nm.199 
Small crystals (< 5 µm) can more readily grow from difficult to crystallize proteins like 
membrane proteins or large complexes, which has opened new doors in structural 
biology.268-271, 332, 333 
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However, in all types of crystallography, crystals are still required and are made 
via a crystallization process where many conditions in a multiple-phase space are 
screened in order to determine favorable conditions where crystals grow with desired 
characteristics.72, 74, 334, 335 In many cases, this can take years to optimize, making 
crystallization the major bottleneck of structural biology. Improved methodologies to 
expedite the process using limited amounts of precious sample are necessary, for 
example, to create large crystals for traditional X-ray sources, or more recently, to select 
for nano- and microcrystal growth for XFELs where very few reliable and widely 
applicable techniques have been developed.235 In crystallization screening, a large variety 
of parameters can be altered including, but not limited to, concentration, temperature, pH, 
and the composition of a precipitant that is introduced to the protein suspension. The 
latter encumbers an even further complexity, as there are a plethora of precipitant buffer 
types and additives (e.g. salts, polyethylene glycols, detergents, etc.) that can be screened 
at different concentrations and then added to a wide range of protein concentrations to 
‘hit’ a favorable condition for crystallization to occur.  
Screening can be performed with a variety of techniques, the most common for 
protein crystallization being vapor diffusion, while other methods like free interface 
diffusion, batch, and dialysis are less frequently used. Each provide a unique pathway 
through crystallization phase space toward crystal-forming conditions. For vapor 
diffusion, a ‘hanging’ or ‘sitting’ drop approach is generally employed in which a 
precipitant solution is placed in a large well and a droplet of protein suspension is placed 
inverted above or in an adjacent well, respectively, within the same chamber sealed air-
tight.336, 337 Over time, the system equilibrates due to solvent vaporization and diffusion 
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in which the concentrations of precipitant and protein in the droplet increase until the 
precipitant concentration in the droplet reaches the concentration in the large well. The 
phase diagram is ideally traversed as solute concentrations change until the nucleation 
zone is reached. In free interface diffusion, the highest number of nuclei (or often 
precipitate) are formed directly at the liquid-liquid interface where the protein and 
precipitant meet in a capillary. With the progression of time, the solutions mix by 
diffusion leading to a concentration gradient, and after full equilibrium, progress to a 
final stage where the protein and precipitant concentrations are equalized.77, 338-340 Both of 
these diffusion-based methods have been successfully used for many proteins, yet the 
exact conditions under which initial nucleation and crystal growth occurs cannot be 
determined. Additionally, vapor diffusion methods cannot be scaled up easily as the 
nucleation rate depends on the high surface to volume ratio. Furthermore, collecting 
crystals from vapor diffusion experiments is very time consuming for high-yield crystal 
production, which is required for serial crystallography methods such as SFX at an XFEL 
where a continuous stream of concentrated protein nano/microcrystals are delivered to 
the beam at room temperature in a liquid injector.282, 283 
The batch crystallization method, where protein and precipitant solution are 
directly mixed together in a desired ratio with well-defined initial concentrations, is one 
of the more scalable crystallization methods. However, it ideally requires some 
knowledge of the phase diagram so that the desired rates of nucleation and crystal growth 
are achieved. Originally, batch methods were employed on the macroscale using common 
laboratory glassware, but as technology has progressed, microbatch has become a critical 
method to reduce precious protein sample consumption and more rapidly parallelize 
 181 
crystallization screens by mixing microliter droplets of various protein samples and 
precipitants in large arrays of wells.341-343 The microbatch setup process has also been 
automated and sample consumption has been reduced further to the sub-microliter regime 
using advanced robot delivery systems.343, 344 However, these systems are generally very 
expensive, thereby limiting their use for a large number of laboratories. 
Microfluidic platforms, which can be quickly fabricated with low cost materials 
and accessible instrumentation, have emerged as an economical and versatile way to 
reduce sample consumption. Microfluidic devices have also been employed for numerous 
biological applications such as diagnostic sensing and assays,92, 127, 132, 345, 346 
separations,257, 259, 347 and protein crystallization78, 279, 348 using the free interface 
diffusion,83, 86, 349 vapor diffusion,82, 350 and microbatch82, 84, 351 approaches. The diffusion-
based approaches are generally hampered by limited crystal production and quantitative 
analysis of crystallization conditions, while the microbatch approaches rely on the 
generation of droplets or the need for moving parts and complex fabrication procedures. 
Here, we propose an easy to fabricate microfluidic device implementing a batch-type 
crystallization approach in an automated fashion without sample interference or the need 
for oils using only ~ 25 nL of protein sample per crystallization well, which is orders of 
magnitude below the microliter volumes required for traditional microbatch-under-oil 
and on-par with advanced robot systems. Our method is based on a gradient generator 
system developed previously352-354 to create many protein and precipitant screening 
conditions by splitting and recombining input solutions through an array of channels. The 
device is fabricated in polydimethylsiloxane (PDMS) in which a previously developed 
“doormat” valve355-357 can be implemented allowing each crystallization ‘well’ to be 
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isolated from other wells. Furthermore, PDMS is compatible with common protein 
crystallization precipitants and organic solvents used for screening. Using this device, we 
demonstrate the capability of crystallizing proteins in these nanowells with the ability to 
image crystals using brightfield microscopy, UV fluorescence, and SONICC. These 
regions were then analyzed quantitatively to determine conditions where crystal 
formation was observed to develop portions of a phase diagram. Combined, this device 
serves as a high-throughput, nanoscale platform eventually allowing complex 
multidimensional protein crystallization screens in a cost effective and adaptable package 
to serve a broad range of crystallography applications. 
 
8.2. Experimental 
8.2.1. Materials and Chemicals 
Fluorescein sodium salt, lysozyme from chicken egg white, sodium acetate, 
sodium chloride (NaCl), polyethylene glycol (PEG 3350), and 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) were all purchased from Sigma Aldrich, USA. 
Magnesium chloride (MgCl2) was purchased from Alfa Aesar, USA. 
Polydimethylsiloxane (PDMS) and its curing agent (Sylgard 184 elastomer kit) were 
purchased from Dow Corning, USA. 1/8” OD Tygon tubing was purchased from Cole 
Parmer, USA. 1/32” OD PEEK tubing and NanoPort assemblies were purchased from 
IDEX Health and Sciences, USA. 
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8.2.2. Microfluidic Chip Fabrication 
The fluid (gradient generator) and control (valve) layer channels were designed 
using AutoCAD 2015 (Autodesk, USA) and sent for film mask printing (CAD/Art 
Services Inc., USA). The film mask was used to perform standard photolithography32 to 
pattern both designs with SU-8 photoresist onto a silicon wafer. Standard soft 
lithography33 was then performed to impress the negative relief of the structures into 
PDMS.259 To fabricate the three layer “doormat” valve system, a thin PDMS membrane 
(~ 25 µm thickness) was spin coated onto a silicon wafer and heated to 70 °C for 1 h to 
cure. An access reservoir was punched into the control channel PDMS layer which was 
then oxygen plasma treated together with the thin layer. These two layers were then 
brought into contact with each other and heated at 70 °C for 30 min to bond them 
irreversibly. The control layer and thin membrane were peeled off the wafer together and 
the fluid layer (with reservoirs punched into fluid inlet/outlet channels and at the location 
of the control layer access port) was aligned to the control layer using a stereo 
microscope (SZ51, Olympus, USA). NanoPort assemblies were then adhered to the fluid 
inlets and a barbed tube fitting was adhered to the control layer reservoir for connection 
to respective pressure pumps. After an initial investment to fabricate the master wafer and 
purchase reusable tubing and fittings (~50-100 USD), each chip can be manufactured for 
~ 2 USD. 
 
8.2.3. Crystallization Experiments 
The assembled chip was connected to two pressure pumps: (i) a positive pressure 
pump (MCFS-EZ, Fluigent, France) connected to a sample reservoir, which was 
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connected to the fluid layer inlets via PEEK tubing to the NanoPort assemblies and (ii) a 
negative pressure pump (MCFS-EZ, Fluigent, France) connected to the control layer 
reservoir fitting directly via Tygon tubing. First, negative pressure (-400 mbar and below) 
was applied to the control layer to deflect the membranes and open the valves. Once all 
valves were opened, crystallization precipitant solution (for lysozyme: 0.1 M sodium 
acetate at pH 4.6 containing 2.5 M NaCl; for phycocyanin: 75 mM HEPES at pH 7.0 
containing 17.5% w/v PEG 3350 and 20 mM MgCl2) and water were pumped into 
separate fluid layer inlets using positive pressure generally between 15-30 mbar. This 
wash step was administered with ~3 times the total volume until all channels were 
completely filled, then water was switched with protein sample (lysozyme: 50 mg/ml, 
phycocyanin: 25 mg/ml) and positive pressure was reapplied. In the case of the 
fluorescein dye calibration, water was added to both inlets for washing, then one inlet 
was pumped with 1 mM fluorescein solution. The filling steps were monitored using a 
CCD camera (iXon, Andor, USA) controlled by MicroManager software (ver. 2.46, 
UCSF, USA) connected to a brightfield/fluorescence microscope (IX71, Olympus, USA) 
equipped with appropriate filter sets. 
After the device was filled with sample and water or precipitant, all pressure 
sources were removed from the chip and a slight positive pressure (100 mbar) was 
applied to the control layer to ensure the valve membrane rapidly returned to its normally 
closed state. For crystallization incubation, pressure on the control layer was maintained 
with a slightly pressurized syringe and the entire system was placed in a humidity 
chamber set at 100% humidity to prevent solvent evaporation out of the PDMS. 
Crystallization was allowed to occur for 2 days followed by imaging of the entire chip 
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using brightfield microscopy, UV fluorescence, and second-order nonlinear imaging of 
chiral crystals (SONICC; Formulatrix, USA). For the calibration experiments with 
fluorescein, the chip was allowed to rest for 1 h after filling to ensure each well had 
mixed completely, and fluorescence intensities of each well on the entire chip were 
recorded. This was repeated four times with the same chip, and the images were analyzed 
for background corrected intensities using ImageJ software (ver. 1.49, NIH).  
 
8.2.4. Theoretical Modeling 
COMSOL Multiphysics 5.1 finite element analysis software was used for 
numerical modeling of the microfluidic gradient mixer to additionally quantify the 
concentration distribution throughout the device. The AutoCAD .dxf file for the fluid 
layer channels was imported into COMSOL to create the model geometry with 
boundaries between each of the crystallization “wells”. These boundaries were either set 
to open (for filling conditions) or closed (during crystallization) depending on the 
COMSOL model study being performed. Two studies were performed, first to model 
filling and second to model the concentration distribution during crystallization. 
In the first, the Creeping Flow module was used to solve for the convective 
velocity field for pressure-driven flow set at the inlet boundaries representing 
experimental pressures of ~ 15 mbar. The Navier-Stokes equation was solved in a 
simplified form for incompressible fluids and neglecting inertial terms:  
 𝜇∇2𝒖 − ∇𝑝 = 0 (8.1) 
where 𝜇 is the dynamic viscosity of the medium and 𝑝 is the pressure. The channel walls 
were set to a no slip (𝒖 = 0) boundary condition and the outlet was set as an open 
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boundary. Fluid properties (viscosity and density) were set to those of water (for 
fluorescein and lysozyme/NaCl modeling) and PEG solutions at room temperature 
(details on the adjustments made for Phycocyanin/PEG modeling can be found in 
Appendix C). With these conditions, Eq. (8.1) was solved at steady state to determine the 
fluid velocity field within the channels during the filling process. 
Next, the Transport of Diluted Species module was used to solve for analyte 
transport by diffusion and convection generated by the solved velocity field: 
 𝑱 = −𝐷∇𝑐 + 𝒖𝑐 (8.2) 
where 𝑱 is the total particle flux, 𝐷 is the diffusion coefficient, 𝑐 is the concentration, and 
𝒖 is the convective velocity field. Literature values of 5×10-10 m2/s for fluorescein,353 
1.4×10-10 m2/s for lysozyme,358 and 2×10-9 m2/s for NaCl359 were used for 𝐷. These 
literature values are in agreement with values we calculated using the Stokes-Einstein 
equation considering hydrodynamic radii of 0.54 nm for fluorescein360, 361 and 1.9 nm for 
lysozyme.362, 363 Values of 𝐷 used for Phycocyanin and PEG are listed in Appendix C. 
Boundary properties within the microfluidic device were also established, whereby the 
channel walls were set to have ‘no flux’ (𝑱 = 0). The inlet channel entrances were set to 
have a normalized particle concentration of 1 and the end boundary of the outlet channel 
was set to an outflow condition (−𝐷∇𝑐 = 0). Combining these particle and channel 
conditions, Eq. (8.2) was solved at steady state to obtain the concentration profile in each 
of the wells. 
Using the steady-state solution of all combined parameters from the first study as 
the initial condition, a second study was set up to model the incubation process after 
filling. Creeping flow was disabled such that diffusion was the only transport process 
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occurring (𝑱 = −𝐷∇𝑐). For the case where no valves were present, a time-dependent 
study spanning 10 days was performed (see Appendix C, Figure C-1). For the case with 
valves present, a “thin impermeable membrane” boundary condition (𝑱 = 0) was set at 
each “well” entrance and exit to mimic the valve function, and the same time-dependent 
study was performed. For all studies, a custom ultra-fine virtual mesh (minimum feature 
size of 1 μm) was built. The COMSOL solver was set to a relative tolerance of 0.001 
using default parameters. Surface plots showing concentration distribution were 
generated and normalized concentration values from the solution of the second study 
were extracted from each well. 
 
8.3. Results and Discussion 
The microfluidic device developed for this work consists of a multilayer design 
combining a gradient generator with a valve system. An overview top-down schematic 
picture of the design with integrated “doormat” valves is shown in Figure 8.1a with the 
fluid layer in black and the control layer in red (see Section 8.2 and Figure 8.2 for more 
details on the “doormat” valve). A series of “split and recombine” pathways forming a 
branching structure establish a concentration gradient throughout the device. However, 
unlike typical gradient generators which serve to form a continuous gradient in an outlet 
channel solution by using the same channel width throughout the device,352-354 our design 
contains boxed regions in between each “split and recombine” point which serve as 
crystallization nanowells with unique concentrations created during gradient generation. 
This is more clearly illustrated in the zoomed-in schematic in Figure 8.1b which 
corresponds to the highlighted area marked in Figure 8.1a. Two inlets were used to allow 
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protein and precipitant to be added for mixing (this can be expandable for a 
multidimensional screening platform, e.g. multiple precipitant inlets whereby gradients 
for each are created simultaneously and are adjustable by independently applied pressures 
and initial solution conditions353). 
 
 
Figure 8.1. Microfluidic crystallization device schematic. a) Overview schematic of 
the nanowell gradient generator (black) with incorporated “doormat” valve system (red 
dashes) showing 207 wells. b) Zoom-in of the highlighted region in (a) detailing the 
“split and recombine” gradient generation design with incorporated valve system. Each 
well is isolated in the fluid layer and becomes connected by the overlapping valve region 
during the filling step. 
 
The developed device exhibits > 200 wells and generates 170 unique 
crystallization conditions (due to the outer most wells serving as a control containing 
only one of the components). The device can be easily expanded with more wells or 
scaled-down with less wells (limited by the maximum size and number of wells allowing 
filling without flow/pressure-drop problems). We used relatively large wells of 750 × 750 
× 100 µm to demonstrate that large crystals can be formed, yet each well still contains a 
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volume of ~ 25 nL. Additionally, the individual well dimensions can also be increased or 
reduced to use even less protein (the lower limit approaches ~ 5 × 5 × 5 μm using the 
employed fabrication process).  
We further integrated a developed “doormat” valve system to seal each 
crystallization nanowell. The necessity of these valves is described in more detail below. 
As outlined in red in Figure 8.1, the fluid layer wells were isolated from one another and 
the control layer was positioned to create a pathway between wells when the valve is 
open. Figure 8.2a shows a corresponding cross section schematic of the employed valve 
system whereby three layers of PDMS are sandwiched together. The top fluid layer is 
discontinuous with a wall between entrance and exit channel regions where the valves are 
placed overlapping. The middle layer is a thin membrane of PDMS irreversibly sealed to 
a bottom control layer (and not strongly bonded to the fluid layer) containing channels 
where a negative pressure is applied, causing the thin membrane to deflect downward. 
This in turn creates a flow pathway between fluid layer channels when the valve is 
actuated during filling (Figure 8.2b). The valve is then returned to the normally closed 
state when the vacuum is removed to seal each crystallization well for incubation (Figure 
8.2c). A realization of the valve in the closed state within an actual PDMS device is 
shown in Figure 8.2d where the membrane is flat with the fluid layer, with arrows 
indicating corresponding locations on the cross section schematic. When the valve is 
actuated, the thin membrane deflects as seen by the protrusions in the PDMS in Figure 
8.2e, making the fluid layer continuous and allowing filling to proceed along the pathway 
marked by the red arrow. 
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Figure 8.2. “Doormat” valve schematic applied to PDMS channels and the device 
filling process. a) The three layer device is shown in the normally-closed state with no 
pressure applied, blocking the channels. b) During filling, a vacuum is applied to the 
control layer which allows the thin membrane to deflect downward (due to not being 
strongly bonded to the fluid layer), opening a pathway between the channels for fluid to 
flow (designated by the red arrow). c) Once the device is filled, the vacuum is removed 
causing the thin membrane to return to its original state, isolating the wells from one 
another for crystallization. d) Brightfield image of a PDMS replica when the valve is 
closed showing the blocked channels, marked with corresponding locations on the 
schematic in (a). e) Brightfield image of the PDMS replica of the device when the valve 
is actuated showing the protruded PDMS membrane and red arrow marking the filling 
pathway. The speckles in the wells relate to defects due to the photolithography process. 
 
To determine how a concentration gradient forms within the device, we 
performed numerical modeling mimicking the experimental setup. A first modeling study 
 191 
considered species transport due to convection from a pressure-driven inlet flow and 
diffusion to calculate the steady state filling concentration profile (modeling details can 
be found in the Section 8.2). Using this profile as the initial condition of a second 
modeling study, fluid flow was disabled and a closed boundary condition was established 
at the entrance and exit of each well to represent the closed valve during incubation. A 
time-dependent solution only considering diffusion was then obtained to quantify the 
final concentration profile of each well.  
Figure 8.3a illustrates the overall normalized concentration distribution 
throughout the device, with the broad concentration gradient apparent on a green-scale. 
To confirm the modeling results, we tested whether a similar concentration gradient 
would establish experimentally by filling the device with fluorescein dye in the right inlet 
and water in the left inlet. Figure 8.3b shows fluorescence microscopy images of each 
well in the device demonstrating the fluorescein concentration gradient established 
(concentration increases with brightness), very similar in appearance to the modeled 
concentration profile shown in Figure 8.3a. Resulting concentrations were quantified 
using background corrected, normalized fluorescence intensities averaged across the 
entire well for five trials, where a normalized concentration of 1 represents the initial 
fluorescein concentration (i.e. the control wells to the far right) and 0 is background.  
The obtained values for all 207 wells including the outermost control wells were 
plotted (black dots) with the modeled normalized concentrations (red crosses) in Figure 
8.3c, organized by rows corresponding to the device geometry. While the crosses 
correlate to their nearest neighboring black dot, some discrepancies can be seen, which is 
likely due to flow rate fluctuations in the middle and lower portion downstream of the  
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Figure 8.3. Fluorescein dye calibration. a) Modeled concentration profile of 
fluorescein illustrating the gradient formed. Concentration increases from black to green. 
b) Fluorescence microscopy images showing the experimental gradient of fluorescein. 
Brighter areas are more concentrated. c) Quantified normalized concentrations in each 
well from the fluorescent dye calibration (black dots) and model (red crosses) indicating 
good agreement between the two. Error bars represent standard deviation for 5 trials and 
are smaller than the data point in places they are not seen. d) Plot of quantified 
concentrations from the numerical model comparing the 170 unique concentrations 
obtained from the dye (black squares), lysozyme (red circles), and NaCl precipitant (blue 
triangles). The outermost control wells with no variation are omitted. 
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inlets where flowrates are smallest. This is also apparent by the larger experimental error 
in this region; however, the errors were generally small, indicating the filling procedure is 
robust and reproducible. Furthermore, the modeled and experimentally determined 
concentrations were in good agreement overall. Additionally, we note that the observed 
concentrations remained consistent over several days (data not shown) due to the 
integrated valve system sealing the chambers. 
We further investigated the necessity of the integrated valves quantitatively. 
Numerical modeling with open valves indicated that the concentrations fully equilibrated 
after a period of 5-10 days, ruining the unique concentrations established by the nanowell 
approach (see Appendix C, Figure C-1). With the integration of the valves, 170 unique 
conditions (i.e. ratios between precipitant and protein) were created as shown in Figure 
8.3d. The plot shows correlated concentration pairs in ascending/descending order with 
arbitrary well numbers to illustrate the inverse concentration distribution relationship 
between the protein (red circles) and precipitant (blue triangles) inlet solutions (the 
outermost control wells were omitted for clarity as they have no concentration variation 
due to being at the outside boundaries of gradient generation where no mixing occurs). 
Furthermore, the final concentrations after mixing did not vary significantly between 
lysozyme and fluorescein (black squares) indicating that the establishment of various 
concentrations in each well is mainly dependent on the convective filling process. This 
allows the concentrations obtained with the fluorescein calibration to be used for 
determining protein concentrations in crystallization trials where fluid properties do not 
vary significantly. We also investigated the potential influence of an initial concentration 
gradient within individual wells immediately after the filling procedure at the start of the 
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crystallization incubation phase. With the well dimensions presented in Figure 8.1, the 
diffusion time of a typical protein (𝐷 ~  𝒪(10-11) m2/s) and precipitant (𝐷 ~ 𝒪(10-10) 
m2/s) across the well at the start of the incubation phase is 20-40 minutes and 5-10 
minutes, respectively, which is not significant in the scheme of a multi-day crystallization 
experiment. 
Having determined experimental success in establishing a concentration gradient 
throughout the device, we applied protein solutions with their respective precipitants to 
attempt to crystallize them and determine nucleation conditions in the crystallization 
phase space. We first investigated lysozyme as it is a commonly used model protein for 
proof of concept studies with NaCl as the precipitant. The device was loaded with each 
solution via the separate inlets as described previously. Since both solutions were clear, 
qualitative confirmation by imaging that the concentration gradient established was not 
possible as in the case of fluorescein, thus the results from the dye experiments were used 
as a reference to determine the concentrations in the device (see above). It should be 
noted that dyes can be incorporated into tolerant crystallization systems to aid 
visualization, however, they were not used in this study to demonstrate that they are not 
required. Once filled, the device was incubated for two days for the crystallization 
process to proceed. 
Figure 8.4a shows a brightfield microscopy image of the wells after incubation 
whereby crystals are shown to have formed in a distinct region where nucleation 
conditions were established (highlighted by multicolored boxes), also indicating that the 
concentrations throughout the device were different and did not equilibrate due to leakage 
or lack of gradient generation. To further clarify the varying regions of the phase space  
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Figure 8.4. Results of lysozyme crystallization. a) Brightfield image of a lysozyme 
crystallization trial after 2 days showing a distinct region where macroscopic crystals 
grew as highlighted by multicolored boxes. b) Zoomed-in images of several unique 
conditions showing a precipitant-only case where a clear solution in the well is observed 
under brightfield and UV fluorescence, (c) a nucleation case where crystals are observed 
and confirmed to be proteinaceous from the UV signal, and (d) a protein-only case where 
a clear solution in the chamber is observed under brightfield, yet a UV signal is emitted 
from the protein molecules. e) Experimental nucleation conditions where crystals were 
observed plotted within a lysozyme phase diagram previously reported by Hekmat et 
al.364 (reproduced with permission), indicating good agreement of the nucleation region. 
The points are color-coded to match the colored boxes in each row in (a) and individual 
wells can be pinpointed using the concentration trends of lysozyme and NaCl. 
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polled in the device, Figure 8.4b-d shows images of zoomed-in wells with unique 
characteristics. Figure 8.4b represents a well on the top left expected to only contain 
precipitant and has no apparent crystals in the brightfield image and no UV signal, 
confirming no protein is present (this would constitute the extreme oversaturated region 
of the phase diagram). Figure 8.4c highlights a well with favorable nucleation conditions 
for crystallization where large lysozyme crystals (P43212 space group
365) are clearly 
visible and confirmed to be protein crystals by the UV signal. Furthermore, crystals grew 
throughout the well, indicating the two solutions were well-mixed. Lastly, Figure 8.4d 
provides a zoom-in of a well located at the bottom right of the device expected to contain 
only protein (constituting the extreme undersaturated region of the phase diagram). The 
brightfield image is indistinguishable from the first scenario, however the UV image 
shows a bulk signal from the non-crystallized lysozyme molecules in solution.  
To determine the nucleation concentrations of the protein and precipitant, we used 
the experimental calibration plot from Figure 8.3c. The corresponding modeled 
concentration profiles for lysozyme and NaCl are shown in Appendix C, Figure C-2. 
Wells where crystals were observed were marked and using the calibrated well 
concentrations, the nucleation concentrations were calculated. This equated to a lysozyme 
concentration range of 18-40 mg/ml and a NaCl concentration range of 29-92 mg/ml, 
respectively. As an established system, we were able to check whether the results of our 
screening procedure were in agreement with previous studies. The obtained nucleation 
conditions are plotted as multicolored circles in Figure 8.4e and overlaid onto a phase 
diagram reported by Hekmat et al.364 for lysozyme crystallized with NaCl in a sitting 
drop.  Each point is color-coded to match the rows in Figure 8.4a, and individual wells 
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can be pinpointed using the concentration trends of lysozyme and NaCl. As shown, our 
nucleation zone is in excellent agreement with this prior study, with a few points 
extending into the reported ‘metastable’ zone that is still beyond the protein solubility 
limit, and none extending into the reported ‘undersaturated’ or ‘precipitation’ zones. We 
remark that the errors reported by Hekmat et al. for the supersolubility curve (as 
indicated in Figure 8.4e) are likely the reason for the overlap of observed protein 
crystallization into the metastable phase.  
A second test of the crystallization device was performed with the pigment 
protein complex phycocyanin (PC), which is a study target at emerging XFEL sources 
due to its implications in photosynthesis. Furthermore, PC can crystallize with a different 
precipitant, PEG, which is viscous and commonly used for protein crystallization. When 
used with PC at optimal concentrations, microcrystals can be formed for SFX at 
XFELs.366 However, to our knowledge, quantitative phase diagrams for PC/PEG have not 
yet been reported. 
The procedure to fill and incubate was performed as described for the other 
experiments but a different imaging technique was employed. PC crystals are second-
harmonic generation microscopy active (H32 space group367) which allowed us to 
perform second-order nonlinear imaging of chiral crystals (SONICC)232, 233 to confirm the 
presence of protein crystals as small as 100 nm with high confidence. SONICC is a 
powerful imaging technique that utilizes the frequency doubling of light that occurs in 
crystals of chiral molecules such as proteins and does not occur in most salt crystals and 
protein molecules in solution or in the form of amorphous aggregates. The signal-to-noise 
ratio depends on the space group, where the signal strength of high symmetry space 
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groups are very weak (this is the reason why lysozyme crystals feature an extremely 
weak signal and cannot be imaged by SONICC).  
 
 
Figure 8.5. Results of PC crystallization. a) SONICC image of a PC crystallization 
trial after 2 days showing a distinct region where crystals grew as highlighted by 
multicolored boxes. b) Zoomed-in images of several unique conditions showing a 
precipitant-only case where nothing is observed under brightfield and SONICC, (c) a 
nucleation case where crystals are observed and confirmed to be proteinaceous from the 
SONICC signal, and (d) a protein-only case where solid blue is observed under 
brightfield and no SONICC signal is apparent. e) A region of phase space showing 
conditions where crystals were observed, color-coded to match the rows in (a). Individual 
wells can be pinpointed using the concentration trends of PC and PEG. 
 
The microfluidic device is compatible with SONICC imaging279 as seen in Figure 
8.5a, which shows the entire array of wells after 2 days of PC crystallization. As before, a 
distinct zone where crystals formed is present (highlighted by multicolor boxes) as 
indicated by the bright SONICC signal. The crystals that formed were much smaller than 
those observed for lysozyme (likely showers of microcrystals and nanocrystals) due to 
the precipitant type and optimal concentration range screened, as we aimed to optimize 
conditions for nano/microcrystallization of PC for SFX experiments. For a detailed view, 
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Figure 8.5b-d shows zoomed-in images of several example wells similar to those shown 
for lysozyme. Figure 8.5b exhibits a precipitant solution-only case with a brightfield 
image void of the visibly blue PC protein and no SONICC signal as expected. In Figure 
8.5c, a well where nucleation conditions are present and crystals were observed shows a 
clearer view of the blue nano/microcrystal shower in the brightfield image with a bright 
corresponding SONICC signal confirming small nano- and micro-sized protein crystals 
as opposed to salt or amorphous protein precipitate. Lastly, Figure 8.5d represents a 
protein-only case showing a solid blue brightfield image with no SONICC signal from 
the non-crystallized protein molecules in solution. 
Because the PEG solution has a significantly higher viscosity than the aqueous 
protein solution (which affects the fluid dynamics during the filling step and thus the 
established concentration gradient), we developed a model to more accurately quantify 
the conditions present in the wells where PC crystals were observed. When solution 
properties are known, a crystallization system (protein and precipitants) can be readily 
calibrated using a model adapted to changing experimental inputs (e.g. applied inlet 
pressures, channel designs/dimensions, etc.), allowing tedious, incremental experimental 
calibration to be avoided. In the case of PC/PEG, a viscosity blending function was 
incorporated into the model as a component of solving the flow profile throughout the 
device to determine the concentration profile of each crystallization well (details of 
changes to the model and a figure of the viscosity profile implemented can be found in 
Appendix C). When considering viscosity, the less viscous protein solution yields a > 0.5 
normalized concentration in more wells compared to the constant viscosity case, which is 
expected due to a lower viscous flow resistance. From the model, nucleation conditions 
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were determined at PC concentrations of 8-22 mg/ml and PEG concentrations of 2-12% 
(w/v). To illustrate the relationship between the protein and precipitant and the nucleation 
regime uncovered, a region of phase space was constructed in Figure 8.5e with dotted 
arrows pointing toward the likely direction of neighboring phases. Additionally, each 
point is color-coded to match the rows in Figure 8.5a, and individual wells can be 
pinpointed using the concentration trends of PC and PEG. Since crystallization of PC 
with PEG has not been systematically studied previously, this nucleation region could be 
used as a foundation for further systematic studies and crystal optimization with different 
protein and precipitant concentration ranges. 
 
8.4. Conclusions 
We demonstrated a novel proof of concept microfluidic device to systematically 
crystallize proteins with nanoscale volumes of sample per trial comparable with current 
generation high-throughput screening platforms. The device utilizes a gradient generator 
to establish many unique concentrations of protein and precipitant and is easily scalable 
in the number of conditions, sample volume requirement, and number of inlet solutions 
for multidimensional precipitant screening. A “doormat” valve was incorporated to 
isolate each crystallization chamber to maintain a global concentration gradient over 
several days. Calibration with fluorescein dye exhibited successful concentration gradient 
generation quantitatively in agreement with a numerical model of the device. Two 
proteins were tested in the device and were successfully crystallized as observed by 
brightfield, UV, and SONICC imaging. Quantitative analysis of the conditions where 
crystals were observed provided nucleation conditions in agreement with those 
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previously reported for lysozyme and uncovered a portion of the PC/PEG phase space. 
Large crystals of lysozyme formed with the addition of a NaCl precipitant and PC 
produced micro/nanocrystal showers using a viscous PEG precipitant, which also 
demonstrated the versatility of the device with various common precipitants. To 
adequately model crystallization screens with varying viscosity, we also demonstrated the 
adaptation of a numerical model for the PC/PEG system. From this initial proof of 
concept study, the device can be readily used for protein crystallization screening in a 
wide range of laboratory settings and with a variety of proteins due to cheap and rapid 
fabrication, simple operation, and low sample volume requirements. Compatibility with 
most protein crystal imaging technologies also allows for straightforward visualization of 
crystal screening trials to determine crystal characteristics for X-ray crystallography. 
Furthermore, this device can enable studying the relationships between crystallization 
conditions and crystal growth characteristics (e.g. number and size), which is important 
in selecting optimal protein crystals for both traditional crystallography and SFX. 
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CHAPTER 9 
CONCLUDING REMARKS 
 
9.1. Dissertation Summary 
Throughout this work, several microfluidic devices were demonstrated 
accomplishing a variety of tasks for two main objectives: fractionation of protein crystals 
into desired size groups for SFX and to provide an efficient protein crystallization 
screening platform. The former was initially accomplished with a proof of concept novel 
sorter for nanoparticles and microparticles employing nDEP using an insulating material 
to generate electric field gradients. The high gradients allowed large particles to deflect 
away from the walls of a constriction channel toward the center of the device while small 
particles less influenced by nDEP flowed into offset collection channels for fractionation. 
Numerical modeling of the sorting device first suggested its suitability to fractionate 
submicrometer particles from micrometer particles, which was then confirmed 
experimentally using a model bead system. The device was also able to separate a 
narrowed size distribution of intact submicrometer protein crystals from a bulk 
suspension with a wide size distribution, as confirmed by dynamic light scattering. 
Brightfield microscopy also indicated differences in the outlet channel size distributions 
and SONICC imaging indicated the protein remained crystalline postsorting. To 
efficiently apply the sorting process to actual SFX experiments requiring a relatively 
large minimum sample volume, the device was scaled-up to operate in high-throughput. 
A device geometry optimization scheme using numerical modeling was demonstrated in 
which optimal geometrical parameters yielding a high sorting efficiency were 
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determined. Models were also developed to investigate the relationship between 
adjustable parameters and sorting efficiency as well as sorting different particle size 
ranges. This second-generation, scaled-up device was then applied to sort submicrometer 
particles from microparticles with high sorting efficiencies, as indicated by dynamic light 
scattering. 
The goal of fractionating protein crystals was to improve SFX samples, thus 
beamtime was acquired at the XFEL located at LCLS in the SLAC National Accelerator 
Laboratory. The second-generation sorting device was used to isolate a significant 
amount of submicrometer proteins crystals measured using two dynamic light scattering 
instruments and NanoSight particle tracking, indicating the sorting process was robust 
and reproducible. Further characterization studies were performed to show that the 
sample remained crystalline as it passed through the sorter (as confirmed by SONICC 
imaging) and the crystals remained highly ordered (as confirmed by TEM imaging). The 
sample also successfully produced diffraction patterns upon delivery into the XFEL 
beam, and produced detailed diffraction patterns with features known as shape 
transforms, which can be used for crystallographic phasing. Furthermore, simulations of 
large SFX datasets from narrowed, submicrometer and widely distributed protein crystal 
suspensions were compared, indicating the crystals from the former group can provide 
accurate data using fewer patterns and > 3500-fold less protein. This supported the 
original objective of using microfluidic sorting to positively impact SFX data analysis. 
For protein crystallization, two different microfluidic devices employing two 
different crystallization methodologies were developed and demonstrated. The first 
device consisted of a linear microchannel with nanoscale volume capacity where protein 
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was added. Precipitant was added to an opposite end and allowed to diffuse through the 
protein solution in the channel to establish a concentration gradient polling the 
crystallization phase space. The device was tested with the membrane protein PSI which 
crystallizes using a salting-in approach (salt is removed from the protein solution). 
Several time durations were examined in which crystal formation was observed after 3, 6, 
and 10 days of incubation as confirmed by two compatible crystal imaging techniques: 
brightfield microscopy and SONICC imaging. Furthermore, crystal characteristics were 
shown to vary with location in the channel where different conditions were present, 
following expected trends (high ionic strength gave few large crystals and low ionic 
strength gave many small crystals). The processes occurring within the device were 
numerically modeled, in which concentration profiles within the channel at various time 
points were determined. By comparing the modeled concentrations to observed crystal 
growth locations at respective time points, part of the phase diagram for PSI was 
constructed and reported with nucleation conditions in agreement with literature values. 
Nucleation conditions were also determined for two other proteins, lysozyme and 
phycocyanin, in good agreement with literature values. These results indicated that the 
device could produce accurate phase diagrams and the numerical model was 
representative. 
The second crystallization method implemented in a microfluidic platform relied 
on directly mixing the protein and precipitant solution, also known as batch 
crystallization. Mixing was performed using a modified microfluidic gradient generator 
design in which two inlets for protein and precipitant split and recombined throughout an 
array of channels. Each junction was bridged by a nanovolume crystallization well with 
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unique solution concentrations for crystal growth. The number and size of the wells can 
be scaled to adjust screening throughput and sample volume requirements in addition to 
changing the number of inlet solutions for multidimensional precipitant screening. Each 
well was isolated by implementing elastomer valves at every entrance and exit channel in 
order to maintain the unique concentrations. The process was first tested using a 
fluorescent dye in which a concentration gradient established experimentally. A 
numerical model of the gradient formed within the device was also developed and was in 
good agreement with the experimental concentration profile. The device was also tested 
with two proteins to examine its crystallization capabilities in which lysozyme and 
phycocyanin crystallized in a distinct region within the device, as observed by several 
compatible imaging techniques: brightfield microscopy, UV fluorescence, and SONICC 
imaging. Using the dye calibration and numerical model, concentrations where crystal 
growth was observed for both proteins were determined and used to quantify part of the 
phase space of both proteins. For lysozyme, the addition of NaCl salt caused large 
crystals to grow at concentrations in agreement with literature values. Phycocyanin was 
mixed with a viscous PEG precipitant which caused showers of microcrystals to form and 
a modified numerical model considering viscosity was developed for quantification. 
Combined, this demonstrated that the device can be reliably used as a versatile 
crystallization screening tool for systematic studies. 
 
9.2. Impact on Crystallography 
Few groups are working on optimizing crystal characteristics for SFX, with the 
majority working toward reducing sample consumption during delivery into the XFEL 
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using more viscous media to decrease flow rate,333, 368 flow-focusing jets to reduce the 
diameter of the stream,369 pulsed jets with droplets to synchronize the sample with the 
beam frequency,370 and fixed target systems where crystal location is controlled with 
respect to the X-ray beam.371, 372 While important, reducing sample consumption has no 
effect on reducing the amount of data needed for an accurate structure or attaining 
diffraction patterns with detailed features (e.g. shape transforms). This objective is 
accomplished with protein crystals of certain characteristics that reduce the randomness 
of data collection and address the crystallography phase problem to avoid the requirement 
of a predetermined structure from the PDB (i.e. for molecular replacement). There are 
attempts to improve crystal characteristics through modification of traditional 
crystallization techniques to establish controlled protocols yielding a targeted crystal 
type.235, 332 However, crystallization is inherently the major bottleneck of crystallization 
and growing any crystal is already a huge feat, thus achieving this goal in a reasonable 
amount of time requires high-throughput crystallization screening. Sorting crystal 
samples can reduce sample consumption, isolate crystals with desired characteristics 
based on the sorting mechanism, and be applied to any sample delivery method of choice. 
Furthermore, microfluidic platforms are capable of efficient crystallization screening, 
making this a complementary method for optimizing crystal samples for SFX. 
The first-generation proof of concept device provided an optimized sample for 
SFX that could have been applied to an SFX experiment (pending an award of nearly 
priceless beamtime). While still in its early stages, this device already demonstrated the 
desired capabilities. Yet, some aspect of the process can always be improved, in this case 
the throughput to achieve an adequate amount of sample in a reasonable amount of time. 
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This led to the development of the second-generation device which was again tested 
extensively to reach the goal of producing an optimized sample for SFX. At this stage, 
beamtime was awarded and the sample extracted from the device was applied to a real 
world application. The protein crystals that had traveled through the entire process of 
sorting and characterization still diffracted, now indicating that the sample remained 
viable for SFX and the optimization process could have a direct impact on the field. The 
follow-up discussion on the ways optimized crystal samples could be beneficial to SFX 
data analysis were discussed in detail in Chapter 6. Additionally, a large SFX dataset was 
simulated to further illustrate the impact of microfluidic sorting on SFX data analysis, 
namely reducing sample amount and the number of diffraction patterns required for an 
accurate dataset. A greater impact will stem from increased adoption and awareness to 
begin integrating these technologies into a variety of SFX experiments from various 
groups. 
Improved protein crystallization screening by means of the two devices discussed 
can also have a significant impact on crystallography in general, and not just SFX. 
Furthermore, adoption should be easier to implement due to avoiding the hurdle of 
obtaining rare beamtime at an XFEL. As mentioned before, the characteristics of the 
devices include cost-effectiveness, simplicity, and fabrication with accessible materials in 
common laboratory settings. Their performance is also on par with extremely expensive 
equipment such as robotic systems, yet use a fraction of the resources. Additionally, the 
devices can be operated with minimal extraneous equipment and the equipment that is 
required is accessible to a wide range of laboratories. In the manner current major 
techniques and tools for crystallization became widespread, microfluidic devices should 
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follow suit and become a major player in this area of research. In both devices presented, 
a large portion of the crystallization phase diagram can be obtained with a few 
experiments, which reduces the major bottleneck of crystallography to reach the end goal 
of efficient protein structure determination. Furthermore, a variety of proteins can be 
studied which broadens the impact of this technology. If the literature is any indication, 
microfluidic devices are becoming increasingly popular to the field of crystallography 
and should continue to grow with more innovation and development.  
 
9.3. Future Directions 
The projects described herein have a defined workflow of progression governed 
by milestones. Milestones were described in detail in each chapter and summarized in 
Section 9.1. However, science operates on the basis of continued innovation using the 
foundations of work that has been presented to the community through publication or 
other means. For sorting, there are several avenues that could be explored to improve the 
currently developed methods in addition to developing new technologies. Important 
characteristics of microfluidic platforms are ease of fabrication (e.g. robust elastomer 
molding processes) and simplified experimental setups (e.g. common voltage and 
pressure sources) to promote widespread adoption. Progression of the sorting project 
would involve applying the process to other proteins to improve samples for a variety of 
SFX experiments, including proteins in high ionic strength buffers. In this case, applied 
voltages would need to be tuned to avoid overheating effects in tandem with adjusting 
device operation, for example, by using capacitive coupling of PDMS in contactless DEP 
(cDEP). Furthermore, pressure-driven flow could be implemented with an AC electric 
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field to decouple the flow and particle transport phenomena, allowing more tunability of 
the applied voltages. With this level of versatility, the sorting mechanism could also be 
applied to other biological samples such as DNA or carbon nanotubes for applications 
related to those analytes. 
Extraction of the fractionated samples from a microfluidic device can also be 
further developed to make the process more seamless and automated. One way this could 
be accomplished is by directly coupling the sorting device to an SFX sample injector 
(either externally or coupled on-chip) such that sorting operates in a continuous mode 
with direct injection of sorted crystals into the XFEL. This would require a high degree of 
synchronization and compatible flow rates between the sorting device and sample 
injector, but would minimize sample loss and lag time from transferring the sample to 
ensure freshness and consistency. 
The sorting device can also be optimized to fractionate more narrow size 
distributions with better control of the exact size distribution being fractionated based on 
the needs of a given application. As discussed in Chapter 5, through numerical modeling, 
increasing the ratio of the inlet channel width with respect to the constriction width 
induced higher electric field gradients, increasing the DEP force. This would allow 
smaller particles to experience more nDEP repulsion which could change their pathway 
from a deflection profile to a focused profile, thus reducing the maximum particle size 
traveling into the side channels. Physical factors would need to be taken into 
consideration to avoid clogging the device, which would require an experimental study 
with several different particle sizes and appropriate detectors and analytical equipment. 
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Additionally, multiplexing the sorting device could achieve various size fractions 
in a controllable fashion. Fractions collected from a single sorting event could be resorted 
iteratively, or serially coupling two (or more) sorters in tandem would allow a first 
sorting event to occur to fractionate a range of particle sizes, followed by the central 
channel (or other outlet channel) solution being sent into a second sorting structure for 
further fractionation. The geometries of each sorting section could be tuned 
independently to acquire different size fractions at each checkpoint. For example, 
assuming a scenario with just two sorting devices connected, three different fractions 
could be isolated: The first deflected solution, the second deflected solution, and the 
solution focused through the second central outlet channel.  
For the case of microfluidic crystallization, two different processes were explored 
and implemented. In both cases, the overarching goal of protein crystallization screening 
is to develop a phase diagram for the protein of interest which provides a picture of the 
crystallization phase space for a given protein and precipitant. Phase diagrams are 
invaluable not only for the protein they represent but also as an aid in determining initial 
steps toward crystallizing similar proteins. The benefit of microfluidic crystallization is 
once again the low sample volume requirement, making it feasible to create multiple 
phase diagrams for a given protein with minimal resources. This would be the most 
important direction to take this project, as both of the developed devices could be used in 
parallel for screening by two unique crystallization pathways (diffusion and batch), 
affording the crystallographer the option of choosing the best technique for their 
application. 
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Parallelization also becomes a key here and is another strong point of microfluidic 
devices. In many cases, crystallization screening can take thousands of trials to find one 
adequate condition. Both of the demonstrated devices are easily capable of being 
parallelized and automated. For the diffusion-based system, multiple linear channels 
could be set up on a single chip, with a variety of independent inlets controlled by valves 
providing various proteins and precipitants. Regarding the nanowell device, it was 
designed to be scalable due to the huge variety of requirements crystallization screening 
can endure. The number of inlets can be changed to allow multiple precipitants to be 
applied, the number of wells can be increased or decreased to adjust the number of 
conditions screened per device, the well geometries can be changed to adjust flow 
profiles and sample volume requirements per screen, among other options. Any of these 
can further increase the efficiency of screening regarding both time and precious sample 
requirements. 
A systematic study of crystal characteristics is also becoming important with the 
maturation of SFX and can be accomplished with further complex designs nearing Lab-
on-a-Chip status. The developed screening approaches demonstrated some dependence of 
the crystal size and number on the solution conditions, but controlled growth of crystals 
in microfluidic devices should also be possible using different reactions at different time 
points with controlled fluid flow and crystal transport. In this case, “designer crystals” 
could be grown in a controlled fashion with characteristics for the application at hand.  
It becomes apparent that the directions both projects can be taken are multifaceted 
and are driven by the creativity of the investigator. Depending on the situation, either of 
the overlying microfluidics approaches demonstrated throughout this dissertation (sorting 
 212 
or crystallization screening) can be applied to improving protein crystallography and 
advancing the processes of protein structure determination.
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Within this Appendix, we provide concentration profiles corresponding to data 
presented in Table 5.2 and Figure 5.6 of Chapter 5, plus an interesting prediction model. 
In Figure A-1, concentration profiles for θ = 90°, 115°, and 135° are shown under 
conditions for sorting micro (2.5 µm) and nano (500 nm) particles. In Figure A-2, 
concentration profiles are shown for intermediate particles sizes (250 nm, 500 nm, and 
750 nm) studied using both constriction widths (50 µm and 150 µm) for sorting within 
the nano regime. In Figure A-3, a 2D voltage correlation model between VI and VS is 
presented illustrating the possibility of predicting these voltages to attain high Σ for 
micro/nano and nano sorting. All models were set up as described in Subsection 5.2.1 of 
Chapter 5. 
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Figure A-1. Concentration profiles of geometries with varying θ. The left half contains 
profiles for nanoparticles (500 nm) and the right contains profiles for microparticles (2.5 
µm). Deflection of nanoparticles occurs for all θ values; however, the degree of 
microparticle focusing varies, leading to a decline in Σ as θ increases. Furthermore, VS 
increases as θ increases to achieve a non-zero sorting efficiency. In all cases, VI = +200 V 
and VC = -750 V (See Table 5.2 in Chapter 5 for Σ and VS values). 
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Figure.A-2. Concentration profiles of intermediate nano regime sizes investigated for 
their sorting potential with respect to 1000 nm particles. On the left half, profiles of each 
size in the 50 µm constriction device are shown and on the right, profiles of each size in 
the 150 µm constriction device are shown. In all cases, the focusing effect amplifies as 
particle size increases; however, this trend is more prominent in the 50 µm constriction 
device due to larger ∇𝑬2 values within the constriction (See Figure 5.3c in Chapter 5). 
The 150 µm constriction device does not provide any appreciable sorting condition as 
indicated by significant deflection of all particle sizes (this is even true for sorting 100 
nm particles from 1000 nm particles as shown in Figure 5.4 of Chapter 5). 
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Figure A-3. Voltage relationships yielding high sorting efficiency. To aid in the 
development of optimal voltage schemes for high sorting efficiencies, we explored 
whether more advanced predictability of two unique channel voltages was possible when 
the voltage of one channel reservoir was set. For this study, we set VC to the discussed 
baseline potential schemes developed for micro/nano (2.5 µm/500 nm) sorting with the 
150 µm constriction (VC = -750 V) and additionally for nano (1 µm/100 nm) sorting with 
the 50 µm constriction (VC = -2250 V). For completeness, potentials schemes were 
inversely increased and decreased away from the baseline VI and VS determined for 
micro/nano and nano sorting (i.e., when VI is increased, VS is decreased due to the trends 
observed earlier in Figure 5.2) until a Σ > 90% was achieved at a different combination. 
The voltage range tested was broad: for micro/nano sorting, VI = 0 to +400 V and 
VS = -50 to -280 V; for nano sorting, VI = 0 to +1200 V and VS = -245 to -935 V. The 
VI/VS combinations giving a Σ > 90% are plotted (holding VC constant). An important 
trend is apparent in both cases, in that there is a highly linear relationship (R2 = 0.99) 
between the two channel voltages. The regression lines have the same slope (0.58), 
indicating a direct upscaling of the voltage schemes with respect to constriction 
width/sorting resolution, thus confirming a consistent sorting mechanism. 
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This Appendix contains the results for microfluidic crystallization of phycocyanin 
and lysozyme using the method described in Chapter 7. We present experimental data in 
the form of bright-field and UV-two photon fluorescence imaging for lysozyme (Figure 
B-1) and bright-field and SONICC imaging for phycocyanin (Figure B-3). We also 
present numerical modeling for concentration profiles of lysozyme (Figure B-2) and 
phycocyanin (Figure B-4) for quantitative analysis of crystallization conditions for both 
proteins. The respective diffusion coefficients for the models are given in Tables B-1 and 
B-2. Using the same analysis described in Chapter 7, we report crystallization conditions 
for both lysozyme and phycocyanin which are in excellent agreement with nucleation 
zone conditions reported in previous literature. 
 
Methods 
Briefly, lysozyme (Sigma Aldrich, USA) was suspended in 0.1 M sodium acetate 
buffer (pH 4.6) at a concentration of 50 mg/ml. The precipitant used was 2.5 M (145 
mg/ml) NaCl in the same buffer. 5 µl of each protein and precipitant were added to the 
microchannel reservoir, and the crystallization procedure was performed as described in 
Chapter 7. 
Phycocyanin was extracted from the cyanobacterium Thermosynechococcus 
elongatus. Briefly, the cells were disrupted using a microfluidizer. Cell debris and 
membranes were removed from the supernatant as described in Zouni et al. 2000.373 The 
supernatant was further purified by ultracentrifugation (Type 70Ti Rotor, Beckman, 
USA) at 50,000 rpm for 1 hour. The supernatant was concentrated by spin centrifugation 
using 100 kDa ultrafiltration devices (Millipore, USA) by a factor of 50 to an OD620nm 
 242 
of 30. During this step, small proteins present in the supernatant are removed as they are 
not retained.  Further concentration of phycocyanin was performed using ultrafiltration 
devices (Microcon®, Millipore, USA) to a concentration of 30 mg/ml as determined by 
absorbance spectrophotometry. The precipitant used was 2 M ammonium sulfate in 80 
mM MES buffer (pH 6.1). 5 µl of each protein and precipitant were added to the 
microchannel reservoir and the crystallization procedure was performed as described in 
Chapter 7. 
Imaging was performed using the SONICC instrument (Formulatrix, USA) and 
numerical solutions were performed with COMSOL Multiphysics 4.3 in the same manner 
described in Chapter 7 using the parameters provided in Tables B-1 and B-2. 
 
Results 
Lysozyme: To study the crystallization of lysozyme, we used bright-field microcopy and 
UV two-photon fluorescence to detect lysozyme crystals in the microchannel. We used 
UV-two photon fluorescence (an additional capability of the SONICC instrument) 
because lysozyme crystallizes in the space group P43212, which is highly symmetric (thus 
is SONICC inactive),232, 233 making SONICC imaging of crystals in the channel not 
possible. Due to the crystallization of lysozyme (and phycocyanin) occurring at high 
ionic strength (compared to PSI which is crystallized by decreasing ionic strength), the 
nucleation region shifted to the opposite side of the channel close to the protein reservoir 
(x = 3 cm). 
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Figure B-1. Crystallization of lysozyme in the microfluidic channel after 2 days. 
Above frame shows the bright-field image sequence and the bottom frame shows the UV-
two photon fluorescence image sequence. Crystals formed at positions between 2.3  3 
cm along the channel (distance away from gelled reservoir).  
 
Table B-1. Numerical modeling parameters for lysozyme and the precipitant ions. 
Species 𝑫𝒄𝒉𝒂𝒏𝒏𝒆𝒍 (m
2/s) 𝑫𝒈𝒆𝒍 (m
2/s) 
   
Na324 1.3×10-9 1.3×10-9 
Cl324 2.0×10-9 2.0×10-9 
Lysozyme358 1.4×10-10 1.1×10-10 
 
 
Figure B-2. Concentration profiles obtained from numerical modeling for lysozyme 
and the two precipitant ions. 
 
Quantification of the 2 day crystallization experimental data gave the following 
nucleation zone concentration ranges which are in excellent agreement with nucleation 
conditions reported by Hekmat et al.:364  
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Lysozyme: ~ 24.8  25 mg/ml 
NaCl: ~ 55  72.5 mg/ml 
 
Phycocyanin 
 
Figure B-3. Crystallization of phycocyanin in the microfluidic channel after 3 days. 
Above frame shows the bright-field image sequence and the bottom frame shows the 
SONICC image sequence. Crystals formed at positions between 2.5  3 cm along the 
channel (distance away from gelled reservoir). 
 
Table B-2. Numerical modeling parameters for phycocyanin and the precipitant ions. 
 
Species 𝑫𝒄𝒉𝒂𝒏𝒏𝒆𝒍 (m
2/s) 𝑫𝒈𝒆𝒍 (m
2/s) 
   
NH4
324 1.96×10-9 1.96×10-9 
SO4
324 1.07×10-9 1.07×10-9 
Phycocyanin325, 374 4.73×10-11 4.73×10-11 
 
 
Figure B-4. Concentration profiles obtained from numerical modeling for phycocyanin 
and the two precipitant ions. 
 
 245 
Quantification of the 3 day crystallization experimental data gave the following 
nucleation zone concentration ranges which are in excellent agreement with nucleation 
conditions reported by Saridakis et al.:375  
 
Phycocyanin: ~ 15 mg/ml 
(NH4)2SO4: ~ 0.83  1 M 
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This appendix contains Figures C-1, C-2, and C-3 which are referred to in 
Chapter 8 in appropriate sections. We show a numerical model illustrating the negative 
effect omitting the valve has on the concentration gradient over time, as well as the 
negligible difference in the concentration gradient of lysozyme compared to fluorescein 
since diffusion coefficients do not significantly impact device filling. Additionally, we 
show the modeled viscosity profile utilized for the Phycocyanin/PEG crystallization 
analysis in Figure 8.5 of Chapter 8 and provide specific details of the model. 
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Figure C-1 shows the concentration changes in the device over a period of 10 days when 
valves are not included to seal the crystallization chambers. Results were obtained with 
the COMSOL model described in Chapter 8, but allowing diffusion throughout the entire 
device after filling. 
 
Figure C-1. Modeled concentration profile time series with open valves over 10 days 
showing a concentration change throughout the device until an equilibrium normalized 
concentration of 0.5 is eventually reached due to diffusion. This occurs when all channels 
are open to one another without the valve system. A globally changing concentration 
gradient would not allow for individual crystallization trials to occur.  
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Figure C-2 shows the normalized concentration distributions of lysozyme and NaCl as 
obtained from the COMSOL model described in Chapter 8. The concentration gradient 
created for both the protein and precipitant is clearly visible.  
 
 
Figure C-2. Modeled concentration profiles of lysozyme and NaCl precipitant (a and 
b, respectively) with inlets marked accordingly. Models were set up as described in 
Subsection 8.2.4 of Chapter 8 using a constant value for viscosity (assumed as water). 
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Figure C-3 shows the viscosity profile obtained with and without the adapted COMSOL 
model taking into account a ~ 6 fold larger viscosity of the PEG-based precipitant 
compared to the protein solution. The model changes are described below. 
 
 
Figure C-3. Modeled viscosity profile (a) without considering any significant viscosity 
difference between the inlet solutions and (b) considering the significant difference in 
viscosity between the Phycocyanin protein solution and the PEG-based precipitant. Due 
to viscous resistance, the lower viscosity protein solution has a more significant 
contribution to the profile. 
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Modeling was performed as described in Subsection 8.2.4 of Chapter 8, but the 
solution viscosity was changed in the Creeping Flow module in COMSOL from a 
constant value to the following viscosity blending function:376 
ln(𝜂) = 𝑥1ln(𝜂1) + 𝑥2ln (𝜂2) 
where 𝜂 is viscosity and 𝑥 is the fraction of the component. The numbers 1 and 2 denote 
Components 1 and 2, respectively. Component 1 was designated as aqueous protein 
solution with a viscosity of 0.001 Pa·s and Component 2 was designated as 17.5% w/v 
PEG3350 with a viscosity of 0.0058 Pa·s as calculated by fitting data from Ninni et al.377  
Appropriate diffusion coefficients were also applied to the Transport of Diluted 
Species module in COMSOL. The diffusion coefficient of Phycocyanin374 was set to 
4.73×10-11 m2/s and PEG378 was set to 1.92×10-10 m2/s. 
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